<SEC-DOCUMENT>0000355019-23-000031.txt : 20230515
<SEC-HEADER>0000355019-23-000031.hdr.sgml : 20230515
<ACCEPTANCE-DATETIME>20230515161732
ACCESSION NUMBER:		0000355019-23-000031
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		60
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230515
DATE AS OF CHANGE:		20230515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		23922693

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar_10-q.htm
<DESCRIPTION>FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2023
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:FONR="http://fonar.com/20230331">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_FONR_fonar.com_20230331 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20220701_20230331 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0wNi0zMA== -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DDocumentFiscalYearFocus_2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentFiscalPeriodFocus_Q3 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:CurrentFiscalYearEndDate">--06-30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
  <ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2022-06-30" id="xdx2ixbrl0068" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParty" contextRef="AsOf2022-06-30" id="xdx2ixbrl0131" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember" id="xdx2ixbrl0194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" id="xdx2ixbrl0196" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0214" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" id="xdx2ixbrl0216" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" id="xdx2ixbrl0256" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember" id="xdx2ixbrl0274" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-01-012022-03-31" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0693" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0697" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0699" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0703" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0705" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0707" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0711" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0715" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0719" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0723" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0727" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0729" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0731" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0733" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0739" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0741" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0743" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0745" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0775" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0777" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0781" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfNonControllingInterest" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0785" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfNonControllingInterest" contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0789" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfNonControllingInterest" contextRef="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0791" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0797" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0799" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0801" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0803" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0809" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0811" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0813" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember" id="xdx2ixbrl0815" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2022-07-01to2023-03-31" id="xdx2ixbrl0854" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInContractAssets" contextRef="From2022-07-01to2023-03-31" id="xdx2ixbrl0866" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-07-01to2023-03-31" id="xdx2ixbrl0875" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2022-07-01to2023-03-31" id="xdx2ixbrl0896" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:PurchaseOfNoncontrollingInterests" contextRef="From2022-07-01to2023-03-31" id="xdx2ixbrl0911" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2021-07-012022-03-31" id="xdx2ixbrl0927" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" id="xdx2ixbrl1037" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" id="xdx2ixbrl1041" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" id="xdx2ixbrl1119" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" id="xdx2ixbrl1123" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember" id="xdx2ixbrl1163" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember" id="xdx2ixbrl1169" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" id="xdx2ixbrl1193" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl1326" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl1330" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1475" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1505" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1535" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20230331.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-01to2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-05_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-05_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-05_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-05_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CommonStockMember259982734">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember259982734">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_TreasuryStockCommonMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2023-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-03-31_custom_SelfFundedHealthInsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:SelfFundedHealthInsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_SelfFundedHealthInsuranceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:SelfFundedHealthInsuranceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-04-30_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-04-012023-04-30_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-04-01</xbrli:startDate>
        <xbrli:endDate>2023-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FORM
<span id="xdx_906_edei--DocumentType_c20220701__20230331_ziADOeD3rwZh"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:DocumentType">10-Q</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Washington,
D.C. 20549</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_edei--DocumentQuarterlyReport_c20220701__20230331" title="Document Quarterly Report"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">[X]</ix:nonNumeric></span>
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt 31.5pt; text-align: center; text-indent: -0.5in"><span id="xdx_900_edei--DocumentTransitionReport_c20220701__20230331_zkOtq9PrH2Jf" style="display: none"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;For
the quarterly period ended <span id="xdx_901_edei--DocumentPeriodEndDate_c20220701__20230331_zg23WjQ1Lnog"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">MARCH 31, 2023</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commission
file number <span id="xdx_90B_edei--EntityFileNumber_c20220701__20230331_zWxYQ563XF94"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><img src="fonar_logo.jpg" alt="" style="height: 19px; width: 125px" /></span></p>

<p style="font: 9pt Sans-Serif; margin: 0 0 6pt; text-align: center; color: Red"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_edei--EntityRegistrantName_c20220701__20230331_zu0xaeucN3Gj"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Exact
name of registrant as specified in its charter)</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20220701__20230331_zjwYCf9qXLsb" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20220701__20230331_zbRhjNDuQYqk"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(State
    or other jurisdiction of <br /> incorporation or organization)</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(I.R.S.
    Employer <br /> Identification No.)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="border-bottom: Black 1pt solid; width: 45%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20220701__20230331" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>&#160;&#160;<span id="xdx_904_edei--EntityAddressCityOrTown_c20220701__20230331" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20220701__20230331" title="Entity Address, State or Province"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td><td style="width: 10%; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 45%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_edei--EntityAddressPostalZipCode_c20220701__20230331" title="Entity Address, Postal Zip Code"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Address
    of principal executive offices)</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Zip
    Code)</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Registrant's
telephone number, including area code: <span id="xdx_907_edei--CityAreaCode_c20220701__20230331_znCaNLmHcYgi"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_90C_edei--LocalPhoneNumber_c20220701__20230331_zt5JMfQ941Hg"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 5pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_902_edei--EntityCurrentReportingStatus_c20220701__20230331" title="Entity Current Reporting Status" style="display: none"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> YES
_X_ NO ___</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was
required to submit such files <span id="xdx_906_edei--EntityInteractiveDataCurrent_c20220701__20230331" title="Entity Interactive Data Current" style="display: none"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> YES
_X_ NO ___</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See definition of accelerated filer, large accelerated filer, smaller reporting company and emerging growth
company in Rule 12b-2 of the Exchange Act. (Check one):Large accelerated filer___ Accelerated filer ___ <span id="xdx_900_edei--EntityFilerCategory_c20220701__20230331" title="Entity Filer Category"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> _X_ Smaller
reporting company _<span id="xdx_90C_edei--EntitySmallBusiness_c20220701__20230331" title="Entity Small Business"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">X</ix:nonNumeric></span>_ Emerging growth company ___<span id="xdx_900_edei--EntityEmergingGrowthCompany_c20220701__20230331_z1hUmIZ4wXh1" style="display: none"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 5pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ___ <span id="xdx_90E_edei--EntityShellCompany_c20220701__20230331" title="Entity Shell Company"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">NO</ix:nonNumeric></span> _X_</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Securities
registered pursuant to Section 12(b) of the Act:&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="border-bottom: Black 1pt solid; width: 28%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Title
    of each class</span></td><td style="width: 8%; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 28%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Trading
    symbol</span></td><td style="width: 8%; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 28%; text-align: center; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Name
    of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_edei--Security12bTitle_c20220701__20230331_zLoriAbHNHMf"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90B_edei--TradingSymbol_c20220701__20230331_zxq2oysy84Ia"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_edei--SecurityExchangeName_c20220701__20230331_zocUlZX5kbWc"><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
the number of shares outstanding of each of the issuer's classes of common stock, as of the close of the latest practicable date.</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Outstanding
    at May 5, 2023</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="width: 48%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock, par value $.0001</span></td><td style="width: 18%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 33%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_edei--EntityCommonStockSharesOutstanding_iI_c20230505__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znuCz9ZrTfx5" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-05-05_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,538,148</ix:nonFraction></span></span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    B Common Stock, par value $.0001</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20230505__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zhfm6bRhIfnl" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-05-05_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">146</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: transparent">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common Stock, par value $.0001</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_edei--EntityCommonStockSharesOutstanding_iI_c20230505__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zI9xzVeHFF7g" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-05-05_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">382,513</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    A Preferred Stock, par value $.0001</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_edei--EntityCommonStockSharesOutstanding_iI_c20230505__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_znVBgxUOtSYh" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2023-05-05_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">313,438</ix:nonFraction></span></span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">INDEX</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 87%; padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PART
    I - FINANCIAL INFORMATION</span></td>
    <td style="width: 6%; padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PAGE</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Item
    1. Financial Statements </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Assets">Condensed Consolidated Balance Sheets - March 31, 2023 (Unaudited) and June 30, 2022</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Income_3-Mos">Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2023 and March 31, 2022 (Unaudited</a>) </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Income_six_months">Condensed Consolidated Statements of Income for the Nine Months Ended March 31, 2023 and March 31, 2022 (Unaudited)</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Equity_3_mos">Condensed Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2023 and March 31, 2022 (Unaudited</a>) </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Equity_9_months">Condensed Consolidated Statements of Changes in Equity for the Nine Months Ended March 31, 2023 and March 31, 2022 (Unaudited)</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#CashFlow">Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2023 and March 31, 2022 (Unaudited)</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">10</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 45.05pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Notes">Notes to Condensed Consolidated Financial Statements (Unaudited)</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">11</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#MDA">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">25</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#QualitativeDisclosures">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">33</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#ControlsAndProcedures">Item 4. Controls and Procedures</a></span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">34</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 5.4pt; text-indent: -4.45pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PART
    II - OTHER INFORMATION </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">34</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#LegalProceedings">Item 1. Legal Proceedings</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">34</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#RiskFactors">Item 1A. Risk Factors</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">34</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#UseOfProceeds">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">36</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Defaults">Item 3. Defaults Upon Senior Securities</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">36</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#MineSafety">Item 4. Mine Safety Disclosures</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">36</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#OtherInformation">Item 5. Other Information</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">36</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 9pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Exhibits">Item 6. Exhibits</a> </span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">37</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 6pt; padding-left: 40pt; text-indent: -17.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Signatures">Signatures</a></span></td>
    <td style="padding-bottom: 6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-bottom: 6pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">37</span></td></tr>
  </table>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Assets"></span>ASSETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_111_pn3n3_zmowQbDn3VSk" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_492_20230331_zkLiDzKpY5j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_499_20220630_zIUzIBpjpUG4" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br /> 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2022 *</span></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrentAbstract_iB_zIT44oasg2ad" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Current
    Assets:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_maCzHSz_zJDVuPz2WCl8" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Cash
    and cash equivalents</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,640</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,723</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--ShortTermInvestments_i01I_maCzHSz_zklEFvLPgzu7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Short
    term investments</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--AccountsReceivableServiceAndRepairFees_i01I_maCzHSz_zdB2gizVZ1i8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Accounts
    receivable &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,720</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,336</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--AccountReceivableRelatedParties_i01I_maCzHSz_zbFN2llfe4U9" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Accounts
    receivable - related party</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0068">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--MedicalReceivable_i01I_maCzHSz_zamkKSyBaZQl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Medical
    receivable &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,460</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,109</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--ManagementAndOtherFees_i01I_maCzHSz_zXxQW39hqOGb" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Management
    and other fees receivable &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,201</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,419</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_maCzHSz_zfSyO6kwy1u8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable &#8211; related medical practices &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,088</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,603</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_maCzHSz_zp378KjHxQkh" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,661</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,360</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzHSz_zU9Qv9ILSeCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Prepaid
    expenses and other current assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,166</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,104</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AssetsCurrent_i01TI_mtCzHSz_maCz7sS_zRI1IvOwWGwi" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Current Assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">121,998</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118,686</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--AccountsReceivableNetLongTerm_i01I_maCz7sS_zJVmVJeIW8R9" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; long term</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,003</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,872</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maCz7sS_zTvRtaDdP0yg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Deferred
    income tax asset - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,911</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,843</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCz7sS_zn6V164esX7h" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Property
    and equipment &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,775</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,282</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCz7sS_z7KU9wWT4qab" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Right-of-use
    Asset &#8211; operating lease</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,581</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,232</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maCz7sS_z9BcVs2iTB77" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Right-of-use
    Asset &#8211; financing lease</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">779</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">928</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_i01I_maCz7sS_zMBdHR24uEI8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Goodwill</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCz7sS_zYoaxsbAMBPa" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Other
    intangible assets &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,494</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherAssets_i01I_maCz7sS_znOP0xaw6FW5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Other
    assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">526</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">526</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Assets_i01TI_mtCz7sS_z7FcDglEZNq3" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,336</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,342</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br /> 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2022 *</span></td></tr>
  <tr id="xdx_404_eus-gaap--LiabilitiesCurrentAbstract_iB_zMMXI8Xkmlrb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Current
    Liabilities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtCurrent_i01I_maCzU7o_ztbVSz9vGFV2" style="vertical-align: bottom; background-color: White">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Current
    portion of long-term debt</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccountsPayableCurrent_i01I_maCzU7o_zvulKCm6YAt6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,719</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,552</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherLiabilitiesCurrent_i01I_maCzU7o_zO3y7CKGhoOb" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,496</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,417</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredRevenueCurrent_i01I_maCzU7o_zibYkutvjxz5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Unearned
    revenue on service contracts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,615</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,289</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--UnearnedRevenueOnServiceContractsRelatedParty_i01I_maCzU7o_zzK1bARhHBmd" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Unearned
    revenue on service contracts &#8211; related party</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParty" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0131">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OperatingLeaseLiabilityCurrent_i01I_maCzU7o_zjJGghHafaB1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Operating
    lease liability - current portion</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,981</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,880</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--FinanceLeaseLiabilityCurrent_i01I_maCzU7o_z9QQrfP4BDP" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Financing
    lease liability - current portion</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">217</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CustomerDeposits_i01I_maCzU7o_zXkuCWJ0Xz6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">826</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">361</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesCurrent_i01TI_mtCzU7o_maCzgNB_zA50jBxPwoD3" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Current Liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,925</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,749</ix:nonFraction></span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zlDKsAr175pe" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Long-Term
    Liabilities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--DeferredRevenueNoncurrent_i01I_maCzkCW_zw1CiIs35uU5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Unearned
    revenue on service contracts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,015</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,857</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maCzkCW_zMg2qO0etc5g" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Deferred
    income tax liability</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--AccountsPayableRelatedPartyNoncurrent_i01I_maCzkCW_zBjw508Cp04g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Due
    to related medical practices</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsPayableRelatedPartyNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCzkCW_zHfLiNgiAUyh" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Operating
    lease liability &#8211; net of current portion</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32,630</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,091</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maCzkCW_zvj9YCUrDi8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Financing
    lease liability &#8211; net of current portion</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">657</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">838</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--LongTermDebtNoncurrent_i01I_pn3n3_maCzkCW_zwNQPGiOonYb" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Long-term
    debt less current portion</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">126</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OtherLiabilities_i01I_maCzkCW_z3rYfmZC9FX3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Other
    liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">57</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">107</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesNoncurrent_i01TI_mtCzkCW_maCzgNB_zAPQztCaAiwe" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 20pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Long-Term Liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,794</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,357</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Liabilities_i01TI_mtCzgNB_maCzwpv_zVSpKUzcJ5bd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,719</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,106</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY (Continued)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_40E_eus-gaap--StockholdersEquityAbstract_iB_zkgq7heHq7L2" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">STOCKHOLDERS'
    EQUITY:</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2022*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    A non-voting preferred stock $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20230331__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zeb21oYGsq41" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zHVujDJwMUGb" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z8TrtRUpDK5f" title="Preferred Stock, Shares Authorized"><span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zhYf040s1Mnf" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">453</ix:nonFraction></ix:nonFraction></span></span> shares authorized at March 31, 2023 and June 30, 2022, <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zMcSBSwCnN1e" title="Preferred Stock, Shares Issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z3y5bUdAlLOf" title="Preferred Stock, Shares Outstanding"><span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zeTEBbQ0Z4hf" title="Preferred Stock, Shares Issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zLJeEscmzbcb" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding
    at March 31, 2023 and June 30, 2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--PreferredStockValue_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zzu7c5YkQ045" title="Preferred Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0194">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--PreferredStockValue_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zobAqm7MIyRf" title="Preferred Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0196">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Preferred
    stock $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zezpDsWx2tff" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zGM8vDqvCOp8" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z00STcY17ml5" title="Preferred Stock, Shares Authorized"><span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zDSE8nU94TOj" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span></span> shares authorized at March 31, 2023 and June 30, 2022, issued and outstanding &#8211; <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zrtfQgqJ55Z3" title="Preferred Stock, Shares Issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zNs48NUmOkRb" title="Preferred Stock, Shares Outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zTQACfj1nNUg" title="Preferred Stock, Shares Issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z7osYMzCoxn2" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--PreferredStockValue_iI_pn3n3_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zWyMQaUlBsra" title="Preferred Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0214">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--PreferredStockValue_iI_pn3n3_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zsybg4OggsFf" title="Preferred Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0216">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pdd" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734" decimals="INF" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zY3saYUncO8l" title="Common Stock, Shares Authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjtiFuwXwAM1" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,500</ix:nonFraction></ix:nonFraction></span></span> shares authorized at March 31, 2023 and June 30, 2022, <span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEHigwqrsUG5" title="Common Stock, Shares, Issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,607</ix:nonFraction></span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9XqGFnfTlPj" title="Common Stock, Shares, Issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,566</ix:nonFraction></span> issued at March 31, 2023 and
    June 30, 2022, respectively <span id="xdx_90E_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfYXohVW74Ej" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,538</ix:nonFraction></span> and <span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zL5PocbbFCEi" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span> outstanding at March 31, 2023 and June 30, 2022 respectively</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--CommonStockValue_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zCiPe0NkbjY9" title="Common Stock Value" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--CommonStockValue_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRbYUWvRvzh2" title="Common Stock Value" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    B Common Stock (10 votes per share) $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zC1a00Dm1tGh" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zbBZ4ciKAyyl" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zyystIQzdxq9" title="Common Stock, Shares Authorized"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zAPYQeImApv" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">227</ix:nonFraction></ix:nonFraction></span></span> shares authorized at March 31, 2023 and June 30, 2022, .<span id="xdx_90B_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zPSGuOm4YUla" title="Common Stock, Shares, Issued"><span id="xdx_90B_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z1989GvWQ3Yi" title="Common Stock, Shares, Outstanding"><span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zy75J1wm4Esb" title="Common Stock, Shares, Issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zaUCbJmGv6pd" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and
    outstanding at March 31, 2023 and June 30, 2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--CommonStockValue_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zAMJQSojICOj" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0254">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--CommonStockValue_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z9tDNnPx0Fmb" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0256">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Class
    C Common Stock (25 votes per share) $<span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEAmKzwwfzGj" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zjBFpl05DC0c" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAaYdYextqz1" title="Common Stock, Shares Authorized"><span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zcuJsUdDCxQj" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span></span> shares authorized at March 31, 2023 and June 30, 2022, <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z2eiHdpusFCg" title="Common Stock, Shares, Issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zB5bdhQqsjX9" title="Common Stock, Shares, Outstanding"><span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znT6KVY0Vlbj" title="Common Stock, Shares, Issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNwLZ4CAUNo8" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding
    at March 31, 2023 and June 30, 2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--CommonStockValue_iI_pn3n3_c20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zbHoOxnOgQDf" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0274">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--CommonStockValue_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHZfc6NrxTlh" title="Common Stock Value" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0276">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--AdditionalPaidInCapital_iI_maCzZTF_zv7nWTEnrP0h" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Paid-in
    capital in excess of par value</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,130</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maCzZTF_zwL6oyCrcjY7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Accumulated
    deficit</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">25,428</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,567</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--TreasuryStockValue_iNI_di_msCzZTF_zbbhbpsb9uT4" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasury
    stock, at cost - <span id="xdx_907_eus-gaap--TreasuryStockCommonShares_iI_pn3n3_c20230331_zaReOVOaqJu7" title="Treasury Stock, Shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">69</ix:nonFraction></span> shares of common stock at March 31, 2023 and <span id="xdx_900_eus-gaap--TreasuryStockCommonShares_iI_pn3n3_c20220630_zTOMjaUcRVHi" title="Treasury Stock, Shares"><ix:nonFraction name="us-gaap:TreasuryStockCommonShares" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">12</ix:nonFraction></span> shares of common stock at June 30, 2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,522</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_iTI_mtCzZTF_maCzKuA_zPm08d0KWdA5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Fonar Corporation&#8217;s Stockholders&#8217; Equity</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157,181</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,290</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--MinorityInterest_iI_maCzKuA_zrXreo0jw757" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Noncontrolling
    interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,564</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,054</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40D_ecustom--StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest_iI_mtCzKuA_maCzwpv_zSQ5xlmT5Uec" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Stockholders' Equity</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,617</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146,236</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzwpv_zGE3b81EUvDj" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Liabilities and Stockholders' Equity</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,336</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,342</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Income_3-Mos"></span>CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_113_pn3n3_zdNK4XcLhmol" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_496_20230101__20230331_z5bDtDQtfRw9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49C_20220101__20220331_zoYVv01PTyKj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FOR
                                            THE THREE MONTHS</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ENDED
                                            MARCH 31,</span></p></td></tr>
  <tr id="xdx_408_eus-gaap--RevenuesAbstract_iB_zSeaqmjXN4N5" style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">REVENUES</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCzTQG_zOKiQDMl79Ch" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,188</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,641</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--ProductSalesNet_i01_maCzTQG_zmAhrcDD5BEc" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Product
    sales &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--ServiceAndRepairFeesNet_i01_maCzTQG_z3hlOK9vxC2h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,831</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,876</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCzTQG_zhc8VpWrIx4g" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
    and repair fees - related parties &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagementAndOtherFeesNet_i01_maCzTQG_zgES7ZmmUqp4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,375</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,904</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCzTQG_zX9gK02bBMhj" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees - related medical practices &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,975</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--Revenues_iT_mtCzTQG_maCzs3h_zKw1ouY91nqj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,422</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,571</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CostsAndExpensesAbstract_iB_zLzSE4lftwc9" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">COSTS
    AND EXPENSES</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzJhl_zcDVs5dnOs37" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to patient fee revenue</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,056</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,306</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--CostsRelatedToProductSales_i01_maCzJhl_zmIm2CmK2Xyk" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to product sales</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">196</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzJhl_ztEbMFeqjqu" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">801</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">747</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzJhl_zlfqVATrrqek" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees - related parties</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzJhl_zGyqAUxjbRok" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,157</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,696</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCzJhl_z9MTHiHAeeP" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees &#8211; related medical practices</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,455</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,698</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzJhl_zDRXZ4jR9Xcf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Research
    and development</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">435</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">354</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzJhl_zPBQe52Nh5Sl" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Selling,
    general and administrative</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,143</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,068</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--CostsAndExpenses_i01T_mtCzJhl_msCzs3h_z7SL6doA3AXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,255</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,933</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzs3h_maCz13X_zIG4ZD574Di5" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    From Operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,167</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,638</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherNonoperatingIncomeExpense_maCz13X_zdZy9FZkOeZg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Expense</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0361">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--InterestExpenses_iN_di_msCz13X_zfXjvNwCho72" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Interest
    (Expense) Income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:InterestExpenses" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:InterestExpenses" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--InvestmentIncomeNet_maCz13X_zl2fFgC29Oi6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Investment
    Income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">356</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCz13X_maCzrfF_zgWy6idTHpsc" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    Before Provision for Income Taxes and Noncontrolling Interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,502</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,727</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzrfF_zlbEEvj6Gjl5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision
    for Income Taxes</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,465</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--ProfitLoss_iT_mtCzrfF_zkEoWVpw92g7" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,485</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,262</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--NetIncomeAttributableToNoncontrollingInterest_iN_di_zD8LujPklTfc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income - Noncontrolling Interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:NetIncomeAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">625</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:NetIncomeAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">971</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_z0Z2dUsAapsj" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,860</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,291</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--StatementOfIncomeAbstract_iB_zaAJL1OZPLE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="color: White; font-size: 10pt">STATEMENT
    OF INCOME</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zYxXty6kSm59" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,627</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,153</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--NetIncomeAvailableToClassNonvotingPreferredStockholders_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_pn3n3" title="Net Income Available to Class A Non-Voting Preferred Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders" contextRef="From2023-01-012023-03-31_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">174</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--NetIncomeAvailableToClassNonvotingPreferredStockholders_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zGDqRstDf2u9" title="Net Income Available to Class A Non-Voting Preferred Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders" contextRef="From2022-01-012022-03-31_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">103</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class C Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetIncomeAvailableToClassCCommonStockholders_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6IitMSoVpU4" title="Net Income Available to Class C Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassCCommonStockholders" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeAvailableToClassCCommonStockholders_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgsNxxw2osjf" title="Net Income Available to Class C Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassCCommonStockholders" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_pip0_z7OwgY5kJBW3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.56</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareDiluted_pip0_zfpUhjYgOO67" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.32</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    and Diluted Income Per Share &#8211; Class C Common</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_eus-gaap--EarningsPerShareBasic_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNpeyAZWOyqj" title="Basic Income Per Share"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIVIQmfCUP91" title="Diluted Income Per Share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zEJ3wfR2XDx6" title="Basic Income Per Share"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zOsOIT0Axfmd" title="Diluted Income Per Share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.09</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_za91GCsqlUg5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,481</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_zFVcL4lXnLza" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Diluted Shares Outstanding - Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,609</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic and Diluted Shares Outstanding &#8211; Class C Common</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zT3MHpI4utyc" title="Weighted Average Basic Shares Outstanding"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zAaCHWpsk2na" title="Weighted Average Diluted Shares Outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zD8iIPQKkA25" title="Weighted Average Basic Shares Outstanding"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTmdZckrKmHg" title="Weighted Average Diluted Shares Outstanding"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-bottom: 0pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-bottom: 0pt; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><br />
FONAR CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Income_six_months"></span>CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_491_20220701__20230331_z7G2Lu1DKOsg" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49D_20210701__20220331_zf6yzUhtTlzh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FOR
                                            THE NINE MONTHS</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ENDED
                                            MARCH 31,</span></p></td></tr>
  <tr id="xdx_401_eus-gaap--RevenuesAbstract_iB_zySiFAhUe1L" style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">REVENUES</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_401_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCz3zS_zTHEUthAHGe9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,393</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,935</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ProductSalesNet_i01_maCz3zS_zI25ukxxhn63" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Product
    sales &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">225</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">481</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ServiceAndRepairFeesNet_i01_maCz3zS_zl3AX5L1ABul" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,489</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,720</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCz3zS_zqRGWFVuMPhg" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
    and repair fees - related parties &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">83</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--ManagementAndOtherFeesNet_i01_maCz3zS_zFk2YFv26JH7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,717</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,985</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCz3zS_zpEAeRBnyDLk" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees - related medical practices &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,962</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,576</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--Revenues_iT_mtCz3zS_maCzdko_zfPZUpPST4Ra" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: 27pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,869</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,780</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--CostsAndExpensesAbstract_iB_zUJhK6Geofwi" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: 0in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">COSTS
    AND EXPENSES</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzboK_zra8lkFL3sbj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to patient fee revenue</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,879</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,785</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--CostsRelatedToProductSales_i01_maCzboK_zLZD7UhyYiLk" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to product sales</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">580</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">352</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzboK_z4pueUJTUqfj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,241</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,190</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzboK_zvna3wtvsVZ1" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees - related parties</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzboK_zIlEieoxcnQd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,281</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,497</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCzboK_zy30BN8dmfH7" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees &#8211; related medical practices</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,345</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,024</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzboK_zI6vfTC88IEh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Research
    and development</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,126</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,109</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzboK_zyddlwPkWzhc" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Selling,
    general and administrative</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,074</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,928</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--CostsAndExpenses_i01T_mtCzboK_msCzdko_zZgl2Fu7Cmid" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: 27pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60,560</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54,917</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzdko_maCzWDB_zc8WqFbr8utb" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    From Operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,309</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,863</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OtherNonoperatingIncomeExpense_maCzWDB_zvKHD53V5bZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    (Expense) Income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">203</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">858</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--InterestExpenses_iN_di_msCzWDB_zCh4xkr2DOGl" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Interest
    Expense</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:InterestExpenses" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">41</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:InterestExpenses" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--InvestmentIncomeNet_maCzWDB_zcf5qEomvZbi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Investment
    Income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">770</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">180</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzWDB_maCzmnj_zearADnj9g4f" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    Before Provision for Income Taxes and Noncontrolling Interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,835</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,892</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzmnj_zLkTayGT3k55" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision
    for Income Taxes</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,889</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,311</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--ProfitLoss_iT_mtCzmnj_zfgS9XnQbdtb" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,946</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,581</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--NetIncomeAttributableToNoncontrollingInterest_iN_di_zJpT5BWJkDHa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income - Noncontrolling Interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:NetIncomeAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,807</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:NetIncomeAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,383</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetIncomeLoss_zhYN6AUrf4Bh" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,139</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,198</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--StatementOfIncomeAbstract_iB_zwKTDBojR9df" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="color: White; font-size: 10pt">STATEMENT
    OF INCOME</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_zljBXy9qJwd4" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,647</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,583</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeAvailableToClassNonvotingPreferredStockholders_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zTLOlcfucbca" title="Net Income Available to Class A Non-Voting Preferred Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders" contextRef="From2022-07-012023-03-31_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">367</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeAvailableToClassNonvotingPreferredStockholders_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zeiuMxnRYcxf" title="Net Income Available to Class A Non-Voting Preferred Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders" contextRef="From2021-07-012022-03-31_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">458</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class C Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--NetIncomeAvailableToClassCCommonStockholders_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zqz1VwtmJNh" title="Net Income Available to Class C Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassCCommonStockholders" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeAvailableToClassCCommonStockholders_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z3GKKyugjVRc" title="Net Income Available to Class C Common Stockholders" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeAvailableToClassCCommonStockholders" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--EarningsPerShareBasic_pip0_zKCSyO8PneSd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.18</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.46</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--EarningsPerShareDiluted_pip0_zZB8G7tzrRI4" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.43</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    and Diluted Income Per Share &#8211; Class C Common</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zkPeqoR6hFJ2" title="Basic Net Income Per Common Share Available to Common Stockholders"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8CL68TSpwM2" title="Diluted Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_908_eus-gaap--EarningsPerShareBasic_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgzQ4mvfMA7c" title="Basic Net Income Per Common Share Available to Common Stockholders"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_znfQrTbUCWDa" title="Diluted Net Income Per Common Share Available to Common Stockholders"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.41</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_zzHZyiT0mYR1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,487</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_zGKHgt9lzxi9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Diluted Shares Outstanding - Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,615</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic and Diluted &#160;Shares Outstanding &#8211; Class C Common</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMh3QLEBblZb"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zHFOa3veq4Sg" title="Weighted Average Diluted Shares Outstanding - Common Stockholders"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4dCRnw72g6a"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zOCVhJh8r0N5" title="Weighted Average Diluted Shares Outstanding - Common Stockholders"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></span></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-bottom: 0pt; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-bottom: 0pt; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;</span></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Equity_3_mos"></span>CONDENSED
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the Three Months Ending March 31, 2023</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" id="xdx_30E_114_zgKyzmW8D1uf" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: middle; background-color: white">
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" style="text-align: right">&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: middle">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Common Stock</td>
    <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Paid in capital in excess of par value</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Accumulated Deficit</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Treasury Stock</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Non Controlling Interests</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Total</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="width: 29%">Balance &#8211; December 31, 2022</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Net income" id="xdx_98C_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXgoZQuw1PJ1" style="text-align: right; width: 8%"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td id="xdx_98D_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zc7SpaKXCR78" title="Net income" style="text-align: right; width: 8%"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,130</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td id="xdx_98F_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zRgZWtVY8oYa" title="Net income" style="text-align: right; width: 9%">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">29,288</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">)</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zRVvBgClWthh" title="Net income" style="text-align: right; width: 8%">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">751</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">)</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td id="xdx_986_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zpKawafscPKg" title="Net income" style="font-size: 11pt; text-align: right; width: 8%">(<span style="font: normal 400 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,022</ix:nonFraction></span></td>
    <td style="text-align: left; width: 1%">)</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Net income" id="xdx_983_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20230101__20230331_zT6YvIDEnTG8" style="text-align: right; width: 6%"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148,070</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: white">
    <td style="text-align: left">Net income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" id="xdx_986_eus-gaap--NetIncomeLoss_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWkzFyONGy71" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" id="xdx_988_eus-gaap--NetIncomeLoss_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zLGMjOaNO121" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_980_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zsC3YmmMofx" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,860</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98D_eus-gaap--NetIncomeLoss_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zL9ykiLRhQO1" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zhmacaZujEzc" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20230101__20230331_zy6wKtAkW4He" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,860</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="text-align: left">Purchase of Treasury stock</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98B_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zw1WWr8jvqr2" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_986_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zbbeffaPO5Q3" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zdsq98MriN0f" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_982_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ztsK3xCSfH7e" title="Net income" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">771</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_98E_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zvxzYzLxIVY2" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_989_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20230101__20230331_zCachv5Y7qY3" title="Net income" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">771</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: middle; background-color: white">
    <td style="text-align: left">Distributions - Non controlling</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" id="xdx_984_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zC7nEpSSSEm2" style="text-align: right"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" id="xdx_988_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_z8tJtD9YoZaj" style="text-align: right"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_986_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zDQB25zb1PXh" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_984_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zS5JVQ9Ugx61" title="Net income" style="text-align: right"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td id="xdx_985_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zlhTqLAFZdoc" title="Net income" style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,167</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Net income" id="xdx_98E_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20230101__20230331_zRnajiAcXcxb" style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,167</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="text-align: left">Income - Non controlling interests</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Net income" id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zuaj7gWU4Sbh" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Net income" id="xdx_985_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zwr9NIfrhQf" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Net income" id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zIrs9IJD8OEd" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Net income" id="xdx_988_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zdo1yQt4Spo4" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Net income" id="xdx_98F_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zL4vt0iODyFl" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">625</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Net income" id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20230101__20230331_zxliCyTneE4d" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">625</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: white">
    <td style="padding-bottom: 2.5pt">Balance &#8211; March 31, 2023</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Net income" id="xdx_98F_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbOVHjo8BTg1" style="border-bottom: black 2pt double; text-align: right"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td id="xdx_982_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zUi4Itwb1CZ8" title="Net income" style="border-bottom: black 2pt double; text-align: right"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,130</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td id="xdx_981_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zHUhsA7Ge6ie" title="Net income" style="border-bottom: black 2pt double; text-align: right">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">25,428</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">)</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td id="xdx_98C_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zgnArmZ1ccPg" title="Net income" style="border-bottom: black 2pt double; text-align: right">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,522</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">)</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zyrRWzVNG9Gk" title="Net income" style="border-bottom: black 2pt double; text-align: right">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,564</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Net income" id="xdx_98C_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20230101__20230331_z47MM5GRNG0i" style="border-bottom: black 2pt double; text-align: right"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,617</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the Three Months Ending March 31, 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Paid
    in capital in excess of par value</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non
    Controlling Interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 29%; font-family: Arial, Helvetica, Sans-Serif; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; December 31, 2021</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlyYYJDrJv7b" title="Balance" style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zi7bX0EPbUI7" title="Balance" style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zVdYUgfmU3P5" title="Balance" style="width: 9%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">38,101</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ztpxtKl6UMBj" title="Balance" style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right">(<span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-12-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">675</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zXLPjt8ZQbr1" title="Balance" style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,314</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220101__20220331_zXA4OTW0U3mk" title="Balance" style="width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">142,442</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--NetIncomeLoss_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztsLmJWJD0J2" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zVW3luBMOxP4" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zZr3VXA1CEs9" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,291</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--NetIncomeLoss_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ztxpLzEnKEe6" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zF8tppeEfgbi" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_pn3n3_c20220101__20220331_z9o4cSMlN0tc" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,291</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Distributions
    - Non controlling</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCKFnBuBw26d" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zmK2fsmkGJG" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zcFOH42LNdT5" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ztRID2hZnScj" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zE5JDATuZvT6" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,430</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220101__20220331_zE2SasMF6DLj" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,430</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    - Non controlling interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaHnMkuXLWoj" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zDPjOUCvKj7" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zJtHiPdGhtHh" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_d0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zZpVpZkHmrB2" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:zerodash" decimals="-3" scale="3" unitRef="USD">&#8212;</ix:nonFraction>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zz5lU35f0vN8" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">971</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220101__20220331_zjzZhSdeefvc" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">971</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    - March 31, 2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zjF8EUmNhbM3" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zUyTr0jkZCr7" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zPtUGhzjavX" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,810</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zfsDmzJCM8D5" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zKcG7Jyw3Cyl" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,773</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220101__20220331_zGJfZ8Yc2dMa" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">144,274</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Equity_9_months"></span>CONDENSED
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the Nine Months Ending March 31, 2023</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: middle">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center">Common Stock</td>
    <td style="border-bottom: black 1pt solid; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Paid in capital in excess of par value</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Accumulated Deficit</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Treasury Stock</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Non Controlling Interests</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center">Total</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="width: 29%">Balance - June 30, 2022</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Balance" id="xdx_982_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdEgXlvWheE2" style="text-align: right; width: 8%"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Balance" id="xdx_989_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zDTYkQveBVE2" style="text-align: right; width: 8%"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td id="xdx_981_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zVJdKX3YizTf" title="Balance" style="font-size: 11pt; text-align: right; width: 9%">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,567</ix:nonFraction><span style="font: normal 400 10pt Arial, Helvetica, Sans-Serif"></span></td>
    <td style="text-align: left; width: 1%">)</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Balance" id="xdx_986_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zFKfpqXeEhW9" style="text-align: right; width: 8%">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">)</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Balance" id="xdx_987_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z6oloMm5MAk4" style="text-align: right; width: 8%">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,054</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">)</td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td>
    <td title="Balance" id="xdx_987_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20220701__20230331_zzMT77ZzmvYk" style="text-align: right; width: 6%"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146,236</ix:nonFraction></td>
    <td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: white">
    <td style="text-align: left">Net income</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9lMcvCpJMuf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0691">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_983_eus-gaap--NetIncomeLoss_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_pn3n3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0693">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98D_eus-gaap--NetIncomeLoss_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_pn3n3" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,139</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98F_eus-gaap--NetIncomeLoss_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_pn3n3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0697">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_986_eus-gaap--NetIncomeLoss_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_pn3n3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0699">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20230331_z1swwlAJQFkj" style="text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,139</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="text-align: left">Purchase of Treasury stock</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98F_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVikFwtEiJN3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0703">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_986_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zhi613tATX0j" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0705">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98D_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zOxqd8u1UaSf" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0707">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_986_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z1eJGI3AbIDb" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,249</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_981_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zQZ0thCO6txd" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0711">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98A_eus-gaap--StockRepurchasedDuringPeriodValue_iN_pn3n3_di_c20220701__20230331_zMxrcub2l7Yi" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,249</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: middle; background-color: white">
    <td>Cancellation of shares</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98C_ecustom--CancellationOfShares_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pn3n3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0715">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98A_ecustom--CancellationOfShares_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_pn3n3" style="text-align: right">(<ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">401</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_988_ecustom--CancellationOfShares_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_pn3n3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0719">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_989_ecustom--CancellationOfShares_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_pn3n3" style="text-align: right"><ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">402</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_987_ecustom--CancellationOfShares_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_pn3n3" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0723">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98D_ecustom--CancellationOfShares_pn3n3_c20220701__20230331_zKiB1PvZCp9g" style="text-align: right"><ix:nonFraction name="FONR:CancellationOfShares" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="text-align: left">Distributions - Non controlling</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98A_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNHFEGkfVPKg" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0727">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98E_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_z6W9jY3Rp748" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0729">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_988_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_z0aV4BXmLWFj" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0731">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_989_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zL2qgJZiJ5Hh" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0733">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_986_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zNEn0Vzse1rk" style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,317</ix:nonFraction></td>
    <td style="text-align: left">)</td>
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98F_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20220701__20230331_zkFRtoiSPZJ5" style="text-align: right">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,317</ix:nonFraction></td>
    <td style="text-align: left">)</td></tr>
  <tr style="vertical-align: middle; background-color: white">
    <td style="text-align: left">Income - Non controlling interests</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Balance" id="xdx_981_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkm1dmYU6bE9" style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0739">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Balance" id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0741">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0743">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Balance" id="xdx_98E_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0745">&#8212;</span>&#160;&#160;</td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Balance" id="xdx_985_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zt4OLPpgK9F3" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,807</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: left">&#160;</td>
    <td title="Balance" id="xdx_989_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20220701__20230331_z5LQFGtwHOSd" style="border-bottom: black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,807</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: middle; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt">Balance - March 31, 2023</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Balance" id="xdx_98A_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zgNF4m5d05W5" style="border-bottom: black 2pt double; text-align: right"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Balance" id="xdx_985_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zCtMLnxm7pvi" style="border-bottom: black 2pt double; text-align: right"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,130</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Balance" id="xdx_98D_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zYYF6RRddaN3" style="border-bottom: black 2pt double; text-align: right">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">25,428</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">)</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Balance" id="xdx_983_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_ztwtxN4ZenVh" style="border-bottom: black 2pt double; text-align: right">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,522</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">)</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Balance" id="xdx_98F_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z6PD5JCBc3Kk" style="border-bottom: black 2pt double; font-size: 11pt; text-align: right">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">6,564</ix:nonFraction><span style="font: normal 400 10pt Arial, Helvetica, Sans-Serif"></span></td>
    <td style="text-align: left">)</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2pt double; text-align: left">$</td>
    <td title="Balance" id="xdx_98A_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20220701__20230331_zElLq0eh25g4" style="border-bottom: black 2pt double; text-align: right"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,617</ix:nonFraction></td>
    <td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the Nine Months Ending March 31, 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt; text-indent: 0pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Paid
    in capital in excess of par value</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non
    Controlling Interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: 0pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    - June 30, 2021</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20210701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMtlOMaaUR8f" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_znAZp4GYBAv4" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zeuoLbzYkPn2" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">46,008</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zCAZffvAzige" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zBexsBF9H2gc" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,049</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iS_pn3n3_c20210701__20220331_zFqmewnywpK5" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135,370</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: 0pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zGZpocvutysd" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0775">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_pn3n3" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0777">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zqapt0M1YD49" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,198</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td title="Balance" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zpJHXI07cVX9" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0781">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20220331_z72M7NDCrych" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,198</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: 0pt; width: 29%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchase
    of Non controlling interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PurchaseOfNonControllingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z80XcDewHEJi" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0785">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
                                                                                                                                                           <td id="xdx_98F_ecustom--PurchaseOfNonControllingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zY4EH80xurZc" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PurchaseOfNonControllingInterest" contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">570</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PurchaseOfNonControllingInterest_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_pn3n3" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 9%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0789">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PurchaseOfNonControllingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_z4495lAWfHl5" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0791">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PurchaseOfNonControllingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zhfaHmTWDwEf" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PurchaseOfNonControllingInterest" contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--PurchaseOfNonControllingInterest_pn3n3_c20210701__20220331_zPwnyXnF28Lh" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right; width: 6%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PurchaseOfNonControllingInterest" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">546</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: 0pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Distributions
    - Non controlling</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvVlzw3cWZni" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0797">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zWJiUi5J3Ilg" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0799">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zOqazNWLwkN4" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0801">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zQa0SaUZriH9" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0803">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_z8RZMncZBQE" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,131</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_pn3n3_di_c20210701__20220331_zca86m50zP2i" title="Balance" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,131</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: 0pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    - Non controlling interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLMANcfwL2zc" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0809">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zlWAaEGWNxE3" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0811">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zobNURzb1R2f" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0813">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zU8t1HFnLDM1" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0815">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zQ9xd9GYdnyh" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,383</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_pn3n3_c20210701__20220331_zUxQSd9ZVcd2" title="Balance" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,383</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: 0pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    - March 31, 2022</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZiqd9Wm5lN" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--AdditionalPaidInCapitalMember_zDpGKiPvArYl" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--RetainedEarningsMember_zLrHGTTXuaQd" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">35,810</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--TreasuryStockCommonMember_zO0irF2KXpFc" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_TreasuryStockCommonMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zxGhQ7J17vb1" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,773</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_iE_pn3n3_c20210701__20220331_zCH4SCCpT3A4" title="Balance" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">144,274</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="CashFlow"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_112_pn3n3_zcWYEPIZL9f2" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_498_20220701__20230331_zfAh2HsivR91" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_491_20210701__20220331_z5kzBOVgjd37" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FOR
                                            THE NINE MONTHS</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ENDED
                                            MARCH 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0pt 0pt 0pt 10pt; text-align: right; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zjBy1ZGez1e7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
    Flows from Operating Activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--ProfitLoss_maCzZJf_zwVvoi8ilcNg" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 40pt; width: 68%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Net
    income</span></td><td style="width: 4%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,946</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,581</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zxhC3HkAxtsh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Adjustments
    to reconcile net income to net cash provided by operating activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--OtherDepreciationAndAmortization_i01_maCzZJf_zSrkyHgPq5Y5" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,357</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,543</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_maCzZJf_zNf5LkgCTbd3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
    on right-of-use assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,306</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,953</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ProvisionForBadDebts_i01_maCzZJf_zuRseSnpLfl4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision
    for bad debts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,441</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,150</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCzZJf_zVczBIajCsj2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Deferred
    income tax &#8211; net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,931</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,484</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--GainOnForgivenessOfPppLoan_i01N_di_msCzZJf_zfi6CjJyabM" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gain
    on forgiveness of PPP loan</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0854">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">701</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zvXuqRmzB8sd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Increase)
    decrease in operating assets, net:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzZJf_zq5SW6rxTZ3l" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts,
    medical and management fee receivable(s)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,604</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,950</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncreaseDecreaseInReceivables_i01N_di_msCzZJf_zigTeuNP5kgi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">32</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInContractAssets_i01N_di_msCzZJf_zEh7DVHWDbu2" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Contract
    assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0866">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInContractAssets" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzZJf_zYROWQqztfme" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">301</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">705</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCzZJf_z8eX1WizTFZ7" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">73</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">112</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCzZJf_zAXwzSxEIOmd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0875">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">132</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB_z3f7OcrOSGzc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Increase
    (decrease) in operating liabilities, net:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCzZJf_zPxlvCRKBXY6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">168</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">855</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maCzZJf_zlaxNT2kKwa6" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,409</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,480</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingLiabilities_i01_maCzZJf_z2RCcRfhbFgg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    lease liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,865</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,579</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_di_msCzZJf_zboeR45Megd" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    lease liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40E_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maCzZJf_zRjnaPIrRfNf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">465</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">370</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_ecustom--IncreaseDecreaseInContractLiabilities_i01_maCzZJf_zDfLBOFjaSTi" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Contract
    liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0896">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInContractLiabilities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">15</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_maCzZJf_zCQqZGn46TJg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">49</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">49</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCzZJf_maCzUNJ_zfKpFnLBNhp4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    cash provided by operating activities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,149</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,117</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zSliLFvuSLG5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Cash
    Flows from Investing Activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzhZ2_z2ldJ32CPKN4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchases
    of property and equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,553</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,807</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_ecustom--PurchaseOfNoncontrollingInterests_i01N_di_msCzhZ2_zEBqxwjtOiW8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Purchase
    of noncontrolling interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0911">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">546</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCzhZ2_zGuUq5NQGYK4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cost
    of patents</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzhZ2_maCzUNJ_zPpIftDHujlj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    cash used in investing activities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,640</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,413</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zsjCs44qE2wk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 20pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Cash
    Flows from Financing Activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzSM6_zYaRqni4xJkd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Repayment
    of borrowings and capital lease obligations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">26</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_i01N_di_msCzSM6_zDo7FVunTOrk" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Purchase
    of treasury stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,249</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0927">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msCzSM6_z4LfhLqc4Q01" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 30pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Distributions
    to noncontrolling interests</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,317</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,131</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzSM6_maCzUNJ_z6GqVmFdWtQ4" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    cash used in financing activities</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,592</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,154</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCzUNJ_zRovHlT4ZUj6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Net
    Increase in Cash and Cash Equivalents</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">917</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,550</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zHIgTFDaJqYc" style="vertical-align: bottom; background-color: White">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
    and Cash Equivalents - Beginning of Period</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,723</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,460</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_z7C84JH8Cq18" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding: 0pt 0pt 0pt 10pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -10pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
    and Cash Equivalents - End of Period</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">49,640</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46,010</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Notes"></span>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zl0QkKRN4qcc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
1 &#8211; <span id="xdx_82F_zjoYqtEItFJb">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
Corporation (the &#34;Company&#34; or &#34;FONAR&#34;) is a Delaware corporation, which was <span style="letter-spacing: -0.1pt">incorporated
on July 17, 1978. FONAR is engaged in the research, development, production and </span>manufacturing of medical scanning equipment, which
uses principles of Magnetic Resonance Imaging (&#34;MRI&#34;) for the detection and diagnosis of human diseases. In addition to deriving
revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base of customers through service and upgrade
programs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America <span style="letter-spacing: -0.05pt">(&#34;HMCA&#34;)
provides comprehensive management services to diagnostic imaging facilities. These </span><span style="letter-spacing: -0.1pt">services
provided by the Company include development, administration, leasing of office spaces, </span>facilities and medical equipment, provision
of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collections and the development
and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_90A_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zRSWF8diuPU1" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span>% interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_905_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_znfURC63pu81" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span>% in HDM, and the original
investors in HDM retained a <span id="xdx_904_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zUejIbMXVdFh" title="The ownership interest of the original investors of HDM"><ix:nonFraction name="FONR:OwnershipInterestOfOriginalInvestorsOfHdm" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span>% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $<span id="xdx_90B_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3d_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_ziuGnZjCD8Ci" title="Direct purchase of Noncontrolling Interests"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="-3" unitRef="USD">546,000</ix:nonFraction></span>. Currently the Company has a direct ownership interest
of <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zL7MfEnHQaX" title="Direct ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; have a <span id="xdx_90A_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zYGm9Nz1Tw26" title="Investors ownership interest percentage"><ix:nonFraction name="FONR:InvestorsOwnershipInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three and nine months ended March 31, 2023, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2023. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2022 for the fiscal
year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company
was able to enact certain decisions to allow the Company to sustain operations during the global pandemic and from further losses or
additional decreases in scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program
(&#8220;PPP&#8221;) and Medicare advances/stimulus payments. The Company has been able to navigate through these challenges and
avoid any significant disruption of the business and the volume has recently risen back to almost pre- COVID-19 levels. Recent
legislation was passed to end the national emergency for COVID-19 which the Company believes with positive cash flows, low debt and
cash on hand, it will be able to maintain operations to pre COVID-19 levels going forward.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div id="xdx_23E_zx6h0Jm3rnQ9" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td id="xdx_231_zeUiQ8Jc7JDk" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23C_z8pgje21i4w1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zOecMMuGzq0e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zWmc9OpRpjpl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zO8wDmuuNsB1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zTJbb5C8Utr7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zFUZev5lKRw" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zKm1sT8ckAE1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zCJlbHruw7yk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_822_zH37tuZ9jrl">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zShxYJYKZrCe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_861_z1cwLrtGsJqd">Principles
of Consolidation</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zn67hGQVlNkg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_861_zzLpcFrOkto9">Revenues</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><p id="xdx_230_zMWgkGz502u6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div id="xdx_237_zpX2qqijTHR8" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23E_zhDa1UR4FcLi" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td id="xdx_236_zUhc8n7gATD1" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_zlYnkGHrjhf1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23D_zF1Zbx4skCA" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zHJD0gRmfXzh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zg3DicuG2St2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zcftQF7H9F8c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zHajQIla88uk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_z7phUjkOTnu2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zvgrG7mmxRse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zdIQV5q4bC5c" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zNwwDiMp8azj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z12o1EQ7Kzfg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86F_z9r8AyDU6xei" style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC Topic 260-10, &#8220;Participating Securities and the
Two-Class method&#8221;, the Company uses the Two-Class method for calculating basic income per share and applied the if converted method
in calculating diluted income per share for the three and nine months ended March 31, 2023 and 2022.</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and nine months ended March 31, 2023 and 2022, diluted EPS
for common shareholders includes <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230101__20230331_z8kpeeiDuqil" title="Shares included upon conversion of Class C Common"><span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220101__20220331_zKoVKw2pQQZ2" title="Shares included upon conversion of Class C Common"><span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20230331_ziBqwqwJUTdh" title="Shares included upon conversion of Class C Common"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20220331_z04fnBBOmodd" title="Shares included upon conversion of Class C Common"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>
</span></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zXFnwxKgAPmc" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br /> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br /> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br /> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,860</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,627</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,291</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" title="Common Stock and Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,153</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,481</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,481</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.60</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.56</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.35</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.09</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br /> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,481</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1037">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,609</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.32</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.09</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23D_zKfNYtQQcioe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div id="xdx_23D_zZCpb251A3P3" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td id="xdx_236_zEacA2mRgkQ2" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_239_zunOWpSvX6fa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zvMVIC1Yleo7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zebaVDsEaIHk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zukDIH0sziD1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zYPaTvVAVnHe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zQQMcnztJSL4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zPlFE51YZ7V" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zhbYGhkcTxik" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zNW6foUfEgdb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zy9D8HeEb8a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zkI7fcBtqpGl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zcggbqP1Womk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zkISDpJsTjhl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zpidn9IgTatl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br /> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br /> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br /> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,139</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" title="Common Stock and Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,647</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">125</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,198</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" title="Common Stock and Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,583</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetIncomeLossAvailableToCommonStockholderBasic" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">157</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,487</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,487</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.25</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.18</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.56</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.46</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.41</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br /> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,487</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" title="Diluted Denominator: Weighted average shares outstanding" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,615</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" title="Total Denominator for Diluted Earnings Per Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedEarningsPerShare" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.16</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.33</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">1.43</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" title="Diluted Income per Common Share" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.41</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_zfAr5NoPyaDa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL5uSIjLpOr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_869_zQOiX1DAhZM4">Recent
Accounting Standards</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected the Company&#8217;s financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not
believe that any of those standards will have a significant impact on our consolidated condensed financial statements at the time they
become effective.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><p id="xdx_237_z8pR803P18jb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_23E_zb9pFB9huST8" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_239_zKe9Q2CdK5ld" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td id="xdx_23B_z7mB0f7HmKr" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23B_z9z92XPMRnk6" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_zksmFRdqjZZ5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zQSCk4mkBogd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zSCPdnJjcBQ2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zNduH6oGHIVa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zJ1afrlxYw6l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zY8op2WbmKWe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z6nmJdOBsoX5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_806_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z6NJBZHCZI5i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; <span id="xdx_82B_zn04OKqJ8TG9">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at March 31, 2023, and June 30, 2022:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zqZUh9VPBLsl" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B6_zLWjIe3nGvP6" style="display: none">Financing receivable noncurrent allowance for Credit loss</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,925</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zJaYQDiLAe14" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20230331_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,720</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zr7LeRJ6okt4" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20230331_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,460</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zfRvJ1t1s07c" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1169">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20230331_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,460</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zN82vr4gSvD4" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">55,043</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zMqmN68lDgXe" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,842</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331_z2lRYZnKXGW5" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35,201</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztFPol0sWH08" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,002</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zbdgiQnHaOjg" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,914</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331_zSAubPsMmUA8" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">9,088</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,541</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,336</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,109</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z8M8ZmFuTWwj" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,109</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zjRCwaddIXxe" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,047</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zyhBAhuWIBXj" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,628</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630_zTMBJd5sfgoe" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNonRelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,419</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3pGzfyAsTH7" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,290</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zhcSK1FmC8Eh" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,687</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630_zVRSXYxlWjzc" title="Management and other fees receivable from related medical practices (&quot;PC&apos;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,603</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zhinEhAPq8c1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div id="xdx_23B_zGekSKF7cpaj" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td id="xdx_235_zQ5v8jHusgRa" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zVNhnvJtqTJ9" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23E_z5Eu0Hwb4Ce9" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zOOuCMyPrJD7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zAmqHLIhNhbg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zZUeV7rMArOd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zl4J8NiZm6x5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zw3C5ippYsx8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zVK27jebsB4h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zFSX2jTOvp3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zI1uLwN9Otc5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zAZkko0xWcN4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following three years as of March 31, 2023 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zk3M3S8Nrvc1" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_8B7_zVuGEp02lIw8" style="display: none">Schedule of facilities owned or managed</span></td><td style="text-align: left">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230331_zyuPkTCCWnul" title="2025" style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueOneToTwoYears" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">792</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230331_zAsflSXtAWT5" title="2026" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20230331_zNgY4R7r7hwj" title="2027" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230331_pn3n3" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,015</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_z801hYFKhXdf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
Receivables</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90D_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230101__20230331_zQ0KBYo30K0f" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.6</ix:nonFraction></span>%
and <span id="xdx_907_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220101__20220331_zvPWAEkHaks8" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.6</ix:nonFraction></span>% of the PCs&#8217; net revenues for the three months ended March 31, 2023 and 2022 respectively, were derived from no-fault
and personal injury protection claims. Approximately <span id="xdx_906_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20230331_zDRtt91TvcEk" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67.9</ix:nonFraction></span>% and <span id="xdx_901_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20210701__20220331_z23GkfayzObl" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.6</ix:nonFraction></span>% of the PCs&#8217; net revenue for the nine months ended March 31,
2023 and 2022, respectively, were derived from no-fault and personal injury protection claims. The Company considers the aging of its
accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps
to collect its receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements
and have historically been within management's expectations.&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div id="xdx_234_zChZctHSPlDa" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td id="xdx_234_zDxLemaTHce9" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_235_zNEtEKDtG5b3" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_zqXSSYb3D4Yk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zYQqAHg1ygB4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zORji2ix2yOb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zGnjXCrUdhY9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zIgTkf4VQPN8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zlSh5RtOFHk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zv3NLrCWGY2f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zf4GkEM9QuD3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zzfjLPQHGvUa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zsTk8IonTVd8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zTR7YaEqtk33" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_90B_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230101__20230331_zKOyxHFSp4Zd" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.7</ix:nonFraction></span>% and <span id="xdx_902_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220101__20220331_zh5z3Wa5IWba" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.2</ix:nonFraction></span>% of the consolidated net
revenues for the three months ended March 31, 2023 and 2022, respectively. Net revenues from management and other fees charged to the
related PCs accounted for approximately <span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20230331_zM2ua95QwnQh" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.3</ix:nonFraction></span>% and <span id="xdx_908_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20210701__20220331_zwQSUijctVFl" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.8</ix:nonFraction></span>% of the consolidated net revenues for the nine months ended March 31, 2023 and
2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three and nine months ended March 31, 2023 and
2022 are summarized in the following table.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="FONR:ScheduleOfPatientFeeRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zintqeAeMla2" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BF_zJjOMnWk6aJg" style="display: none">Schedule of patient fee revenue</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
                                            the Three Months</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Ended
                                            March 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-01-012023-03-31_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,037</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-01-012022-03-31_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,095</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-01-012023-03-31_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">303</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-01-012022-03-31_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">287</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-01-012023-03-31_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,186</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-01-012022-03-31_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,624</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-01-012023-03-31_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,662</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-01-012022-03-31_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,635</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,188</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,641</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
                                            the Nine Months</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Ended
                                            March 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012023-03-31_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,905</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012022-03-31_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,249</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012023-03-31_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">788</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012022-03-31_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">809</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012023-03-31_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,683</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012022-03-31_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,092</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012023-03-31_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,017</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012022-03-31_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,785</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,393</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,935</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zRGIuXR46sti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div id="xdx_231_z4N839rjKsA" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td id="xdx_23C_zeNrFvoQfkdk" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zV139U1HdC2g" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_230_zV9ZCNSwMFN6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zPGNjI7oyKs3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z3ASCd7ILGE7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z2s9utTQPje4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zmWUXnnv7FE1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zkjDVnxTrKRc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zK9FVJeK9vMd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_zFtD9UIckw03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; <span id="xdx_822_z8YaEraSjH61">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will
not apply the standard to the comparative periods presented in the condensed consolidated financial statements. We have also elected
the transition package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior
conclusions about lease identification, lease classification and indirect costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of March 31, 2023
is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_zf6de1HtaBH8" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8BD_zOfwVh5Cq7Fe" style="display: none">Lessee operating leases liability maturity</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Twelve
    Months Ending <br />March 31,</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    Lease <br />Payments</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2024" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,613</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2024" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2025" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,661</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2025" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2026" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,304</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2026" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2027" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,520</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="2027" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">204</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="2028" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,642</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zXcKMcW9uTX9" title="2028" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1326">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="Thereafter" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,835</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zZL2xC0vNGm3" title="Thereafter" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1330">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PresentValueDiscount_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="Present value discount" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">9,964</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PresentValueDiscountFinancingLease_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="Present value discount" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">62</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" title="Total lease liability" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,611</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" title="Total lease liability" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiability" contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">874</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div id="xdx_231_zQcI3SsPEzy7" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td id="xdx_235_zP4XO41G1iah" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_234_zueyz6cUkJ44" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23A_ziXm7qpi6PZ1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zF3tkOA8vIRg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z7TAw1B4rovj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z4uZ7mQjMp5h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zBei0jBwhqY" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_z57nZbR3SaE7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zIRI9jbtaVE" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zM27HCXjJac1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
5 - <span id="xdx_82E_zaQmlCkoIXH5">INVENTORIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zHHVGifWLXr5" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8B8_zJlWPuC2Xmz2" style="display: none">Schedule of inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49A_20230331_zoqVkC5bN56e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49B_20220630_zPUFMbxA9ku1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br />2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br />2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzjFD_zR68CrEwejXk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,456</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,126</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzjFD_zLHNioTC1cK2" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">234</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzjFD_zx6wIeBIEmS" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,661</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,360</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--IntangibleAssetsDisclosureTextBlock_zyKSmmN3pD8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_822_zBwRpSudoelc">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_z1AjpVHk6Ms6" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B1_zEbTVwVJb3L9" style="display: none">Schedule of other intangible assets - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br />2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br />2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,420</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,333</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non-compete</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331_pn3n3" title="Gross other intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,475</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" title="Gross other intangible assets" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,388</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331_pn3n3" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,981</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" title="Less: Accumulated amortization" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,684</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331_pn3n3" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,494</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" title="Other intangible assets-net" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended March 31, 2023 and 2022 amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zjPIwtAHpyj5" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-03-31_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">46</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zvLoY5iIZ7c6" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-03-31_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the three months ended March 31, 2023 and 2022 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zhMYvqkAbzE2" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-03-31_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zeFPp5Ypbq3g" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-03-31_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended March 31, 2023 and 2022 amounted to $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5HzUsaLk31k" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zCF0lGgKsDY4" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-01-012022-03-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the nine months ended March 31, 2023 and 2022 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zxZeKK1OYcc3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-03-31_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zitapwsRoVt7" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-03-31_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">140</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the nine months ended March 31, 2023and 2022 amounted to $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-03-31_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zzkFjrIh4aj9" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-03-31_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">38</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the nine months ended March 31, 2023 and 2022 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z9qGoaLyIHPh" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012023-03-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zISASBoy3thl" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012022-03-31_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span>, respectively.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 19 -->
    <div id="xdx_23C_zXztXOKBurOd" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td id="xdx_236_zDRnK5eLOfee" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_z2viDewE9Cul" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23E_zsta4AfIo165" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zMZ37xuCLssd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zQXooix6JMy4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zifApvme7vd9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zakCw2WvVE1h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_z6ArDmPCdu26" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zC1aM9F8C7Nd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_801_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zdDSwhYOTkKb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; <span id="xdx_825_zgOb5BPq8i5h">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHrcBkEQFTg4" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8B1_zS8sgM1f5Bq4" style="display: none">Schedule of other current liabilities</span></td><td style="font-size: 11pt">&#160;</td>
    <td colspan="3" id="xdx_495_20230331_zNaAi5NQOBld" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220630_zVn1pwwmIpl" style="font-size: 11pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
                                            31,</span></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></p></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
                                            30,</span></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzBfQ_zE56UO2NpdVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,046</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,653</ix:nonFraction></span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzBfQ_zDw15wTFKYD2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">249</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzBfQ_z9cJaKOmmVL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">200</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">382</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzBfQ_zW8pYuhRjlT8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzBfQ_zz0d1PDiaIsb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">89</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzBfQ_zFnq5SwfZDkc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzBfQ_zbxbF8jxpnK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzBfQ_z7fBg2Q0UjKl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    general and administrative expenses</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">902</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">854</ix:nonFraction></span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzBfQ_zPzaRuODK2g4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,496</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,417</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zDqs0rjkEDSb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_82E_zdcn7lbVPgLh">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2022. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


<ix:exclude><!-- Field: Page; Sequence: 20 -->
    <div id="xdx_233_zCh3wBh3Ic5i" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td id="xdx_23A_zijDJNduDTpl" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_z92Rl9O5yHcc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zVFjMeKQk0J5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zYnB2ZLrvNk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zlJ7CaR617w2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zXdE4gDvrr79" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zCZ7QFcSSaek" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zkxHft1iK8j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zuSHwJSRXNeh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zWWzC2pW4798" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - SEGMENT AND RELATED INFORMATION (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zxDidcHDxzyh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zG5iedbA3Qha" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B9_z0QG7wJSlePg" style="display: none">Summarized segment financial information</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the three
    months ended March, 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br /> Equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br /> of Diagnostic <br /> Imaging <br /> Centers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,884</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,538</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331_pn3n3" title="Net revenues from external customers" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">25,422</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zhiQbGlmYfT6" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1475">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,141</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,308</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,167</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,075</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,139</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,191</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2023-01-012023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,204</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended March 31, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,039</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,532</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331_pn3n3" title="Net revenues from external customers" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24,571</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zWo1LAFkij4d" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1505">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20220101__20220331_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">537</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,175</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,638</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">64</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,121</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,185</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,620</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-01-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,663</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the nine
    months ended March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br /> Equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br /> of Diagnostic <br /> Imaging <br /> Centers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,797</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67,072</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331_pn3n3" title="Net revenues from external customers" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,869</ix:nonFraction></span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--IntersegmentNetRevenues_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">735</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zm1qfv1Egyp2" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1535">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_c20220701__20230331_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">735</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,495</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,804</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,309</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">201</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,156</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,357</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">87</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,553</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,640</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the nine months ended March 31, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,284</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">66,496</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331_pn3n3" title="Net revenues from external customers" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72,780</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">720</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zanQVRQd1vtl" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1565">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_c20210701__20220331_pn3n3" title="Inter-segment net revenues" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">720</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,054</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">18,917</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331_pn3n3" title="(Loss) Income from operations" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,863</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,344</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331_pn3n3" title="Depreciation and amortization" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,543</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">230</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,577</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331_pn3n3" title="Capital expenditures" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,807</ix:nonFraction></span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zdikaxwrwYga" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">&#160;</p>

<ix:exclude><p id="xdx_233_zPYnqjDPf0h3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><!-- Field: Page; Sequence: 21 -->
    <div id="xdx_233_ze48oAzZIqJ2" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_232_zrQ35p1QzZ44" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_233_zSXYS62V1Pkh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p></ix:exclude>

<ix:exclude><p id="xdx_233_z1erOXXiRVxc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zKU0D8xcFSua" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zKZn7bkhRjK4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zEm9IHWUYTG4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zqIt60QZF6C2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zJuQhiUalaPk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zt6gMUnrIiAe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_809_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zP94toHF7ba7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_82F_zKUwW8USZ4s3">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2023 and March 31, 2022, the Company paid $<span id="xdx_902_eus-gaap--InterestPaid_c20220701__20230331_pn3n3" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--InterestPaid_c20210701__20220331_pn3n3" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">279</ix:nonFraction></span> for interest, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2023 and March 31, 2022, the Company paid $<span id="xdx_90D_eus-gaap--IncomeTaxesPaid_c20220701__20230331_pn3n3" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,140</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20210701__20220331_pn3n3" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,105</ix:nonFraction></span> for income taxes, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zxTgmwXhR8Yh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; <span id="xdx_828_zro1ji9JsGG2">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90D_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926_zjYV2rN8KZ84" title="Stock purchase plan"><ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="AsOf2022-09-26" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">9</ix:nonFraction></span> million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the nine months ended March 31, 2023, the Company
repurchased <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20230331_zl6jleIiHv4c" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">70</ix:nonFraction></span> shares at a cost of $<span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodValue_c20220701__20230331_pn3n3" title="Number of shares repurchased, value"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,249</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_90B_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_iI_pn3n3_c20230331_zNLr7P6z7nu" title="Maximum limit for individual claims under stop-loss umbrella policy for health insurances"><ix:nonFraction name="FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span> per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of March 31, 2023 and June 30, 2022, the Company had approximately $<span id="xdx_901_eus-gaap--SelfInsuranceReserve_c20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--SelfFundedHealthInsuranceMember_pn3n3" title="Self-funded health insurance reserve"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2023-03-31_custom_SelfFundedHealthInsuranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">35</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--SelfInsuranceReserve_c20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--SelfFundedHealthInsuranceMember_pn3n3" title="Self-funded health insurance reserve"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-06-30_custom_SelfFundedHealthInsuranceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span>, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the
condensed consolidated balance sheets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 22 -->
    <div id="xdx_23D_zqzhcHi5xU9l" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td id="xdx_232_zqVnZ59hkg59" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_237_ztKvYsfhlAVi" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zOFKb44ZmXa5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_z2Cueit4g4fh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zbeBXcCGYcM4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zcsQsKluoKz8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zxONvM7FrJ5a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zG5lyvl7xtFc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zd3BjxA4atne" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zwiNmwcRTUBg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11 - <span id="xdx_823_zCubvGHEu9x9">INCOME TAXES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740-270, &#8220;Income Taxes &#8211; Interim Reporting&#8221;, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the nine months ended March 31, 2023 and 2022, the Company recorded income tax expense of $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20220701__20230331_pn3n3" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,889</ix:nonFraction></span> in 2023 as compared
to $<span id="xdx_909_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20210701__20220331_pn3n3" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2021-07-012022-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,311</ix:nonFraction></span> in 2022. The 2023 provision is comprised of a current income tax component of $<span id="xdx_905_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220701__20230331_pn3n3" title="Income tax component - current"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">958</ix:nonFraction></span> and a deferred income tax component of $<span id="xdx_909_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220701__20230331_pn3n3" title="Income tax component - deferred"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,931</ix:nonFraction></span>.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2019.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company recorded a deferred tax asset of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_c20230331_pn3n3" title="Deferred tax asset"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10,911</ix:nonFraction></span> and a deferred tax liability of $<span id="xdx_90F_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20230331_pn3n3" title="Deferred tax liability"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span> as of March 31, 2023, primarily relating to net
operating loss carryforwards of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_c20230331_pn3n3" title="Operating Loss Carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2023-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,191</ix:nonFraction></span> available to offset future taxable income through 2032. The net operating losses
begin to expire in 2023 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss
carryforwards. As of March  31, 2023, no such changes in ownership have occurred.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 23 -->
    <div id="xdx_23D_zAMFB9mjb62h" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td id="xdx_233_zaBwQsKH3FAj" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_23A_zgqrs8CNVjOg" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_232_zuOYyEcoV3k1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zlbMCpOfRhw6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zzLWEMnqSLVk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zp9gfiNkYjJ9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2023 and 2022</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z9g3rfiL899j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zMUCK16I3xx" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zH56jwBbOpU4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_ze2oKhTqto8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zVZiDiornqlk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_902_ecustom--ExciseTax_pip0_dp_c20220701__20230331_zDJfJO9kFbTk" title="Excise tax"><ix:nonFraction name="FONR:ExciseTax" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>% excise tax on share
repurchases that occur after December 31, 2022 and introduces a <span id="xdx_90F_ecustom--CorporateMinimumTax_pip0_dp_c20220701__20230331_zqT8bTRouTu6" title="Corporate minimum tax"><ix:nonFraction name="FONR:CorporateMinimumTax" contextRef="From2022-07-01to2023-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company does not
expect the IRA to have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2023-03-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zuhnhZ7GtVMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
12 &#8211; <span id="xdx_826_zrDzIiQSJd6g">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to March 31, 2023 and through the date the condensed consolidated financial statements
were issued.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
April 2023, the Company repurchased <span id="xdx_904_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z13GysIc4lNa" title="Stock repurchase plan, shares"><ix:nonFraction name="us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" contextRef="AsOf2023-04-30_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6</ix:nonFraction></span> shares at a cost of $<span id="xdx_904_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHDvpBbYpYJ7" title="Stock repurchase plan"><ix:nonFraction name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" contextRef="AsOf2023-04-30_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">101</ix:nonFraction></span> which was authorized under the stock repurchase plan adopted in September
2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
April 2023, the Company amended the revolving credit agreement. The agreement was extended to July 7, 2023. The interest rate on borrowings
is at the current prime rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230401__20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh0Mrg79Vbad" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-04-012023-04-30_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.00</ix:nonFraction></span>% along with certain financial covenants.&#160;&#160;</span></p>

</ix:nonNumeric><p id="xdx_817_zziNjmdCkthc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="MDA"></span>Item
2. &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited
condensed financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q and with our audited
consolidated financial statements and notes thereto for the year ended June 30, 2022 included in our Annual Report on Form 10-K for the
fiscal year ended June 30, 2022 filed with the U.S. Securities and Exchange Commission (SEC) on September 28, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the nine month period ended March 31, 2023, we reported a net income of $9.9 million on revenues of $72.9 million as compared to net
income of $13.6 million on revenues of $72.8 million for the nine month period ended March 31, 2022. Operating income decreased from
$17.9 million for the nine month period ended March 31, 2022 to $12.3 million for the nine month period ended March 31, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the three month period ended March 31, 2023, we reported a net income of $3.9 million on revenues of $25.4 million as compared to net
income of $3.3 million on revenues of $24.6 million for the three month period ended March 31, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">While
our revenues increased slightly, our costs and expenses increased, but by a greater amount resulting in our operating income decreasing
to $12.3 million for the nine months ended March 31, 2023 as compared to $17.9 million for the nine months ended March 31, 2022. In terms
of percentages, costs and expenses increased 10.2% from $54.9 million for the first nine months of fiscal 2022 to $60.6 million for the
first nine months of fiscal 2023, while revenues increased 0.1%, from $72.8 million for the first nine months of fiscal 2022 to $72.9
million for the first nine months of fiscal 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Fonar&#8217;s
wholly owned subsidiary, Health Management Corporation of America (&#8220;HMCA&#8221;), has the controlling interest in Health Diagnostics
Management, LLC (&#8220;HDM&#8221;). HMCA presently has a direct ownership interest of 70.8% in HDM, and the investors in HDM have a
29.2% ownership interest, as compared to HMCA&#8217;s 70% ownership interest and the investors&#8217; 30% ownership interest in HDM in
fiscal 2021. This change resulted from the Company&#8217;s purchase of non-controlling interests from the minority shareholders for $546,000
in the second quarter of fiscal 2022. The management of the diagnostic imaging centers business segment is being conducted by HDM, operating
under the name &#8220;Health Management Company of America&#8221;. For the sake of simplicity, HMCA, and HDM are referred to as &#8220;HMCA&#8221;,
unless otherwise indicated.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
most significant adverse impact on our Company in fiscal 2022 and fiscal 2023 has been the continuing effects of the COVID-19 pandemic.
During April 2023 legislation was passed to end the national emergency for COVID-19 and it seems the worst has passed. This is by no
means a problem confined to our Company, but despite our best efforts and improved ability to cope with the pandemic and the availability
of new vaccines, the impact on our results of operation and financial condition is potentially volatile and severe.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused disruptions in the United States and international markets which have adversely affected our workforce,
financial condition, profitability and business operations. The Company was able to enact certain decisions to allow the Company to survive
during the global pandemic and prevent further losses or additional decreases in scan volume. Although we are unable to predict if there
will be additional consequences on our operations from the continuing global pandemic of COVID-19 and its variants, the Company believes
with the ending of the national emergency and with its strong cash position and general financial condition, it will be able to continue
operations going forward.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">One
of the concerns we have had is the increased strictness in enforcement of certain COVID-19 mandates, which directly impacts the
conduct of our business, such as the requirement that employees in healthcare facilities be vaccinated. Another concern we have is
the newer variants that are more transmissible. We are in fact facing some of these challenges now. As a result, between absences
due to illness and the loss of unvaccinated employees whose duties required them to be in contact with patients, we were sometimes
unable to keep a scanning facility open for all shifts. The New York State Supreme Court recently invalidated the requirement that
all medical employees must be vaccinated. This decision is currently under appeal and we are unsure of the outcome. Also at the end
of the first quarter of fiscal 2023, our Florida locations were effected by Hurricane Ian and had to be shut down for several days.
During the first nine months of fiscal 2023, the aggregate number of scans performed by the sites we manage or own declined slightly
to 139,339 scans from 140,650 scans in the first nine months of fiscal 2022. Nevertheless, we have been able to navigate through
these challenges and avoid any significant disruption to our business</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Forward
Looking Statements</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain
statements made in this Quarterly Report on Form 10-Q are &#34;forward-looking statements&#34; (within the meaning of the Private Securities
Litigation Reform Act of 1995) regarding the plans and objectives of Management for future operations. Such statements involve known
and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements
included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based,
in part, on assumptions involving the expansion of business. Assumptions relating to the foregoing involve judgments with respect to,
among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible
to predict accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking
statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this Report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking
statement included herein, the inclusion of such information should not be regarded as a representation by us or any other person that
our objectives and plans will be achieved.</span></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Results
of Operations</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
operate in two industry segments: the manufacture and servicing of medical (MRI) equipment, which is conducted by Fonar, and diagnostic
facilities management services, which is conducted through HMCA.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Manufacturing
and Service of MRI Equipment</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenues
from MRI product sales decreased to $225,000 for the first nine months of fiscal 2023 from $481,000 for the first nine months of fiscal
2022. Costs related to product sales increased from $352,000 for the nine month period ended March 31, 2022 to $580,000 for the nine
month period ended March 31, 2023. Economic uncertainty and lower reimbursement rates for MRI scans, have depressed the market for our
MRI scanner products, notwithstanding our scanners&#8217; unique technological capabilities (e.g. multi positional scanning). Due to
the low sales volumes of our MRI product, period to period comparisons are not necessarily indicative of any trends.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
revenues decreased to $5.6 million for the nine month period ended March 31, 2023 as compared to $5.8 million for the nine month period
ended March 31, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
relating to providing service increased slightly to $2.3 million for the nine month period ended March 31, 2023 as compared to $2.2 million
for the nine month period ended March 31, 2022. Because of our ability to monitor the performance of customers&#8217; scanners from our
facilities in Melville, New York on a daily basis and to detect and repair any irregularities before more serious and costly problems
develop, we have been able to contain our costs of providing service.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were approximately $375,000 in foreign revenues for the first nine months of fiscal 2023 as compared to approximately $466,000 in foreign
revenues for the first nine months of fiscal 2022, representing a decrease in foreign revenues of 19.5%. We do not regard this as a material
trend, but as part of a normal although sometimes volatile variation resulting from low volumes of foreign sales.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
recognize MRI scanner sales revenues on the &#8220;percentage of completion&#8221; basis, which means the revenues are recognized as
the scanner is manufactured. Revenues recognized in a particular quarter do not necessarily reflect new orders or progress payments made
by customers in that quarter. We build the scanner as the customer meets certain benchmarks in site preparation and our installation
of the scanner, in order to minimize the time lag between incurring costs of manufacturing and our receipt of the cash progress payments
from the customer which are due upon delivery. Consequently, there can be a disparity between the revenues recognized in a fiscal period
and the number of product sales. Generally, the revenues from a scanner sale are recognized in a fiscal quarter or quarters following
the quarter in which the sale was made.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenues
for the medical equipment segment decreased to $5.8 million for the first nine months of fiscal 2023 from $6.3 million for the first
nine months of fiscal 2022. Operating losses for our medical equipment segment increased to an operating loss of $2.5 million, for the
first nine months of fiscal 2023 as compared to an operating loss of $1.1 million for the first nine months of fiscal 2022.</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diagnostic
Facilities Management Services</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">HMCA
revenues increased in the first nine months of fiscal 2023 by 0.8% to $67.1 million from $66.5 million for the first nine months of fiscal
2022. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage of our revenues
derived from our medical equipment segment increased slightly to 92.0% for the first nine months of fiscal 2023, from 91.3% for the first
nine months of fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
current strategy is to counter the effects of lower reimbursement rates by increasing the scan volume of the facilities it owns or manages
by adding additional scanners at current centers and increasing our marketing efforts. As a result of the COVID-19 virus, however, the
Company had seen decreases in its scan volume. Nevertheless, the Company continued its program of adding additional scanners. The scan
volume decreased slightly in the first nine months of 2023. Other factors that have led to the slight decrease can also be attributable
to Hurricane Ian which caused the Florida locations to be closed for several days. The continuation of the COVID-19 virus and its various
variants that are more transmittable may delay the completion of the installation of some of the scanners. If scan volumes decrease however,
and remain at lower volumes, the Company, notwithstanding its ample cash reserves, may need to consider reducing the size of its operations
temporarily as a last resort.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">New
York State mandated that as of October 7, 2021, all workers at hospitals, long-term care facilities and diagnostic centers be COVID-19-vaccinated.&#160;
Workers who were not vaccinated either resigned, were transferred to a non-diagnostic facility within the company, or were dismissed.
The resulting reduction in the number of workers available at sites owned or managed by HMCA, had been challenging and had significantly
reduced the pool of qualified and vaccinated workers. Also this is combined with the emergence of the new highly transmissible variants.
HMCA owned or managed sites struggling with reduced staff either had cut their business hours and therefore scanned fewer patients or,
when possible, maintained regular business hours by paying employees who are willing to work extra hours at overtime rates.&#160; The
NYS Supreme Court recently invalidated the requirement that all medical employees must be vaccinated. This decision is currently under
appeal and we are unsure of the outcome.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Although
the number of scans performed at our centers and at our client&#8217;s centers has recovered to pre-COVID-19 levels, it has decreased
from approximately 140,600 in the first nine months of fiscal 2022 to approximately 139,300 in the first nine months of fiscal 2023.
The decrease in scans was due to a shortage of MRI technologists who operate the scanners, which is an industry-wide issue that caused
our centers to be open for fewer hours. We believe that the worst part of this shortage has passed and we just recently came back to
full employment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
now manage or own a total of 41 MRI scanners. Twenty-four (24) MRI scanners are located in New York and seventeen (17) are located in
Florida. HMCA experienced an operating income of $14.8 million for the first nine months of fiscal 2023 compared to operating income
of $18.9 million for the first nine months of fiscal 2022.</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ability of HMCA to maintain its profitability is principally due to HMCA&#8217;s success in marketing the scanning services of the facilities
managed or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government
programs and the lockdowns imposed as a result of the COVID-19 virus. The reductions in reimbursement rates are not unique to HMCA or
HMCA&#8217;s clients but are being experienced by the industry in general.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
cost of revenues for the first nine months of fiscal 2023 as compared to the first nine months of fiscal 2022 increased by 3.3% from
$35.3 million to $36.5 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Consolidated</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the first nine months of fiscal 2023, our consolidated net revenues increased by 0.1% to $72.9 million from $72.8 million for the first
nine months of fiscal 2022, and total costs and expenses increased by 10.2% to $60.6 million from $54.9 million for the first nine months
of fiscal 2023 and for the first nine months of fiscal 2022 respectively. As a result, our operating income decreased to $12.3 million
in the first nine months of fiscal 2023 as compared to $17.9 million in the first nine months of fiscal 2022. An increase in selling,
general and other administrative costs in particular resulted in the increase of cost and expenses as compared to the increase in net
revenues.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Selling,
general and administrative expenses increased to $20.1 million in the first nine months of fiscal 2023 from $15.9 million in the first
nine months of fiscal 2022. This increase in selling, general and administrative expenses was due mainly to more reserves taken on management
fees. Some of these reserves had been taken in the ordinary course of business and some in connection with the impact of the COVID-19
virus. </span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Research
and development expenses remained constant at $1.1 million for the first nine months of fiscal 2023 and the first nine months of fiscal
2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Interest
expense in the first nine months of fiscal 2023 increased by 355% to $41,000 from $9,000 in the first nine months of fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
increased to $2.7 million at March 31, 2023 as compared to $2.4 million at June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
management fee and medical receivables increased by 4.2% to $64.7 million at March 31, 2023 from $62.1 million at June 30, 2022 as a
result of slower collections and increased scan volume due to the opening of a new location in Florida. The slower collections were primarily
due to an increase in no-fault and workers&#8217; compensation revenue, which typically takes longer to collect.</span></p>


<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
results of operations for the first nine months of fiscal 2023 reflect an increase in revenues from management, patient and other fees,
as compared to the first nine months of fiscal 2022 ($67.1 million for the first nine months of fiscal 2023 as compared to $66.5 million
for the first nine months of fiscal 2022), and a decrease in the MRI equipment segment revenues ($5.8 million for the first nine months
of fiscal 2023 as compared to $6.3 million for the first nine months of fiscal 2022). Revenues were 8.0% from the MRI segment and 92.0% from HMCA, for the first nine months of fiscal 2023, as compared to 8.7% from the MRI equipment segment and 91.3% from HMCA
for the first nine months of fiscal 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">As
a result of the Patient Protection and Affordable Care Act (PPACA) we have experienced a reduction of reimbursement rates and less interest
in our MRI equipment. Any changes to the PPACA may result in further changes in the healthcare industry and our business.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements. Nevertheless,
factors beyond our control, such as the COVID-19 virus, the timing and rate of market growth, economic conditions, the availability of
credit and payor reimbursement rates, or unexpected expenditures and the timing of such expenditures, make it difficult to forecast future
operating results.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">As
mentioned, one of the effects of the PPACA on our business has been the reduction in Medicare reimbursement rates for MRI scans. This
also has resulted in a reduction in the reimbursement rates by commercial insurers and government programs which tie their reimbursement
rates to the Medicare rates. Nevertheless, the patient volume of the scanning centers we manage or own has enabled us to maintain healthy
operating results in spite of these challenges. We believe we are pursuing the correct policies to cope with these problems and the problems
caused by the COVID-19 pandemic, and to improve the Company&#8217;s operating results.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
Upright&#174; MRI (also referred to as the Stand-Up&#174; MRI), together with our works-in-progress, are intended to significantly improve
our competitive position.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting,
reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in
some positions and not others. This enables surgical corrections that heretofore would not have been addressable for lack of visualizing
the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better treatment outcome for
his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built multi-position
adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the MRI technologist to
ask the patient to position himself/herself in the exact position that generates his/her pain so that images of the patient in the position
that explicitly generates the patient&#8217;s pain can be nailed down. Full-range-of-motion studies of the joints in virtually any direction
are possible, a particularly promising feature for sports injuries.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting,
reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in
some positions and not others. This enables surgical corrections that heretofore would not have been addressable for lack of visualizing
the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better treatment outcome for
his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built multi-position
adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the MRI technologist to
ask the patient to position himself/herself in the exact position that generates his/her pain so that images of the patient in the position
that explicitly generates the patient&#8217;s pain can be nailed down. Full-range-of-motion studies of the joints in virtually any direction
are possible, a particularly promising feature for sports injuries.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
addition, FONAR had announced the publication of a book &#8220;THE CRANIOCERVICAL SYNDROME and MRI&#8221; that highlights the unique
attributes of FONAR UPRIGHT&#174; MRI Imaging (S. Karger, A.G. based in Basel, Switzerland- www.karger.com/Book/Home/261956) which has
been published by S. Karger, an approximately 125 year old company and an academic publisher of scientific and medical journals and books.
The seven chapter monograph examines the rapid advances in MRI made possible by the FONAR UPRIGHT&#174; Multi-Position MRI that are transforming
the treatment of patients suffering from the craniocervical syndrome (CCS). It is written by leading international experts in the field
to practitioners with a better understanding of the subtle anatomy and MRI appearances at the craniocervical junction, along with insight
into the clinical significance of cerebrospinal fluid (CSF) flow measurements and its potential role in generating the devastating impairments
of the neurodegenerative diseases: Alzheimer&#8217;s (5.1 million patients in the United States), childhood and adult Autism (3.0 million),
Parkinson&#8217;s (1.0 million), Multiple Sclerosis (250,000-350,000) and Amyotrophic Lateral Sclerosis (ALS) (30,000). It calls attention
to the revolutionary importance of FONAR&#8217;s UPRIGHT&#174; MRI imaging technology and the prospect of significantly relieving the
suffering of the above totaled 9.38 million patients afflicted with these disorders.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Fonar
also had announced a major diagnostic breakthrough in multiple sclerosis achieved with advanced Upright&#174; MRI. Medical researchers
at FONAR published a paper reporting a diagnostic breakthrough in multiple sclerosis (MS), based on observations made possible by the
Company&#8217;s unique Upright&#174; Multi-Position&#8482; MRI scanner. The findings reveal that the cause of multiple sclerosis may be
biomechanical and related to earlier trauma to the neck, which can result in obstruction of the flow of cerebrospinal fluid (CSF), which
is produced and stored in the central anatomic structures of the brain known as the ventricles. Since the ventricles produce a large
net volume of CSF each day (500 cc), the obstruction can result in a build up of pressure within the ventricles, resulting in leakage
of the CSF and the antigenic polypeptides it contains into the surrounding brain tissue. This leakage could be responsible for generating
the brain lesions of multiple sclerosis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
paper, titled &#8220;The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis,&#34;
appears in the journal Physiological Chemistry and Physics and Medical NMR (Sept. 20, 2011).</span></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">This
capability of the Fonar Upright&#174; technology has demonstrated its key value on patients with the Arnold-Chiari syndrome [Cerebellar
Tonsil Extopia (CTE)], which is believed to affect 200,000 to 500,000 Americans. In this syndrome, brain stem compression and subsequent
severe neurological symptoms occur in these patients, because the brain stem descends and is compressed at the base of the skull in the
foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the skull. Conventional lie-down
MRI scanners cannot make an adequate evaluation of this pathology since the patient's pathology is most visible and the symptoms most
acute when the patient is scanned in the upright fully weight-bearing position.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
combined study of 1,200 neck pain patients published in &#8220;Brain Injury&#8221; (July 2010) by eight university medical centers reported
that cerebellar tonsil ectopia (CTE) of 1mm or greater was found and visualized 2.5 times (250%) more frequently when patients who had
sustained automobile whiplash injuries were scanned upright rather than lying down.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI has also demonstrated its value for patients suffering from scoliosis. Scoliosis patients have been typically subjected
to routine x-ray exams for years and must be imaged upright for an adequate evaluation of their scoliosis. Because the patient must be
standing for a complete evaluation of the extent of the patient&#8217;s scoliosis, an x-ray machine has been the only modality that could
provide that service. The Upright&#174; MRI is the only MRI scanner which allows the patient to stand during the MRI exam. Fonar has developed
an RF receiver and scanning protocol that for the first time allows scoliosis patients to obtain diagnostic pictures of their spines
without the risks of x-rays. A study by the National Cancer Institute (2000) of 5,466 women with scoliosis reported a 70% increase in
breast cancer resulting from 24.7 chest x-rays these patients received on the average in the course of their scoliosis treatment. The
Upright&#174; MRI examination of scoliosis enables the needed imaging evaluation of the degree of spine scoliosis without exposing the
patient to the risk of breast cancer from x-radiation. Currently scoliosis affects more than 3,000,000 American women.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
addition, the University of California, Los Angeles (UCLA) reported their results of their study of 1,302 patients utilizing the Fonar
Upright&#174; MRI at the 22nd Annual Meeting of the North American Spine Society on October 23, 2007. The UCLA study showed the superior
ability of the Fonar Upright&#174; MRI to detect spine pathology, including spondylolisthesis, disc herniations and disc degeneration,
as compared to visualizations of the spine produced by traditional single position static MRIs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;The
UCLA study by MRI of 1,302 back pain patients when they were in the Fonar Upright&#174; MRI and examined in a full range of flexion and
extension positions made possible by Fonar&#8217;s new Upright&#174; technology established that significant &#8220;misses&#8221; of pathology
were occurring with static single position MRI imaging. At L4-5, the vertebral level responsible for 49.8% of lumbar disc herniations,
35.1% of the spondylolistheses (vertebral instabilities) visualized by the Upright&#174; MRI, were being missed by static single position
MRI (510 patients). Since this vertebral segment is responsible for the majority of all disc herniations, the finding may reveal a significant
cause of failed back surgeries. The UCLA study further showed the &#8220;miss-rate&#8221; of vertebral instabilities by static only MRI
was even higher, 38.7%, at the L3-4 vertebral segment. Additionally, the UCLA study showed that MRI examinations of the cervical spine
that did not perform extension images of the neck &#8220;missed&#8221; disc bulges 23.75% of the time (163 patients).</span></p>


<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
UCLA study further reported that they were able to quantitatively measure the dimensions of the central spinal canal with the &#8220;highest
accuracy&#8221; using the FONAR Upright&#174; MRI thereby enabling the extent of spinal canal stenosis that existed in patients to be
measured. Spinal canal stenosis gives rise to the symptom complex intermittent neurogenic claudication manifest as debilitating pain
in the back and lower extremities, weakness and difficulties in ambulation and leg paresthesias. Spinal canal stenosis is a spinal compression
syndrome separate and distinct from the more common nerve compression syndrome of the spinal nerves as they exit the vertebral column
through the bony neural foramen.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Fonar Upright&#174; MRI can also be useful for MRI directed emergency neuro-surgical procedures as the surgeon would have unhindered access
to the patient&#8217;s head when the patient is supine with no restrictions in the vertical direction. This easy-entry, mid-field-strength
scanner could prove ideal for trauma centers where a quick MRI-screening within the first critical hour of treatment will greatly improve
patients&#8217; chances for survival and optimize the extent of recovery.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;MRI
has brought a new dimension to MEDICAL TREATMENT, the power to VISUALIZE ANATOMIC DETAIL in the body's VITAL SOFT TISSUES (brain, heart,
kidney, liver, spleen, lungs, pancreas, intestines) plus MRI's new power to non-invasively QUANTIFY (e.g. measure T1, T2, diffusion,
chemical spectra) the response of these VITAL TISSUES to treatment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Liquidity
and Capital Resources</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents, and short term investments increased by 1.8% from $48.7 million at June 30, 2022 to $49.7 million at March 31,
2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
provided by operating activities for the first nine months of fiscal 2023 was $10.1 million. Cash provided by operating activities was
attributable principally to net income of $9.9 million, depreciation and amortization of $3.4 million, amortization on right-to-use assets
of $3.3 million, provision for bad debts of $4.4 million and deferred income tax of $1.9 million, offset by an increase in accounts,
management fee receivables and medical receivables of $5.6 million and a decrease in other current liabilities of $4.4 million.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
used in investing activities for the first nine months of fiscal 2023 was $3.6 million. Cash used in investing activities during the
first nine months of fiscal 2023 consisted of patent costs of $87,000 and the purchase of property and equipment of $3.6 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
used in financing activities for the first nine months of fiscal 2023 was $5.6 million. The principal uses of cash in financing activities
during the first nine months of fiscal 2022 were the repayment of principal on long-term debt and capital lease obligations of $26,000,
the purchase of treasury stock of $1.2 million and distributions to non-controlling interests of $4.3 million.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
liabilities decreased by 8.2% to $48.7 million at March 31, 2023 from $53.1 million at June 30, 2022. &#8220;Other&#8221; current liabilities
decreased by 45.5% to $3.5 million at March 31, 2023 from $6.4 million at June 30, 2022. The current portion of our service contract
liabilities decreased by 15.0% to $3.6 million at March 31, 2023 as compared to $4.3 million at June 30, 2022. Customer deposits increased
from $361,000 at June 30, 2022 to $826,000 at March 31, 2023.</span></p>


<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">As
of March 31, 2023, the total of $3.5 million in &#8220;other&#8221; current liabilities included accrued salaries and payroll taxes of
$2.0 million, state income taxes payable of $200,000 and other general and administrative expenses of $900,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
working capital increased to $108.1 million at March 31, 2023 from $101.9 million at June 30, 2022. This resulted from an increase in
current assets ($118.7 million at June 30, 2022 as compared to $122.0 million at March 31, 2023), and a decrease in current liabilities
from $16.7 million at June 30, 2022 to $13.9 million at March 31, 2023.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry, and tax planning strategies in making this assessment. At the present, the Company
believes that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized.
In recognition of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, (principally
related to research and development tax credits and allowance for doubtful accounts). A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of any portion or all of the valuation allowance.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s effective income tax rate is based on expected income, statutory rates and tax planning opportunities available in the
various jurisdictions in which it operates. For interim financial reporting, the Company estimates the annual income tax rate based on
projected taxable income for the full year and records a quarterly income tax provision or benefit in accordance with the anticipated
annual rate. The Company refines the estimates of the year&#8217;s taxable income on a periodic basis as new information becomes available,
including actual year-to-date financial results. This continual estimation process often results in a change to the expected effective
income tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in
estimate occurs so that the year-to-date provision reflects the expected income tax rate. Significant judgment is required in determining
the effective tax rate and in evaluating tax positions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
August 16, 2020 Congress enacted the Inflation Reduction Act (&#8220;IRA&#8221;). The IRA includes provisions imposing a 1% excise tax
on share repurchases that occur after December 31, 2022 and introduces a 15% corporate alternative minimum tax (&#8220;CAMT&#8221;) on
adjusted financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company
does not expect the IRA to have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Fonar
is committed to making capital expenditures for the remainder of the 2023 fiscal year, for placing a scanner at a new stand-alone facility
located in New York which is scheduled to open in May. The current estimated costs of these capital expenditures is approximately $150,000.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Critical
to our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number of scans
performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers with enhanced
equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment and upgrades at
competitive prices.</span></p>


<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
is seeking to promote wider market recognition of Fonar&#8217;s scanner products, and to increase demand for Upright&#174; scanning at
the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, the uncertainty resulting from the Patient
Protection and Affordable Care Act or its repeal or modification, and the impact of the COVID-19 virus on the economy in general, the
sale of medical equipment has and may continue to suffer.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company believes that its business plan has been responsible for the past nine consecutive fiscal years and first nine months of fiscal
2023 of profitability and that its capital resources will be adequate to support operations through at least May 15, 2024. The future
effects on our business of healthcare legislation, the impact of the COVID-19 virus, the Deficit Reduction Act, the 2.3% excise tax on
sales of medical equipment, reimbursement rates, public health conditions and the general economic and business climate are not known
at the present time. Nevertheless, there is a possibility of adverse consequences to our business operations from these causes. Although
the Company cannot predict the full effect of COVID-19 for the three fiscal or any later period, the Company believes that it has adequate
revenues, cash reserves and other assets that will enable it to continue to operate until at least May 15, 2024.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="QualitativeDisclosures"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="ControlsAndProcedures"></span>Item
4. Controls and Procedures</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Disclosure
Controls and Procedures</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
carried out an evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, under the supervision and with the
participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the design
and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act
of 1934, as amended (the &#8216;&#8216;Exchange Act&#8217;&#8217;). Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under
the Exchange Act is accumulated and communicated to the issuer&#8217;s management, including its principal executive and principal financial
officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based upon
our evaluation, our chief executive officer and chief financial officer have concluded that the Company&#8217;s disclosure controls and
procedures were effective as of the March 31, 2023, in ensuring that material information that we are required to disclose in reports
that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the same time periods specified
in the Securities and Exchange Commission rules and forms.</span></p>


<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Changes
in Internal Control over Financial Reporting</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no changes in our system of internal control over financial reporting during our most recently completed fiscal quarter that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PART
II &#8211; OTHER INFORMATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><tr style="vertical-align: top"><td></td></tr></table>


<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="LegalProceedings"></span>Item
1 &#8211; Legal Proceedings: There were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended
June 30, 2022 and Form 10-Q for the fiscal quarter ended December 31, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="RiskFactors"></span>Item
1A &#8211; Risk Factors: An investment in the securities of the Company is subject to various risks, the most significant of which are
summarized below.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.
Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning center
clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government programs
and private insurance companies. To date, the impact of these reductions has been countered by increasing scanning volume notwithstanding
the COVID-19 pandemic, and reducing our operating expenses, thereby maintaining profitability in this business segment. There is, however,
no assurance that we will be able to continue to do so.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2.
Demand for MRI Scanners. The reduced reimbursement rates also affects our sales of MRI scanners negatively. With lower revenue projections,
prospective customers would demand lower prices for scanners. Although the reduced reimbursements may not affect foreign demand, a lower
number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3.
Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources, production
capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although Fonar
is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be convinced
that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective will be reached, particularly with
customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing
positions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4.
Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic
imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties
to the facilities we manage or own for the services we perform. If these physicians and other third parties were to reduce the number
of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net revenue and operating
margins.</span></p>


<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5.
Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations
is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic
imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting
has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed care
organizations in New York or Florida could have a negative impact on the utilization and pricing of services performed at the facilities
HMCA manages or owns to the extent these organizations exert control over patients&#8217; access to diagnostic imaging services, selections
of the provider of such services and reimbursement rates for those services.</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6.
Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete
for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established
hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7.
Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the number
of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will continue to increase
the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift
in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients may result
in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding
decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand for MRI scans as they
become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions
on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase
patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events could have a material
adverse effect on our business, financial condition, and results of operations.</span></p>


<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8.
Current and future changes in Florida Insurance Law. On March 24, 2023, Florida Governor Ron DeSantis signed into law House Bill 837.
Dubbed the Tort Reform Act, the bill makes sweeping changes to Florida&#8217;s negligence laws, including reducing the statute of limitations,
barring recovery for plaintiffs who are found to be 50% or greater at fault, and changing the rules of evidence regarding admissibility
of the costs of prior and future medical treatment. The bill is viewed as a boon to insurance companies, and is largely aimed at reducing
the cost of personal injury lawsuits to Insurers operating in Florida&#8217;s motor vehicle and general liability markets. The full impact
of the bill remains to be seen. Certain provisions of the bill are expected to negatively impact our reimbursement percentage and/or
reimbursement rates. We expect that some percentage of our patients who are seeking treatment following motor vehicle accidents will
not meet the new 51% threshold, and as a result we expect an increase in the percentage of uncollectible billings from those patients.
We are unable to estimate what percentage that might be. Further, changes to the evidentiary admissibility rules may lead to a higher
percentage of our billings being paid at commercial rates instead of at the presently prevailing PIP schedule, a reduction in reimbursement
of approximately 60%. These changes will negatively impact our Florida diagnostic imaging facilities (both those we own and those we
manage) with more unpaid bills, and lower reimbursement rates. The extent of those reductions are unclear at this time.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
addition to the above, Florida legislature continues to propose an outright repeal of Florida&#8217;s No-Fault law. SB 586 and its companion
statute H 429, again propose a repeal of Personal Injury Protection and replacing it with $25,000 Bodily Injury Coverage and Property
Damage Liability Coverage. Similar legislative efforts occurred in 2019, and 2021. The 2019 proposals failed to pass the Senate, and
the 2021 proposals were approved by both houses before ultimately being vetoed by the Governor. We cannot predict whether Florida will
continue to pursue the repeal of the No-Fault Law in light of the passage of HB 837, and whether such efforts will be successful.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Currently,
drivers and passengers get car damages and PIP, paid for up to $10,000, no matter who is at fault in an accident. Drivers have to pay
an additional cost to insurance companies to pay for bodily injuries which covers them if they are at fault. While PIP is required, coverage
for bodily injury is not.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Eliminating
PIP would mean that the $10,000 drivers now get paid toward medical costs through their insurers might not be there for them to pay for
injured drivers. Importantly, payments would be reduced by approximately 60% due to claims being paid at commercial rates or through
legal settlements instead of at the presently prevailing PIP fee schedule. This would negatively impact our Florida diagnostic imaging
facilities (both those we own and those we manage) with more unpaid bills, lower reimbursement rates and elongated waiting times.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9.
Federal and state privacy and information security laws. We must comply with numerous federal and state laws and regulations governing
the collection, dissemination, access, use, security and privacy of Protected Health Information (&#8216;PHI&#8217;), including Health
Insurance Portability and Accountability Act (&#8216;HIPAA&#8217;) and its implementing privacy and security regulations, as amended
by the federal Health Information Technology for Economic and Clinical Health (&#8216;HITECH&#8217;) Act and collectively referred to
as HIPAA. If we fail to comply with applicable privacy and security laws, regulations and standards, properly maintain the integrity
of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, our business, reputation, results
of operations, financial position and cash flows could be materially and adversely affected.</span></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Information
security risks have significantly increased in recent years because of the proliferation of new technologies, the use of the internet
and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers,
terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission and
storage of confidential, proprietary and other information in our computer systems and networks.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">10.
COVID-19. Although we believe we have taken the proper steps and are making a good recovery from the impact of the COVID-19 virus, the
long term impact of COVID-19, and the impact of societal efforts to combat the pandemic, reverberate throughout the medical industry.
New York State requirements that medical employees must be vaccinated if they care for patients, including our technicians and support
staff caring for scanning patients, was invalidated by New York State Supreme Court Judge Gerard J. Neri. That decision is currently
pending on Appeal, and New York&#8217;s Governor continues to enforce it. The uncertainty surrounding the current and future status of
the vaccine mandate has resulted in fewer available employees and adversely affected our ability to staff a full number of shifts. The
ultimate and economic and medical impact of the virus worldwide and at home, remains uncertain.</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">11.
Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic
and global economic and other conditions, including recessions or economic slowdowns, disruptions of credit markets and military conflicts.
Turbulence and uncertainty in the United States and international markets and economies may adversely affect our workforce, liquidity,
financial condition, revenues, profitability and business operations generally.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="UseOfProceeds"></span>Item
2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds: None</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Defaults"></span>Item
3 - Defaults Upon Senior Securities: None</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="MineSafety"></span>Item
4 - Mine Safety Disclosure: Not Applicable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="OtherInformation"></span>Item
5 - Other Information: None&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Exhibits"></span>Item
6 - Exhibits and Reports on Form 8-K:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="width: 15%; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">a)</span></p>
                                              <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></td><td style="width: 10%; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 75%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-31.htm">Exhibit 31.1 Certification. See Exhibits</a></span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">b)</span></p>
                                  <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
                                  <p style="margin-top: 0; margin-bottom: 0"></p></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-32.htm">Exhibit 32.1 Certification. See Exhibits</a></span></p>
                                                                           <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">c)</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501923000009/fonar_8-k.htm" style="-sec-extract: exhibit">Report on Form 8-K filed on February 15, 2023, Item 2.02: Results of Operations and Financial Condition for the fiscal quarter ended December 31, 2022</a></span></td></tr>
  </table>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Signatures"></span>SIGNATURES</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Registrant)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">________________</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">By:
/s/ Timothy Damadian</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Timothy
Damadian</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Chairman
of the Board of Directors, President, Principal Executive Officer and Treasurer</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">________________</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">/s/
Luciano Bonanni</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Luciano
Bonanni</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Executive
Vice President, Chief Operating Officer, Acting Principal Financial Officer</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Dated:
May 15, 2023</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
Damadian and Luciano Bonanni each certify that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            have reviewed this report on Form 10-Q of Fonar Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, this report does not contain any untrue statement of a material fact or
                                            omit to state a material fact necessary to make the statements made, in light of the circumstances
                                            under which such statements were made, not misleading with respect to the period covered
                                            by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, the financial statements, and other financial information included in this
                                            report, fairly present in all material respects the financial condition, results of operations
                                            and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            am responsible for establishing and maintaining disclosure controls and procedures (as defined
                                            in Exchange Act Rules 13a-15(e) and 15(e)) and internal control over financial reporting
                                            (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">designed
                                            such disclosure controls and procedures or caused such disclosure controls over procedures
                                            to be designed under my supervision to ensure that material information relating to the registrant,
                                            including its consolidated subsidiaries, is made known to us by others within those entities,
                                            particularly during the period in which this report is being prepared;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">designed
                                            such internal control over financial reporting, or caused such internal control over financial
                                            reporting to be designed under my supervision, to provide reasonable assurance regarding
                                            the reliability of financial reporting and the preparation of financial statements for external
                                            purposes in accordance with generally accepted accounting principles;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">evaluated
                                            the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented
                                            in this report my conclusions about the effectiveness of the disclosure controls and procedures
                                            as of the end of the period covered by this report; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">disclosed
                                            in this report any change in the registrant&rsquo;s internal control over financial reporting
                                            that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
                                            fourth fiscal quarter in the case of an annual report) that has materially affected, or is
                                            reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
                                            reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            have disclosed, based on my most recent evaluation of internal control over financial reporting,
                                            to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board
                                            of directors (or persons performing the equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">all
                                            significant deficiencies and material weaknesses in the design or operation of internal control
                                            over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
                                            ability to record, process, summarize and report financial information; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Any
                                            fraud, whether or not material, that involves management or other employees who have a significant
                                            role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">May
    15, 2023</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 50%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Timothy Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Luciano
Bonanni,</FONT></P>

<P STYLE="margin-bottom: 0pt"></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Acting
Principal Financial Officer&nbsp;</FONT></P>
<FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
connection with the Quarterly Report of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10-Q for the fiscal quarter
ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy
Damadian, Principal Executive Officer, and I, Luciano Bonanni, Acting Principal Financial Officer of the Company, certify, pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal
    Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Luciano
                                            Bonanni&nbsp;</FONT></P>
                                                                                                 <P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Acting
                                            Principal Financial Officer&nbsp;</FONT></P>
<FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;May
15, 2023</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>fonr-20230331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOauOuaP9wZ93qekhsGR6bela3yErvtvkqyzzXDnGsV4P -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:FONR="http://fonar.com/20230331" elementFormDefault="qualified" targetNamespace="http://fonar.com/20230331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" id="CondensedConsolidatedStatementsOfIncome">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" id="CondensedConsolidatedStatementsOfIncomeParenthetical">
	  <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" id="CondensedConsolidatedStatementOfChangesInEquity">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
	  <link:definition>00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
	  <link:definition>00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases" id="OperatingFinancingLeases">
	  <link:definition>00000011 - Disclosure - OPERATING &amp; FINANCING LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
	  <link:definition>00000012 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
	  <link:definition>00000013 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
	  <link:definition>00000014 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
	  <link:definition>00000015 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
	  <link:definition>00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000018 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000019 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
	  <link:definition>00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" id="OperatingFinancingLeasesTables">
	  <link:definition>00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000024 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
	  <link:definition>00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
	  <link:definition>00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
	  <link:definition>00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
	  <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
	  <link:definition>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1">
	  <link:definition>00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
	  <link:definition>00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
	  <link:definition>00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
	  <link:definition>00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
	  <link:definition>00000036 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
	  <link:definition>00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
	  <link:definition>00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" id="SegmentAndRelatedInformation-SumarizedSegments-Details">
	  <link:definition>00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
	  <link:definition>00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000043 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ControllingInterestMember" name="ControllingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalEquipmentMember" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SelfFundedHealthInsuranceMember" name="SelfFundedHealthInsuranceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_UnearnedRevenueOnServiceContractsRelatedParty" name="UnearnedRevenueOnServiceContractsRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsPayableRelatedPartyNoncurrent" name="AccountsPayableRelatedPartyNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" name="StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InterestExpenses" name="InterestExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeAttributableToNoncontrollingInterest" name="NetIncomeAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StatementOfIncomeAbstract" name="StatementOfIncomeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders" name="NetIncomeAvailableToClassNonvotingPreferredStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeAvailableToClassCCommonStockholders" name="NetIncomeAvailableToClassCCommonStockholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" name="StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CancellationOfShares" name="CancellationOfShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfNonControllingInterest" name="PurchaseOfNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnForgivenessOfPppLoan" name="GainOnForgivenessOfPppLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInContractAssets" name="IncreaseDecreaseInContractAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInContractLiabilities" name="IncreaseDecreaseInContractLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PurchaseOfNoncontrollingInterests" name="PurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingFinancingLeasesAbstract" name="DisclosureOperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" name="ScheduleOfPatientFeeRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" name="LesseeOperatingLeasesLiabilityMaturityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" name="OwnershipInterestOfOriginalInvestorsOfHdm" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestorsOwnershipInterest" name="InvestorsOwnershipInterest" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncomeLossAvailableToCommonStockholderBasic" name="NetIncomeLossAvailableToCommonStockholderBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EarningsPerShareBasics" name="EarningsPerShareBasics" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" name="WeightedAverageNumberOfDilutedSharesOutstandings" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConvertibleClassCStock" name="ConvertibleClassCStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" name="WeightedAverageNumberOfDilutedEarningsPerShare" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNonRelatedParties" name="ManagementAndOtherFeesNonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StateIncomeTaxesPayable" name="StateIncomeTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesFromExternalCustomers" name="NetRevenuesFromExternalCustomers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" name="MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExciseTax" name="ExciseTax" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CorporateMinimumTax" name="CorporateMinimumTax" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>fonr-20230331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20230331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20230331.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230331.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230331.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230331.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230331.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230331.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230331.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20230331.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230331.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230331.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230331.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230331.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230331.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:label="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InterestExpenses" xlink:label="loc_FONRInterestExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONRInterestExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInContractAssets" xlink:label="loc_FONRIncreaseDecreaseInContractAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInContractAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="loc_FONRPurchaseOfNoncontrollingInterests" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_FONRPurchaseOfNoncontrollingInterests" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000011 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000036 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>fonr-20230331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20230331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20230331.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230331.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230331.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230331.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230331.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230331.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230331.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20230331.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230331.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230331.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230331.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230331.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230331.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapShortTermInvestments_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountReceivableRelatedParties_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRMedicalReceivable_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagementAndOtherFees_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssetsCurrent_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_FONRAccountsReceivableNetLongTerm_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapGoodwill_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapOtherAssets_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsCurrentAbstract_130" xlink:to="loc_us-gaapAssets_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtCurrent_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapAccountsPayableCurrent_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilitiesCurrent_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueCurrent_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_FONRCustomerDeposits_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesCurrent_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredRevenueNoncurrent_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_130" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent_130" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLongTermDebtNoncurrent_130" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapOtherLiabilities_130" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilitiesNoncurrent_130" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_130" xlink:to="loc_us-gaapLiabilities_130" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract_130" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue_130" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_130" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital_130" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_130" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue_130" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_130" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest_130" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:label="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest_130" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_130" xlink:type="arc" order="49" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_FONRProductSalesNet_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_FONRServiceAndRepairFeesNet_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_FONRManagementAndOtherFeesNet_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_130" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_FONRCostsRelatedToProductSales_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_130" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_130" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_130" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_130" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_130" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_130" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_130" xlink:to="loc_us-gaapCostsAndExpenses_130" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_130" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_130" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InterestExpenses" xlink:label="loc_FONRInterestExpenses_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInterestExpenses_130" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_130" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_130" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_130" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_130" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAttributableToNoncontrollingInterest" xlink:label="loc_FONRNetIncomeAttributableToNoncontrollingInterest_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeAttributableToNoncontrollingInterest_130" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StatementOfIncomeAbstract" xlink:label="loc_FONRStatementOfIncomeAbstract_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStatementOfIncomeAbstract_130" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic_130" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders" xlink:label="loc_FONRNetIncomeAvailableToClassNonvotingPreferredStockholders_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeAvailableToClassNonvotingPreferredStockholders_130" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAvailableToClassCCommonStockholders" xlink:label="loc_FONRNetIncomeAvailableToClassCCommonStockholders_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeAvailableToClassCCommonStockholders_130" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockCommonMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:label="loc_FONRStockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CancellationOfShares" xlink:label="loc_FONRCancellationOfShares_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfShares_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PurchaseOfNonControllingInterest" xlink:label="loc_FONRPurchaseOfNonControllingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPurchaseOfNonControllingInterest_70" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000011 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_EarningsPerShareBasics" xlink:label="loc_FONREarningsPerShareBasics_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONREarningsPerShareBasics_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:label="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="loc_FONRManagementAndOtherFeesNonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFeesNonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_210" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000036 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="loc_FONRNetRevenuesFromExternalCustomers_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetRevenuesFromExternalCustomers_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_130" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_SelfFundedHealthInsuranceMember" xlink:label="loc_FONRSelfFundedHealthInsuranceMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRSelfFundedHealthInsuranceMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapSelfInsuranceReserve_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_30" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>fonr-20230331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="us-gaap_TreasuryStockCommonMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonMember" xlink:to="us-gaap_TreasuryStockCommonMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonMember_lbl" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ControllingInterestMember" xlink:label="FONR_ControllingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ControllingInterestMember" xlink:to="FONR_ControllingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ControllingInterestMember_lbl" xml:lang="en-US">Controlling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DoubtfulMember" xlink:label="us-gaap_DoubtfulMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DoubtfulMember" xlink:to="us-gaap_DoubtfulMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DoubtfulMember_lbl" xml:lang="en-US">Doubtful [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance / Managed Care</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation/Personal Injury</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalEquipmentMember" xlink:label="FONR_MedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalEquipmentMember_lbl" xml:lang="en-US">Medical Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_SelfFundedHealthInsuranceMember" xlink:label="FONR_SelfFundedHealthInsuranceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SelfFundedHealthInsuranceMember" xlink:to="FONR_SelfFundedHealthInsuranceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SelfFundedHealthInsuranceMember_lbl" xml:lang="en-US">Self Funded Health Insurance [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">&#160;Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">&#160;Short term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">&#160;Accounts receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">&#160;Accounts receivable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">&#160;Medical receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">&#160;Management and other fees receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">&#160;Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">&#160;Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">&#160;Deferred income tax asset - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">&#160;Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;Right-of-use Asset &#8211; operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;Right-of-use Asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">&#160;Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">&#160;Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">&#160;Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">&#160;Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:to="FONR_UnearnedRevenueOnServiceContractsRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParty_lbl" xml:lang="en-US">&#160;Unearned revenue on service contracts &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">&#160;Operating lease liability - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">&#160;Financing lease liability - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">&#160;Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">&#160;Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsPayableRelatedPartyNoncurrent" xlink:to="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsPayableRelatedPartyNoncurrent_lbl" xml:lang="en-US">&#160;Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">&#160;Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">&#160;Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xml:lang="en-US">&#160;Long-term debt less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">&#160;Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">&#160;Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">&#160;Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">&#160;Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost - 69 shares of common stock at March 31, 2023 and 12 shares of common stock at June 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">&#160;Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">&#160;Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:label="FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:to="FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">&#160;Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">&#160;Total Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xml:lang="en-US">Treasury Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue &#8211; net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees - related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees - related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income From Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (Expense) Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InterestExpenses" xlink:label="FONR_InterestExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InterestExpenses" xlink:to="FONR_InterestExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_InterestExpenses_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAttributableToNoncontrollingInterest" xlink:label="FONR_NetIncomeAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeAttributableToNoncontrollingInterest" xlink:to="FONR_NetIncomeAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_NetIncomeAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income - Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StatementOfIncomeAbstract" xlink:label="FONR_StatementOfIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StatementOfIncomeAbstract" xlink:to="FONR_StatementOfIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StatementOfIncomeAbstract_lbl" xml:lang="en-US">STATEMENT OF INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Income Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders" xlink:label="FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders" xlink:to="FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders_lbl" xml:lang="en-US">Net Income Available to Class A Non-Voting Preferred Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAvailableToClassCCommonStockholders" xlink:label="FONR_NetIncomeAvailableToClassCCommonStockholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeAvailableToClassCCommonStockholders" xlink:to="FONR_NetIncomeAvailableToClassCCommonStockholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeAvailableToClassCCommonStockholders_lbl" xml:lang="en-US">Net Income Available to Class C Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding &#8211; Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding - Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:label="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:to="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CancellationOfShares" xlink:label="FONR_CancellationOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfShares" xlink:to="FONR_CancellationOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_CancellationOfShares_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PurchaseOfNonControllingInterest" xlink:label="FONR_PurchaseOfNonControllingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNonControllingInterest" xlink:to="FONR_PurchaseOfNonControllingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_PurchaseOfNonControllingInterest_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:to="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">&#160;Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="FONR_GainOnForgivenessOfPppLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnForgivenessOfPppLoan_lbl" xml:lang="en-US">Gain on forgiveness of PPP loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInContractAssets" xlink:label="FONR_IncreaseDecreaseInContractAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractAssets" xlink:to="FONR_IncreaseDecreaseInContractAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInContractAssets_lbl" xml:lang="en-US">Contract assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="FONR_IncreaseDecreaseInContractLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractLiabilities" xlink:to="FONR_IncreaseDecreaseInContractLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInContractLiabilities_lbl" xml:lang="en-US">Contract liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="FONR_PurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_PurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">&#160;Purchase of noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">&#160;Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xml:lang="en-US">&#160;Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">&#160;Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">&#160;Net Increase in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of earning per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Financing receivable noncurrent allowance for Credit loss</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Schedule of facilities owned or managed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:to="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:label="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:to="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee operating leases liability maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Summarized segment financial information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Direct purchase of Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Direct ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InvestorsOwnershipInterest" xlink:label="FONR_InvestorsOwnershipInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestorsOwnershipInterest_lbl" xml:lang="en-US">Investors ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:to="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeLossAvailableToCommonStockholderBasic_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xml:lang="en-US">Basic Denominator: Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_EarningsPerShareBasics" xlink:label="FONR_EarningsPerShareBasics" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EarningsPerShareBasics" xlink:to="FONR_EarningsPerShareBasics_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EarningsPerShareBasics_lbl" xml:lang="en-US">Basic income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:label="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:to="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_lbl" xml:lang="en-US">Diluted Denominator: Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ConvertibleClassCStock" xlink:label="FONR_ConvertibleClassCStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConvertibleClassCStock_lbl" xml:lang="en-US">Convertible Class C Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:to="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedEarningsPerShare_lbl" xml:lang="en-US">Total Denominator for Diluted Earnings Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Income per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - Related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_MedicalReceivable_2_lbl" xml:lang="en-US">Medical Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="FONR_ManagementAndOtherFeesNonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNonRelatedParties" xlink:to="FONR_ManagementAndOtherFeesNonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices ("PC's")</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueOneToTwoYears" xlink:to="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Percentage of net revenue derived from no-fault and personal injury protection claim</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage of consolidated net revenue from management fees charged to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Total Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets-net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StateIncomeTaxesPayable" xlink:label="FONR_StateIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StateIncomeTaxesPayable_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other general and administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="FONR_NetRevenuesFromExternalCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromExternalCustomers" xlink:to="FONR_NetRevenuesFromExternalCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesFromExternalCustomers_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Stock purchase plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Number of shares repurchased, value</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xml:lang="en-US">Maximum limit for individual claims under stop-loss umbrella policy for health insurances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ExciseTax" xlink:label="FONR_ExciseTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExciseTax" xlink:to="FONR_ExciseTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExciseTax_lbl" xml:lang="en-US">Excise tax</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CorporateMinimumTax" xlink:label="FONR_CorporateMinimumTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CorporateMinimumTax" xlink:to="FONR_CorporateMinimumTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CorporateMinimumTax_lbl" xml:lang="en-US">Corporate minimum tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_lbl" xml:lang="en-US">Stock repurchase plan, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Stock repurchase plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A Non Voting Preferred Stock Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">The percentage of ownership interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">The percentage of ownership interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EarningsPerShareBasics" xlink:to="FONR_EarningsPerShareBasics_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EarningsPerShareBasics_doc" xml:lang="en-US">The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:to="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_doc" xml:lang="en-US">The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ConvertibleClassCStock_doc" xml:lang="en-US">The shares of convertible class C stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetRelatedParty_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_doc" xml:lang="en-US">The amount of Patient fee revenue, net of contractual allowances and discounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscount_doc" xml:lang="en-US">Present value discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscountFinancingLease_doc" xml:lang="en-US">Present value discount financing lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StateIncomeTaxesPayable_doc" xml:lang="en-US">the value of state income taxes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromExternalCustomers" xlink:to="FONR_NetRevenuesFromExternalCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesFromExternalCustomers_doc" xml:lang="en-US">Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalEquipmentMember_doc" xml:lang="en-US">Medical equipment - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">The amount of intersegment net revenues.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management of Diagnostic Imaging Centers - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenues [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InterestExpenses" xlink:to="FONR_InterestExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InterestExpenses_2_lbl" xml:lang="en-US">InterestExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncomeAttributableToNoncontrollingInterest" xlink:to="FONR_NetIncomeAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncomeAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">NetIncomeAttributableToNoncontrollingInterest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:to="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_3_lbl" xml:lang="en-US">StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CancellationOfShares" xlink:to="FONR_CancellationOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CancellationOfShares_2_lbl" xml:lang="en-US">Cancellation of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNonControllingInterest" xlink:to="FONR_PurchaseOfNonControllingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfNonControllingInterest_2_lbl" xml:lang="en-US">Purchase of Non controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnForgivenessOfPppLoan_2_lbl" xml:lang="en-US">GainOnForgivenessOfPppLoan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInContractAssets" xlink:to="FONR_IncreaseDecreaseInContractAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInContractAssets_2_lbl" xml:lang="en-US">IncreaseDecreaseInContractAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_2_lbl" xml:lang="en-US">IncreaseDecreaseInCustomerAdvance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PurchaseOfNoncontrollingInterests" xlink:to="FONR_PurchaseOfNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PurchaseOfNoncontrollingInterests_2_lbl" xml:lang="en-US">PurchaseOfNoncontrollingInterests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_3_lbl" xml:lang="en-US">PresentValueDiscountFinancingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiability_2_lbl" xml:lang="en-US">Finance Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>fonr-20230331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20230331.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20230331.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20230331.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20230331.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20230331.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20230331.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20230331.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20230331.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20230331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20230331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20230331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20230331.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20230331.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20230331.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20230331.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20230331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20230331.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20230331.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20230331.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20230331.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20230331.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20230331.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20230331.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20230331.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20230331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20230331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20230331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParty" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsPayableRelatedPartyNoncurrent" xlink:label="loc_FONRAccountsPayableRelatedPartyNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_FONRAccountsPayableRelatedPartyNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaapLongTermDebtNoncurrent" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:label="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="loc_us-gaapTreasuryStockCommonShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockCommonShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InterestExpenses" xlink:label="loc_FONRInterestExpenses" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInterestExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAttributableToNoncontrollingInterest" xlink:label="loc_FONRNetIncomeAttributableToNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StatementOfIncomeAbstract" xlink:label="loc_FONRStatementOfIncomeAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStatementOfIncomeAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders" xlink:label="loc_FONRNetIncomeAvailableToClassNonvotingPreferredStockholders" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeAvailableToClassNonvotingPreferredStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeAvailableToClassCCommonStockholders" xlink:label="loc_FONRNetIncomeAvailableToClassCCommonStockholders" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeAvailableToClassCCommonStockholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember" xlink:label="loc_us-gaapTreasuryStockCommonMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockCommonMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:label="loc_FONRStockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CancellationOfShares" xlink:label="loc_FONRCancellationOfShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCancellationOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PurchaseOfNonControllingInterest" xlink:label="loc_FONRPurchaseOfNonControllingInterest" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPurchaseOfNonControllingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests" xlink:label="loc_FONRStockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_2" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRStockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInContractAssets" xlink:label="loc_FONRIncreaseDecreaseInContractAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_FONRIncreaseDecreaseInContractAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IncreaseDecreaseInContractLiabilities" xlink:label="loc_FONRIncreaseDecreaseInContractLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInContractLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PurchaseOfNoncontrollingInterests" xlink:label="loc_FONRPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_FONRPurchaseOfNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000011 - Disclosure - OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000012 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000013 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000014 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:label="loc_FONRLesseeOperatingLeasesLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRLesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000024 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetIncomeLossAvailableToCommonStockholderBasic" xlink:label="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetIncomeLossAvailableToCommonStockholderBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_EarningsPerShareBasics" xlink:label="loc_FONREarningsPerShareBasics" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONREarningsPerShareBasics" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:label="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WeightedAverageNumberOfDilutedEarningsPerShare" xlink:label="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedEarningsPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementAndOtherFeesNonRelatedParties" xlink:label="loc_FONRManagementAndOtherFeesNonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFeesNonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000036 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="loc_FONRNetRevenuesFromExternalCustomers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetRevenuesFromExternalCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_SelfFundedHealthInsuranceMember" xlink:label="loc_FONRSelfFundedHealthInsuranceMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRSelfFundedHealthInsuranceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000043 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_ExciseTax" xlink:label="loc_FONRExciseTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRExciseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20230331.xsd#FONR_CorporateMinimumTax" xlink:label="loc_FONRCorporateMinimumTax" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRCorporateMinimumTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:label="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>fonar_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar_logo.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" !# ;H# 2(  A$! Q$!_\0
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M1?R76I:O?2WE]<2MEI)9'+LQ/N2:SJ_%L=Q%FF)Q<ZL*LHQ;T2>RZ?\ !/\
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MA^$LYI9EEM)0PN(TY8JRA4BE=);)27O+S4NQW5% (/0T5]B?@!Q/[0GBW5_
M7P/\9>.?#LJ)J.C^&;Z]L7DCW*LL4#NA([C('%?C"O\ P7#_ ."@( SXXT(\
M?] !/\:_8K]KC_DV+XC?]B5JF/\ P$DK^;A<XY'TK\^XUQ^-P5>C&A4<4TV[
M.W4_JKZ.?"O#?$.6YA/,\)3KN$Z:BYQ4K)J3:5^Y]>M_P7$_X* GIXYT,?\
M< 3_ !I#_P %PO\ @H&>GCO1!_W (_\ &OD2C-?$?VYG'_01+[S^DO\ B&?A
M]_T*J'_@M'UW_P /P_\ @H(1@^/-$_\ !!'_ (T?\/PO^"@?_0^:)_X((_\
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M#_HH6N_^$O=?_$U];]=X<_GI?^2GX5_JQXO_ /0+C?\ P&L>N_\ #OS]C/\
MZ-G\'_\ @I2C_AWY^QG_ -&T>#__  4I7D!_X+K?\$\0<?\ "P-=_P#"7NO_
M (FE_P"'ZO\ P3Q/3XA:Y_X2]U_\31]=X<_GI?\ DH?ZK^+_ /T"XW[JQ[MX
M._9+_9T^$FJMXS^%_P &?#FA:Q#;2)!J-C8+'(@9<$;AV/>OS;^(W_!"']H3
MXE?$+6_'^I_M"^$&GUG5)[R4RI,6S)(S8/TSC\*^UKS]NKX,?M4_LD_%#Q]^
MSOX@U&[3P_H-W#<32V$MM)',;9G7:' )X[BOPR'C[XVXR/&OBSTYU.Z_^*KY
M_B3%Y/&E1BZ7M(.\ERNROL]EKLS]5\&N'N/JV+S&K2Q_U2O!PIS5:FJDVM9)
M>_).-M[>:/MYO^#>KX[8^7]H/P9_W[FJ73O^#>CXV/J$$>H?M >$3 TRB?R(
MI2^S(SM]\=*^'/\ A/\ XV_]#KXL_P#!G=?_ !5>X?\ !-SQ'\4_$?[</PXT
MKQ#XL\236;^(HVGBNM0N&C8 $X8,V",CO7S6%JY#B<5"DL))<S2UF^OR/V/.
ML#XIY3D^(QKS^E)4H3G98>";Y8MV3YGJ[=C]A_V>O^"?7[*_[/?A6VT#PG\'
M="NKF&)5N-6U6P2YN;A]HRQ>0$C)SP,"O1Q\$/@^!C_A5/AG_P $-O\ _$5T
MED7,1WYSNJ:OUNGA,/1@H0@DEY+_ "/X,Q><9KF&)EB,3B)SG)ZR<FVWZMG*
M_P#"D/@]_P!$I\,_^"&W_P#B*/\ A2/P@'3X4>&/_!#;_P#Q%=515^QH_P J
M^Y'/]<QG_/R7WL\I^+/[%7[+_P 9O#\WA[QW\#?#4\4L943VVEQP319[K)&H
M8'\:_.#QW_P;U?$P>-M4/@;XZ^&[?16OI&TJ#4XY?/CMRQ*+(1P6"X!(ZXK]
M<KC/DMCKBOQ8_P""X&N_$CP[^W1=1>%?$FNVMM/X8L)&BTZ^G2/=^\7.$8#.
M *^6XHPV64L''$5Z'/9VT?*]?-'[9X)YOQMC<_J93EF9_5XS@YOVD?:P]UK:
M,G:+=]U;169T)_X-ZOCKV_:"\&?]\34L7_!OC\>[:5;F#]H;P>DD3!DDC2;*
M,#P1[YKX?_X3_P"-O_0Z^+/_  9W7_Q5'_"??&X]/&WBSKU_M.Y_^*KX+ZYD
M,=5@Y_\ @;_R/Z@ED'BHXO\ XR"B_P#N6ATU_F9_2+X"M/$.G?#[2K#Q=J,%
MYJL&E0QZE>6V?+GG6("1USV+ D?6OYI_'?/CC63_ -16X_\ 1K5^^/\ P2ZU
MK7->_8 ^'FH^);JYN+W^QYDFFO'9I&VW$JC<6Y/ '6OP/\=C/CG61_U%KG_T
M8U?0<:557P6%J)6NF_PB?EOT<\#/+.)L]P<I*3IRA"Z5D^6=572Z)VT1DUI^
M%O!7C#QQ>3:?X,\*ZCJT]O;-<7$.G6;S-'"N-TC! 2%&1D]!FLP'(S7V7_P0
MEOU@_;QM],DP8[_PGJ,,D;='&(VP1W^[7Q.786.-Q]+#MVYVE<_H_BW.ZO#?
M#.+S6E!3E0@Y\KT3MJU=;:7/C3GN"/K17VY_P6+_ ."?$_[-/Q*?XX?#31C_
M ,(5XFO&,\<"?)IEXQR8R/X4?DKVSD>E?$=/,,!7RW%RP]9:K\5T:#A3B;+>
M+\AHYK@I7A46JZQE]J,NS3T?W['M?[!?[8WBO]BOX]V'Q(TEY)]&NRMKXFTH
M-\MW:%ADX_OI]Y3ZC'0FOZ OA=\2?!OQ7\!Z;\1_ .KQW^D:O:I<65S"P(9&
M X/H1T([$5_,E@'J*^_?^"*G_!0P_!7QU'^S#\6]=*>%O$%Q_P 2"\N'^33K
MYCQ&2>D<G3V;!Z$D?4\(9[]3K_4ZS]R3T\G_ )'XAX^^&3XBRY\09;"^)HQ]
M^*6M2FNOG*'3JXW71'[)*P8;A7X-_P#!::T%I_P4-\9# _>063_G;(:_>&U<
M20*ZG((XQ7X9_P#!<O3?L/\ P4&U^4C'VG1M/E'_ (#J/Z5]+QQ&^3I_WXGY
M!]&JHH>(%2/>A/\ ]*@?']7O#(SXDT\'_G^B_P#0Q5&KWAC_ )&73O\ K^A_
M]#%?DT/B1_==?^#+T?Y'],OP_P#E\)Z0H_Z!<'_HM:W:PO !SX5TG_L%P?\
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MOV.[_P#8C_:,O?A&=4>_TNYLH]2T"]D #RVDC.H#X_B5XW4_[H/>O#:^O/\
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M,D[;K]6>!Q+XB<'<'XR&%S?%>RG./,ERS=U=J]XQ:W3/S8HK]*/^(<#XE_\
M1U&A?^$Q-_\ 'Z/^(<#XE_\ 1U&A?^$Q-_\ 'Z[?]5,]?_+G\8_YGSO_ !'+
MPN_Z&*_\ J__ "!^:]%?I1_Q#@?$O_HZC0O_  F)O_C]'_$.!\2_^CJ-"_\
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H45WY3AZ%+FY();;)(\GB+.LXS>E2>/Q-2MRMVYYRG:]KVYF[7\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647047515728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 05, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,538,148<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041895536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">&#160;Cash and cash equivalents</a></td>
<td class="nump">$ 49,640<span></span>
</td>
<td class="nump">$ 48,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">&#160;Short term investments</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">&#160;Accounts receivable &#8211; net</a></td>
<td class="nump">3,720<span></span>
</td>
<td class="nump">4,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">&#160;Accounts receivable - related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">&#160;Medical receivable &#8211; net</a></td>
<td class="nump">20,460<span></span>
</td>
<td class="nump">20,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">&#160;Management and other fees receivable &#8211; net</a></td>
<td class="nump">35,201<span></span>
</td>
<td class="nump">33,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related medical practices &#8211; net</a></td>
<td class="nump">9,088<span></span>
</td>
<td class="nump">8,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">&#160;Inventories</a></td>
<td class="nump">2,661<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">&#160;Prepaid expenses and other current assets</a></td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">1,104<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">121,998<span></span>
</td>
<td class="nump">118,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">1,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">&#160;Deferred income tax asset - net</a></td>
<td class="nump">10,911<span></span>
</td>
<td class="nump">12,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">&#160;Property and equipment &#8211; net</a></td>
<td class="nump">22,775<span></span>
</td>
<td class="nump">22,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">&#160;Right-of-use Asset &#8211; operating lease</a></td>
<td class="nump">33,581<span></span>
</td>
<td class="nump">34,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">&#160;Right-of-use Asset &#8211; financing lease</a></td>
<td class="nump">779<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">&#160;Goodwill</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">&#160;Other intangible assets &#8211; net</a></td>
<td class="nump">3,494<span></span>
</td>
<td class="nump">3,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">&#160;Other assets</a></td>
<td class="nump">526<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">199,336<span></span>
</td>
<td class="nump">199,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,719<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">3,496<span></span>
</td>
<td class="nump">6,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">&#160;Unearned revenue on service contracts</a></td>
<td class="nump">3,615<span></span>
</td>
<td class="nump">4,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_UnearnedRevenueOnServiceContractsRelatedParty', window );">&#160;Unearned revenue on service contracts &#8211; related party</a></td>
<td class="nump">28<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">&#160;Operating lease liability - current portion</a></td>
<td class="nump">3,981<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">&#160;Financing lease liability - current portion</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">826<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">13,925<span></span>
</td>
<td class="nump">16,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">&#160;Unearned revenue on service contracts</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">&#160;Deferred income tax liability</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsPayableRelatedPartyNoncurrent', window );">&#160;Due to related medical practices</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">&#160;Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">32,630<span></span>
</td>
<td class="nump">33,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">&#160;Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">657<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">&#160;Long-term debt less current portion</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">&#160;Other liabilities</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">34,794<span></span>
</td>
<td class="nump">36,357<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">&#160;Total Liabilities</a></td>
<td class="nump">48,719<span></span>
</td>
<td class="nump">53,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">&#160;Paid-in capital in excess of par value</a></td>
<td class="nump">184,130<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">&#160;Accumulated deficit</a></td>
<td class="num">(25,428)<span></span>
</td>
<td class="num">(33,567)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 69 shares of common stock at March 31, 2023 and 12 shares of common stock at June 30, 2022</a></td>
<td class="num">(1,522)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">&#160;Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">157,181<span></span>
</td>
<td class="nump">150,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">&#160;Noncontrolling interests</a></td>
<td class="num">(6,564)<span></span>
</td>
<td class="num">(4,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest', window );">&#160;Total Stockholders' Equity</a></td>
<td class="nump">150,617<span></span>
</td>
<td class="nump">146,236<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">&#160;Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">199,336<span></span>
</td>
<td class="nump">199,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock Value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsPayableRelatedPartyNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsPayableRelatedPartyNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_UnearnedRevenueOnServiceContractsRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_UnearnedRevenueOnServiceContractsRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041295984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,607<span></span>
</td>
<td class="nump">6,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,538<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">453<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647047716576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue &#8211; net of contractual allowances and discounts</a></td>
<td class="nump">$ 8,188<span></span>
</td>
<td class="nump">$ 7,641<span></span>
</td>
<td class="nump">$ 21,393<span></span>
</td>
<td class="nump">$ 21,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">1,876<span></span>
</td>
<td class="nump">5,489<span></span>
</td>
<td class="nump">5,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees - related parties &#8211; net</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">12,375<span></span>
</td>
<td class="nump">11,904<span></span>
</td>
<td class="nump">36,717<span></span>
</td>
<td class="nump">35,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees - related medical practices &#8211; net</a></td>
<td class="nump">2,975<span></span>
</td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">8,962<span></span>
</td>
<td class="nump">8,576<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">25,422<span></span>
</td>
<td class="nump">24,571<span></span>
</td>
<td class="nump">72,869<span></span>
</td>
<td class="nump">72,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">4,056<span></span>
</td>
<td class="nump">3,306<span></span>
</td>
<td class="nump">11,879<span></span>
</td>
<td class="nump">9,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">747<span></span>
</td>
<td class="nump">2,241<span></span>
</td>
<td class="nump">2,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees - related parties</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">7,157<span></span>
</td>
<td class="nump">6,696<span></span>
</td>
<td class="nump">20,281<span></span>
</td>
<td class="nump">20,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related medical practices</a></td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">4,345<span></span>
</td>
<td class="nump">5,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">1,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">7,143<span></span>
</td>
<td class="nump">6,068<span></span>
</td>
<td class="nump">20,074<span></span>
</td>
<td class="nump">15,928<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">21,255<span></span>
</td>
<td class="nump">18,933<span></span>
</td>
<td class="nump">60,560<span></span>
</td>
<td class="nump">54,917<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income From Operations</a></td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">5,638<span></span>
</td>
<td class="nump">12,309<span></span>
</td>
<td class="nump">17,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (Expense) Income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(203)<span></span>
</td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InterestExpenses', window );">Interest Expense</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income</a></td>
<td class="nump">356<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">4,502<span></span>
</td>
<td class="nump">5,727<span></span>
</td>
<td class="nump">12,835<span></span>
</td>
<td class="nump">18,892<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(2,465)<span></span>
</td>
<td class="num">(2,889)<span></span>
</td>
<td class="num">(5,311)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">4,485<span></span>
</td>
<td class="nump">3,262<span></span>
</td>
<td class="nump">9,946<span></span>
</td>
<td class="nump">13,581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeAttributableToNoncontrollingInterest', window );">Net Income - Noncontrolling Interests</a></td>
<td class="num">(625)<span></span>
</td>
<td class="num">(971)<span></span>
</td>
<td class="num">(1,807)<span></span>
</td>
<td class="num">(3,383)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">3,860<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">8,139<span></span>
</td>
<td class="nump">10,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StatementOfIncomeAbstract', window );"><strong>STATEMENT OF INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Income Available to Common Stockholders</a></td>
<td class="nump">$ 3,627<span></span>
</td>
<td class="nump">$ 2,153<span></span>
</td>
<td class="nump">$ 7,647<span></span>
</td>
<td class="nump">$ 9,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 1.18<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding &#8211; Common Stockholders</a></td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
<td class="nump">6,615<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StatementOfIncomeAbstract', window );"><strong>STATEMENT OF INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders', window );">Net Income Available to Class A Non-Voting Preferred Stockholders</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StatementOfIncomeAbstract', window );"><strong>STATEMENT OF INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeAvailableToClassCCommonStockholders', window );">Net Income Available to Class C Common Stockholders</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding &#8211; Common Stockholders</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeAvailableToClassCCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeAvailableToClassCCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StatementOfIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StatementOfIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042093040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 1.18<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
<td class="nump">6,615<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041924416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Treasury Stock, Common [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Jun. 30, 2021</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 185,101<span></span>
</td>
<td class="num">$ (46,008)<span></span>
</td>
<td class="num">$ (675)<span></span>
</td>
<td class="num">$ (3,049)<span></span>
</td>
<td class="nump">$ 135,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,198<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,131)<span></span>
</td>
<td class="num">(4,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,383<span></span>
</td>
<td class="nump">3,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfNonControllingInterest', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(570)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="num">(546)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
<td class="num">(35,810)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(3,773)<span></span>
</td>
<td class="nump">144,274<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
<td class="num">(38,101)<span></span>
</td>
<td class="nump">675<span></span>
</td>
<td class="num">(3,314)<span></span>
</td>
<td class="nump">142,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,430)<span></span>
</td>
<td class="num">(1,430)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">971<span></span>
</td>
<td class="nump">971<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
<td class="num">(35,810)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(3,773)<span></span>
</td>
<td class="nump">144,274<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Jun. 30, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
<td class="num">(33,567)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(4,054)<span></span>
</td>
<td class="nump">146,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,139<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">8,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,249)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,249)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,317)<span></span>
</td>
<td class="num">(4,317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,807<span></span>
</td>
<td class="nump">1,807<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CancellationOfShares', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(401)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,130<span></span>
</td>
<td class="num">(25,428)<span></span>
</td>
<td class="num">(1,522)<span></span>
</td>
<td class="num">(6,564)<span></span>
</td>
<td class="nump">150,617<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,130<span></span>
</td>
<td class="num">(29,288)<span></span>
</td>
<td class="num">(751)<span></span>
</td>
<td class="nump">6,022<span></span>
</td>
<td class="nump">148,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,860<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(771)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(771)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,167)<span></span>
</td>
<td class="num">(1,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="nump">625<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 184,130<span></span>
</td>
<td class="num">$ (25,428)<span></span>
</td>
<td class="num">$ (1,522)<span></span>
</td>
<td class="num">$ (6,564)<span></span>
</td>
<td class="nump">$ 150,617<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CancellationOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CancellationOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647040303232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">&#160;Net income</a></td>
<td class="nump">$ 9,946<span></span>
</td>
<td class="nump">$ 13,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>&#160;Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,357<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">3,306<span></span>
</td>
<td class="nump">2,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="nump">4,441<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax &#8211; net</a></td>
<td class="nump">1,931<span></span>
</td>
<td class="nump">3,484<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnForgivenessOfPppLoan', window );">Gain on forgiveness of PPP loan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">(5,604)<span></span>
</td>
<td class="num">(4,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInContractAssets', window );">Contract assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(301)<span></span>
</td>
<td class="num">(705)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(73)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">168<span></span>
</td>
<td class="num">(855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(4,409)<span></span>
</td>
<td class="num">(5,480)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(2,865)<span></span>
</td>
<td class="num">(2,579)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(175)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer deposits</a></td>
<td class="nump">465<span></span>
</td>
<td class="num">(370)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInContractLiabilities', window );">Contract liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">10,149<span></span>
</td>
<td class="nump">10,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>&#160;Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,553)<span></span>
</td>
<td class="num">(3,807)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PurchaseOfNoncontrollingInterests', window );">&#160;Purchase of noncontrolling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(546)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(3,640)<span></span>
</td>
<td class="num">(4,413)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>&#160;Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">&#160;Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">&#160;Purchase of treasury stock</a></td>
<td class="num">(1,249)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">&#160;Distributions to noncontrolling interests</a></td>
<td class="num">(4,317)<span></span>
</td>
<td class="num">(4,131)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(5,592)<span></span>
</td>
<td class="num">(4,154)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">&#160;Net Increase in Cash and Cash Equivalents</a></td>
<td class="nump">917<span></span>
</td>
<td class="nump">1,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">48,723<span></span>
</td>
<td class="nump">44,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 49,640<span></span>
</td>
<td class="nump">$ 46,010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnForgivenessOfPppLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnForgivenessOfPppLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInContractAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInContractAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050044640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zl0QkKRN4qcc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
1 &#8211; <span id="xdx_82F_zjoYqtEItFJb">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
Corporation (the "Company" or "FONAR") is a Delaware corporation, which was <span style="letter-spacing: -0.1pt">incorporated
on July 17, 1978. FONAR is engaged in the research, development, production and </span>manufacturing of medical scanning equipment, which
uses principles of Magnetic Resonance Imaging ("MRI") for the detection and diagnosis of human diseases. In addition to deriving
revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base of customers through service and upgrade
programs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">FONAR,
through its wholly-owned subsidiary Health Management Corporation of America <span style="letter-spacing: -0.05pt">("HMCA")
provides comprehensive management services to diagnostic imaging facilities. These </span><span style="letter-spacing: -0.1pt">services
provided by the Company include development, administration, leasing of office spaces, </span>facilities and medical equipment, provision
of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collections and the development
and implementation of practice growth and marketing strategies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"/></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_90A_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zRSWF8diuPU1" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM">24.2</span>% interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_905_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_znfURC63pu81" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM">45.8</span>% in HDM, and the original
investors in HDM retained a <span id="xdx_904_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zUejIbMXVdFh" title="The ownership interest of the original investors of HDM">30.0</span>% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $<span id="xdx_90B_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3d_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_ziuGnZjCD8Ci" title="Direct purchase of Noncontrolling Interests">546,000</span>. Currently the Company has a direct ownership interest
of <span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zL7MfEnHQaX" title="Direct ownership interest percentage">70.8</span>% and the investors&#8217; have a <span id="xdx_90A_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zYGm9Nz1Tw26" title="Investors ownership interest percentage">29.2</span>% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three and nine months ended March 31, 2023, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2023. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2022 for the fiscal
year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company
was able to enact certain decisions to allow the Company to sustain operations during the global pandemic and from further losses or
additional decreases in scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program
(&#8220;PPP&#8221;) and Medicare advances/stimulus payments. The Company has been able to navigate through these challenges and
avoid any significant disruption of the business and the volume has recently risen back to almost pre- COVID-19 levels. Recent
legislation was passed to end the national emergency for COVID-19 which the Company believes with positive cash flows, low debt and
cash on hand, it will be able to maintain operations to pre COVID-19 levels going forward.</span></p>
















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647140252480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zCJlbHruw7yk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_822_zH37tuZ9jrl">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zShxYJYKZrCe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_861_z1cwLrtGsJqd">Principles
of Consolidation</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zn67hGQVlNkg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_861_zzLpcFrOkto9">Revenues</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z12o1EQ7Kzfg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86F_z9r8AyDU6xei" style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC Topic 260-10, &#8220;Participating Securities and the
Two-Class method&#8221;, the Company uses the Two-Class method for calculating basic income per share and applied the if converted method
in calculating diluted income per share for the three and nine months ended March 31, 2023 and 2022.</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and nine months ended March 31, 2023 and 2022, diluted EPS
for common shareholders includes <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230101__20230331_z8kpeeiDuqil" title="Shares included upon conversion of Class C Common"><span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220101__20220331_zKoVKw2pQQZ2" title="Shares included upon conversion of Class C Common"><span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20230331_ziBqwqwJUTdh" title="Shares included upon conversion of Class C Common"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20220331_z04fnBBOmodd" title="Shares included upon conversion of Class C Common">128</span></span></span>
</span></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zXFnwxKgAPmc" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,860</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,627</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,291</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,153</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.60</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.56</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.35</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1037">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,609</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.32</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>































<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br/> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br/> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,139</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,647</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">125</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">10,198</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9,583</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">157</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.25</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.56</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.46</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,615</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.43</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AF_zfAr5NoPyaDa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL5uSIjLpOr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_869_zQOiX1DAhZM4">Recent
Accounting Standards</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected the Company&#8217;s financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not
believe that any of those standards will have a significant impact on our consolidated condensed financial statements at the time they
become effective.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647040839584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_806_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z6NJBZHCZI5i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; <span id="xdx_82B_zn04OKqJ8TG9">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at March 31, 2023, and June 30, 2022:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zqZUh9VPBLsl" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B6_zLWjIe3nGvP6" style="display: none">Financing receivable noncurrent allowance for Credit loss</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,925</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zJaYQDiLAe14" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,720</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">30</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zr7LeRJ6okt4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">30</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zfRvJ1t1s07c" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1169">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zN82vr4gSvD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">55,043</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zMqmN68lDgXe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">19,842</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331_z2lRYZnKXGW5" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35,201</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztFPol0sWH08" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">15,002</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zbdgiQnHaOjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,914</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331_zSAubPsMmUA8" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9,088</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,541</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,336</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z8M8ZmFuTWwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zjRCwaddIXxe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">50,047</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zyhBAhuWIBXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,628</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630_zTMBJd5sfgoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">33,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3pGzfyAsTH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zhcSK1FmC8Eh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,687</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630_zVRSXYxlWjzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,603</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A9_zhinEhAPq8c1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following three years as of March 31, 2023 is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zk3M3S8Nrvc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_8B7_zVuGEp02lIw8" style="display: none">Schedule of facilities owned or managed</span></td><td style="text-align: left">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230331_zyuPkTCCWnul" style="width: 43%; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">792</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230331_zAsflSXtAWT5" style="text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">216</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20230331_zNgY4R7r7hwj" style="border-bottom: Black 1pt solid; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,015</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A1_z801hYFKhXdf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
Receivables</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_90D_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230101__20230331_zQ0KBYo30K0f" title="Percentage of net revenue derived from no-fault and personal injury protection claim">67.6</span>%
and <span id="xdx_907_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220101__20220331_zvPWAEkHaks8" title="Percentage of net revenue derived from no-fault and personal injury protection claim">66.6</span>% of the PCs&#8217; net revenues for the three months ended March 31, 2023 and 2022 respectively, were derived from no-fault
and personal injury protection claims. Approximately <span id="xdx_906_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20230331_zDRtt91TvcEk" title="Percentage of net revenue derived from no-fault and personal injury protection claim">67.9</span>% and <span id="xdx_901_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20210701__20220331_z23GkfayzObl" title="Percentage of net revenue derived from no-fault and personal injury protection claim">66.6</span>% of the PCs&#8217; net revenue for the nine months ended March 31,
2023 and 2022, respectively, were derived from no-fault and personal injury protection claims. The Company considers the aging of its
accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps
to collect its receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements
and have historically been within management's expectations.&#160;</span></p>


























<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_90B_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230101__20230331_zKOyxHFSp4Zd" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">11.7</span>% and <span id="xdx_902_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220101__20220331_zh5z3Wa5IWba" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">12.2</span>% of the consolidated net
revenues for the three months ended March 31, 2023 and 2022, respectively. Net revenues from management and other fees charged to the
related PCs accounted for approximately <span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20230331_zM2ua95QwnQh" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">12.3</span>% and <span id="xdx_908_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20210701__20220331_zwQSUijctVFl" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">11.8</span>% of the consolidated net revenues for the nine months ended March 31, 2023 and
2022, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three and nine months ended March 31, 2023 and
2022 are summarized in the following table.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zintqeAeMla2" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BF_zJjOMnWk6aJg" style="display: none">Schedule of patient fee revenue</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
                                            the Three Months</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Ended
                                            March 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,037</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,095</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">303</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">287</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,186</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,624</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,662</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,635</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,188</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,641</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
                                            the Nine Months</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Ended
                                            March 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,905</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,249</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">788</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">809</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,683</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,092</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,017</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,785</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,393</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,935</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AA_zRGIuXR46sti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//310-10/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647045296912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_zFtD9UIckw03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; <span id="xdx_822_z8YaEraSjH61">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will
not apply the standard to the comparative periods presented in the condensed consolidated financial statements. We have also elected
the transition package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior
conclusions about lease identification, lease classification and indirect costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of March 31, 2023
is as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_zf6de1HtaBH8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8BD_zOfwVh5Cq7Fe" style="display: none">Lessee operating leases liability maturity</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Twelve
    Months Ending <br/>March 31,</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    Lease <br/>Payments</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,613</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,661</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,304</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,520</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">204</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,642</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zXcKMcW9uTX9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1326">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,835</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zZL2xC0vNGm3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1330">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PresentValueDiscount_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(9,964</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PresentValueDiscountFinancingLease_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(62</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">36,611</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">874</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049912320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zM27HCXjJac1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
5 - <span id="xdx_82E_zaQmlCkoIXH5">INVENTORIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zHHVGifWLXr5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8B8_zJlWPuC2Xmz2" style="display: none">Schedule of inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49A_20230331_zoqVkC5bN56e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49B_20220630_zPUFMbxA9ku1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br/>2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzjFD_zR68CrEwejXk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,456</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,126</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzjFD_zLHNioTC1cK2" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">234</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzjFD_zx6wIeBIEmS" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,661</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,360</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049886448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_80F_eus-gaap--IntangibleAssetsDisclosureTextBlock_zyKSmmN3pD8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_822_zBwRpSudoelc">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_z1AjpVHk6Ms6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B1_zEbTVwVJb3L9" style="display: none">Schedule of other intangible assets - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br/>2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,420</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,333</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non-compete</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,475</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,388</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,981</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,684</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,494</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,704</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended March 31, 2023 and 2022 amounted to $<span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zjPIwtAHpyj5" title="Amortization of Intangible Assets">46</span> and $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zvLoY5iIZ7c6" title="Amortization of Intangible Assets">44</span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the three months ended March 31, 2023 and 2022 amounted to $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zhMYvqkAbzE2" title="Amortization of Intangible Assets">0</span> and $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zeFPp5Ypbq3g" title="Amortization of Intangible Assets">13</span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended March 31, 2023 and 2022 amounted to $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5HzUsaLk31k" title="Amortization of Intangible Assets">50</span> and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zCF0lGgKsDY4" title="Amortization of Intangible Assets">50</span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the nine months ended March 31, 2023 and 2022 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zxZeKK1OYcc3" title="Amortization of Intangible Assets">147</span> and $<span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zitapwsRoVt7" title="Amortization of Intangible Assets">140</span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the nine months ended March 31, 2023and 2022 amounted to $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets">0</span> and $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zzkFjrIh4aj9" title="Amortization of Intangible Assets">38</span>, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the nine months ended March 31, 2023 and 2022 amounted to $<span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z9qGoaLyIHPh" title="Amortization of Intangible Assets">150</span> and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zISASBoy3thl" title="Amortization of Intangible Assets">150</span>, respectively.</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049936544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_801_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zdDSwhYOTkKb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; <span id="xdx_825_zgOb5BPq8i5h">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHrcBkEQFTg4" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8B1_zS8sgM1f5Bq4" style="display: none">Schedule of other current liabilities</span></td><td style="font-size: 11pt">&#160;</td>
    <td colspan="3" id="xdx_495_20230331_zNaAi5NQOBld" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220630_zVn1pwwmIpl" style="font-size: 11pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
                                            31,</span></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></p></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
                                            30,</span></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzBfQ_zE56UO2NpdVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,046</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,653</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzBfQ_zDw15wTFKYD2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">210</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">249</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzBfQ_z9cJaKOmmVL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">200</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">382</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzBfQ_zW8pYuhRjlT8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">11</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzBfQ_zz0d1PDiaIsb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">89</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">120</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzBfQ_zFnq5SwfZDkc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">79</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzBfQ_zbxbF8jxpnK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzBfQ_z7fBg2Q0UjKl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    general and administrative expenses</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">902</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">854</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzBfQ_zPzaRuODK2g4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,496</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,417</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041849120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zDqs0rjkEDSb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_82E_zdcn7lbVPgLh">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2022. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zG5iedbA3Qha" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B9_z0QG7wJSlePg" style="display: none">Summarized segment financial information</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the three
    months ended March, 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br/> Equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br/> of Diagnostic <br/> Imaging <br/> Centers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,884</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">23,538</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">25,422</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zhiQbGlmYfT6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1475">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(1,141</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,308</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,167</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,075</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,139</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,191</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,204</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended March 31, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,039</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">22,532</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">24,571</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zWo1LAFkij4d" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1505">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(537</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,175</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,638</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,121</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,185</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">43</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,620</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,663</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the nine
    months ended March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br/> Equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br/> of Diagnostic <br/> Imaging <br/> Centers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,797</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">67,072</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">72,869</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--IntersegmentNetRevenues_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">735</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zm1qfv1Egyp2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1535">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">735</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(2,495</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">14,804</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">12,309</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">201</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,156</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,357</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">87</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,553</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,640</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the nine months ended March 31, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,284</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">66,496</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">72,780</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">720</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zanQVRQd1vtl" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1565">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">720</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(1,054</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">18,917</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">17,863</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">199</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,344</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,543</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">230</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,577</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,807</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AC_zdikaxwrwYga" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">&#160;</p>





















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//280/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-26<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-34<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-21<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049815696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_809_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zP94toHF7ba7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_82F_zKUwW8USZ4s3">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2023 and March 31, 2022, the Company paid $<span id="xdx_902_eus-gaap--InterestPaid_c20220701__20230331_pn3n3" title="Interest paid">42</span> and $<span id="xdx_900_eus-gaap--InterestPaid_c20210701__20220331_pn3n3" title="Interest paid">279</span> for interest, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2023 and March 31, 2022, the Company paid $<span id="xdx_90D_eus-gaap--IncomeTaxesPaid_c20220701__20230331_pn3n3" title="Income taxes paid">1,140</span> and $<span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20210701__20220331_pn3n3" title="Income taxes paid">1,105</span> for income taxes, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//230/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050003296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zxTgmwXhR8Yh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; <span id="xdx_828_zro1ji9JsGG2">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90D_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926_zjYV2rN8KZ84" title="Stock purchase plan">9</span> million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the nine months ended March 31, 2023, the Company
repurchased <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20230331_zl6jleIiHv4c" title="Number of shares repurchased">70</span> shares at a cost of $<span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodValue_c20220701__20230331_pn3n3" title="Number of shares repurchased, value">1,249</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_90B_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_iI_pn3n3_c20230331_zNLr7P6z7nu" title="Maximum limit for individual claims under stop-loss umbrella policy for health insurances">150</span> per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of March 31, 2023 and June 30, 2022, the Company had approximately $<span id="xdx_901_eus-gaap--SelfInsuranceReserve_c20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--SelfFundedHealthInsuranceMember_pn3n3" title="Self-funded health insurance reserve">35</span> and $<span id="xdx_902_eus-gaap--SelfInsuranceReserve_c20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--SelfFundedHealthInsuranceMember_pn3n3" title="Self-funded health insurance reserve">79</span>, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the
condensed consolidated balance sheets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049954432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zwiNmwcRTUBg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11 - <span id="xdx_823_zCubvGHEu9x9">INCOME TAXES</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740-270, &#8220;Income Taxes &#8211; Interim Reporting&#8221;, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the nine months ended March 31, 2023 and 2022, the Company recorded income tax expense of $<span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20220701__20230331_pn3n3" title="Income tax expense">2,889</span> in 2023 as compared
to $<span id="xdx_909_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20210701__20220331_pn3n3" title="Income tax expense">5,311</span> in 2022. The 2023 provision is comprised of a current income tax component of $<span id="xdx_905_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220701__20230331_pn3n3" title="Income tax component - current">958</span> and a deferred income tax component of $<span id="xdx_909_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220701__20230331_pn3n3" title="Income tax component - deferred">1,931</span>.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2019.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company recorded a deferred tax asset of $<span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_c20230331_pn3n3" title="Deferred tax asset">10,911</span> and a deferred tax liability of $<span id="xdx_90F_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20230331_pn3n3" title="Deferred tax liability">216</span> as of March 31, 2023, primarily relating to net
operating loss carryforwards of approximately $<span id="xdx_909_eus-gaap--OperatingLossCarryforwards_c20230331_pn3n3" title="Operating Loss Carryforwards">5,191</span> available to offset future taxable income through 2032. The net operating losses
begin to expire in 2023 for federal tax and state income tax purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss
carryforwards. As of March  31, 2023, no such changes in ownership have occurred.</span></p>






















<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Inflation Reduction Act (&#8220;IRA&#8221;) was enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_902_ecustom--ExciseTax_pip0_dp_c20220701__20230331_zDJfJO9kFbTk" title="Excise tax">1</span>% excise tax on share
repurchases that occur after December 31, 2022 and introduces a <span id="xdx_90F_ecustom--CorporateMinimumTax_pip0_dp_c20220701__20230331_zqT8bTRouTu6" title="Corporate minimum tax">15</span>% corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company does not
expect the IRA to have a material impact to the Company&#8217;s financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050076480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zuhnhZ7GtVMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
12 &#8211; <span id="xdx_826_zrDzIiQSJd6g">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to March 31, 2023 and through the date the condensed consolidated financial statements
were issued.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
April 2023, the Company repurchased <span id="xdx_904_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z13GysIc4lNa" title="Stock repurchase plan, shares">6</span> shares at a cost of $<span id="xdx_904_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHDvpBbYpYJ7" title="Stock repurchase plan">101</span> which was authorized under the stock repurchase plan adopted in September
2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
April 2023, the Company amended the revolving credit agreement. The agreement was extended to July 7, 2023. The interest rate on borrowings
is at the current prime rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230401__20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh0Mrg79Vbad" title="Interest rate">8.00</span>% along with certain financial covenants.&#160;&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050644928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zShxYJYKZrCe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_861_z1cwLrtGsJqd">Principles
of Consolidation</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenues</a></td>
<td class="text"><p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zn67hGQVlNkg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_861_zzLpcFrOkto9">Revenues</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z12o1EQ7Kzfg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86F_z9r8AyDU6xei" style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC Topic 260-10, &#8220;Participating Securities and the
Two-Class method&#8221;, the Company uses the Two-Class method for calculating basic income per share and applied the if converted method
in calculating diluted income per share for the three and nine months ended March 31, 2023 and 2022.</span></p>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and nine months ended March 31, 2023 and 2022, diluted EPS
for common shareholders includes <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230101__20230331_z8kpeeiDuqil" title="Shares included upon conversion of Class C Common"><span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220101__20220331_zKoVKw2pQQZ2" title="Shares included upon conversion of Class C Common"><span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20230331_ziBqwqwJUTdh" title="Shares included upon conversion of Class C Common"><span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20220331_z04fnBBOmodd" title="Shares included upon conversion of Class C Common">128</span></span></span>
</span></span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">shares
upon conversion of Class C Common.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zXFnwxKgAPmc" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,860</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,627</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,291</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,153</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.60</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.56</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.35</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1037">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,609</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.32</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>































<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br/> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br/> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,139</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,647</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">125</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">10,198</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9,583</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">157</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.25</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.56</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.46</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,615</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.43</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8AF_zfAr5NoPyaDa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL5uSIjLpOr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_869_zQOiX1DAhZM4">Recent
Accounting Standards</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected the Company&#8217;s financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not
believe that any of those standards will have a significant impact on our consolidated condensed financial statements at the time they
become effective.&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>




















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049941024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of earning per share</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zXFnwxKgAPmc" style="display: none">Schedule of earning per share</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,860</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,627</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,291</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,153</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.60</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.56</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.35</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,481</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1037">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1041">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,609</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.32</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.09</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>































<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br/> March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine
    months ended <br/> March 31, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,139</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,647</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">125</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">10,198</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9,583</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">157</span></td><td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.25</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.18</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.56</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.46</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,487</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1119">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1123">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,615</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.16</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.33</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.43</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.41</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041906256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Financing receivable noncurrent allowance for Credit loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zqZUh9VPBLsl" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom">
    <td><span id="xdx_8B6_zLWjIe3nGvP6" style="display: none">Financing receivable noncurrent allowance for Credit loss</span></td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="3" style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, 2023</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,925</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zJaYQDiLAe14" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,720</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">30</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zr7LeRJ6okt4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1163">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">30</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zfRvJ1t1s07c" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1169">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--MedicalReceivable_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,460</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zN82vr4gSvD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">55,043</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zMqmN68lDgXe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">19,842</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331_z2lRYZnKXGW5" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35,201</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztFPol0sWH08" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">15,002</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zbdgiQnHaOjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,914</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331_zSAubPsMmUA8" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9,088</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,541</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,336</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z8M8ZmFuTWwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1193">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zjRCwaddIXxe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">50,047</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zyhBAhuWIBXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,628</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630_zTMBJd5sfgoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">33,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3pGzfyAsTH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zhcSK1FmC8Eh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,687</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630_zVRSXYxlWjzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,603</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Schedule of facilities owned or managed</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zk3M3S8Nrvc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span id="xdx_8B7_zVuGEp02lIw8" style="display: none">Schedule of facilities owned or managed</span></td><td style="text-align: left">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230331_zyuPkTCCWnul" style="width: 43%; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">792</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230331_zAsflSXtAWT5" style="text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">216</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20230331_zNgY4R7r7hwj" style="border-bottom: Black 1pt solid; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,015</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock', window );">Schedule of patient fee revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zintqeAeMla2" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BF_zJjOMnWk6aJg" style="display: none">Schedule of patient fee revenue</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
                                            the Three Months</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Ended
                                            March 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,037</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,095</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">303</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">287</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,186</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,624</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,662</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,635</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,188</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,641</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
                                            the Nine Months</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Ended
                                            March 31,</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,905</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,249</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">788</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">809</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,683</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,092</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,017</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,785</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,393</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,935</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfPatientFeeRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049856000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock', window );">Lessee operating leases liability maturity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_zf6de1HtaBH8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span id="xdx_8BD_zOfwVh5Cq7Fe" style="display: none">Lessee operating leases liability maturity</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Twelve
    Months Ending <br/>March 31,</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    Lease <br/>Payments</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,613</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,661</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,304</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,520</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">204</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2028</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,642</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zXcKMcW9uTX9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1326">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,835</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zZL2xC0vNGm3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1330">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--PresentValueDiscount_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(9,964</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PresentValueDiscountFinancingLease_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(62</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">36,611</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--FinanceLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">874</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049961632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zHHVGifWLXr5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8B8_zJlWPuC2Xmz2" style="display: none">Schedule of inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49A_20230331_zoqVkC5bN56e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49B_20220630_zPUFMbxA9ku1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br/>2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2022</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzjFD_zR68CrEwejXk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,456</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,126</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzjFD_zLHNioTC1cK2" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">234</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzjFD_zx6wIeBIEmS" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,661</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,360</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647049884864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of other intangible assets - net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_z1AjpVHk6Ms6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B1_zEbTVwVJb3L9" style="display: none">Schedule of other intangible assets - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
    31, <br/>2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,420</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,333</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non-compete</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,475</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,388</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,981</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,684</span></td><td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets - net</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,494</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,704</span></td><td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050725456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of other current liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHrcBkEQFTg4" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: center"><span id="xdx_8B1_zS8sgM1f5Bq4" style="display: none">Schedule of other current liabilities</span></td><td style="font-size: 11pt">&#160;</td>
    <td colspan="3" id="xdx_495_20230331_zNaAi5NQOBld" style="font-size: 11pt; text-align: center">&#160;</td><td style="font-size: 11pt">&#160;</td>
    <td colspan="3" id="xdx_497_20220630_zVn1pwwmIpl" style="font-size: 11pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">March
                                            31,</span></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></p></td><td style="font-size: 11pt; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
                                            30,</span></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzBfQ_zE56UO2NpdVe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,046</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 8%; font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,653</span></td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzBfQ_zDw15wTFKYD2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">210</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">249</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzBfQ_z9cJaKOmmVL" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">200</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">382</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzBfQ_zW8pYuhRjlT8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">11</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzBfQ_zz0d1PDiaIsb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">89</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">120</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzBfQ_zFnq5SwfZDkc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">35</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">79</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzBfQ_zbxbF8jxpnK6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td><td style="font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzBfQ_z7fBg2Q0UjKl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    general and administrative expenses</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">902</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">854</span></td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzBfQ_zPzaRuODK2g4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,496</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,417</span></td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050000816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized segment financial information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zG5iedbA3Qha" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span id="xdx_8B9_z0QG7wJSlePg" style="display: none">Summarized segment financial information</span></td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the three
    months ended March, 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br/> Equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br/> of Diagnostic <br/> Imaging <br/> Centers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,884</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">23,538</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">25,422</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zhiQbGlmYfT6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1475">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(1,141</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,308</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,167</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,075</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,139</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,191</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,204</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended March 31, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,039</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">22,532</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">24,571</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zWo1LAFkij4d" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1505">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(537</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,175</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,638</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">64</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,121</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,185</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">43</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,620</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,663</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the nine
    months ended March 31, 2023</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br/> Equipment</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br/> of Diagnostic <br/> Imaging <br/> Centers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,797</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">67,072</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">72,869</span></td><td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--IntersegmentNetRevenues_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">735</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zm1qfv1Egyp2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1535">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--IntersegmentNetRevenues_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">735</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(2,495</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">14,804</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">12,309</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">201</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,156</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,357</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">87</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,553</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,640</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the nine months ended March 31, 2022</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,284</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">66,496</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">72,780</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">720</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zanQVRQd1vtl" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1565">&#8212;</span>&#160;&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--IntersegmentNetRevenues_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">720</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(1,054</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">18,917</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">17,863</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">199</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,344</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,543</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">230</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,577</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-family: Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,807</span></td><td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647046233360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Direct purchase of Noncontrolling Interests</a></td>
<td class="nump">$ 546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Direct ownership interest percentage</a></td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm', window );">The ownership interest of the original investors of HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestorsOwnershipInterest', window );">Investors ownership interest percentage</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestorsOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestorsOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestOfOriginalInvestorsOfHdm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647047723472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 3,860<span></span>
</td>
<td class="nump">$ 2,291<span></span>
</td>
<td class="nump">$ 8,139<span></span>
</td>
<td class="nump">$ 10,198<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningsPerShareBasics', window );">Basic income per common share</a></td>
<td class="nump">$ 0.60<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="nump">$ 1.25<span></span>
</td>
<td class="nump">$ 1.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">$ 157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningsPerShareBasics', window );">Basic income per common share</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedSharesOutstandings', window );">Diluted Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 3,627<span></span>
</td>
<td class="nump">$ 2,153<span></span>
</td>
<td class="nump">$ 7,647<span></span>
</td>
<td class="nump">$ 9,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningsPerShareBasics', window );">Basic income per common share</a></td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 1.18<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedSharesOutstandings', window );">Diluted Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare', window );">Total Denominator for Diluted Earnings Per Share</a></td>
<td class="nump">6,609<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
<td class="nump">6,615<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income per Common Share</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="nump">$ 0.32<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConvertibleClassCStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares of convertible class C stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConvertibleClassCStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EarningsPerShareBasics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EarningsPerShareBasics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncomeLossAvailableToCommonStockholderBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncomeLossAvailableToCommonStockholderBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedEarningsPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedEarningsPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedSharesOutstandings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedSharesOutstandings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647050533216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042152976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">$ 3,720<span></span>
</td>
<td class="nump">$ 4,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">20,460<span></span>
</td>
<td class="nump">20,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">35,201<span></span>
</td>
<td class="nump">33,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">9,088<span></span>
</td>
<td class="nump">8,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">3,925<span></span>
</td>
<td class="nump">4,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">20,460<span></span>
</td>
<td class="nump">20,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">55,043<span></span>
</td>
<td class="nump">50,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">15,002<span></span>
</td>
<td class="nump">13,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember', window );">Doubtful [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">19,842<span></span>
</td>
<td class="nump">16,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">$ 5,914<span></span>
</td>
<td class="nump">$ 4,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042105520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueOneToTwoYears', window );">2025</a></td>
<td class="nump">$ 792<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2026</a></td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2027</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 1,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueOneToTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueOneToTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 910<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482546/910-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041868816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 8,188<span></span>
</td>
<td class="nump">$ 7,641<span></span>
</td>
<td class="nump">$ 21,393<span></span>
</td>
<td class="nump">$ 21,935<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance / Managed Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
<td class="nump">2,905<span></span>
</td>
<td class="nump">3,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">303<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation/Personal Injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">5,186<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
<td class="nump">13,683<span></span>
</td>
<td class="nump">13,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 1,662<span></span>
</td>
<td class="nump">$ 1,635<span></span>
</td>
<td class="nump">$ 4,017<span></span>
</td>
<td class="nump">$ 4,785<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Patient fee revenue, net of contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647047500560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Percentage of net revenue derived from no-fault and personal injury protection claim</a></td>
<td class="nump">67.60%<span></span>
</td>
<td class="nump">66.60%<span></span>
</td>
<td class="nump">67.90%<span></span>
</td>
<td class="nump">66.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage of consolidated net revenue from management fees charged to related party medical practices</a></td>
<td class="nump">11.70%<span></span>
</td>
<td class="nump">12.20%<span></span>
</td>
<td class="nump">12.30%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042173712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 5,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">5,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">5,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">4,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">3,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">21,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present value discount</a></td>
<td class="num">(9,964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">36,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present value discount</a></td>
<td class="num">(62)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value discount financing lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042119904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,456<span></span>
</td>
<td class="nump">$ 2,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Total Inventories</a></td>
<td class="nump">$ 2,661<span></span>
</td>
<td class="nump">$ 2,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647041823120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 20,475<span></span>
</td>
<td class="nump">$ 20,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">16,981<span></span>
</td>
<td class="nump">16,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets-net</a></td>
<td class="nump">3,494<span></span>
</td>
<td class="nump">3,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">5,420<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">4,150<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042190576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042156336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 2,046<span></span>
</td>
<td class="nump">$ 4,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StateIncomeTaxesPayable', window );">State income taxes payable</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other general and administrative expenses</a></td>
<td class="nump">902<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Current Liabilities</a></td>
<td class="nump">$ 3,496<span></span>
</td>
<td class="nump">$ 6,417<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StateIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>the value of state income taxes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StateIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481573/470-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647044829664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">$ 25,422<span></span>
</td>
<td class="nump">$ 24,571<span></span>
</td>
<td class="nump">$ 72,869<span></span>
</td>
<td class="nump">$ 72,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">4,167<span></span>
</td>
<td class="nump">5,638<span></span>
</td>
<td class="nump">12,309<span></span>
</td>
<td class="nump">17,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,139<span></span>
</td>
<td class="nump">1,185<span></span>
</td>
<td class="nump">3,357<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">2,204<span></span>
</td>
<td class="nump">1,663<span></span>
</td>
<td class="nump">3,640<span></span>
</td>
<td class="nump">3,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">2,039<span></span>
</td>
<td class="nump">5,797<span></span>
</td>
<td class="nump">6,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">735<span></span>
</td>
<td class="nump">720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="num">(1,141)<span></span>
</td>
<td class="num">(537)<span></span>
</td>
<td class="num">(2,495)<span></span>
</td>
<td class="num">(1,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">87<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">23,538<span></span>
</td>
<td class="nump">22,532<span></span>
</td>
<td class="nump">67,072<span></span>
</td>
<td class="nump">66,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">5,308<span></span>
</td>
<td class="nump">6,175<span></span>
</td>
<td class="nump">14,804<span></span>
</td>
<td class="nump">18,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,075<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
<td class="nump">3,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">$ 2,191<span></span>
</td>
<td class="nump">$ 1,620<span></span>
</td>
<td class="nump">$ 3,553<span></span>
</td>
<td class="nump">$ 3,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intersegment net revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesFromExternalCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesFromExternalCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-18<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647042291536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="nump">$ 1,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647047573520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Number of shares repurchased, value</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="nump">$ 1,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance', window );">Maximum limit for individual claims under stop-loss umbrella policy for health insurances</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_SelfFundedHealthInsuranceMember', window );">Self Funded Health Insurance [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_SelfFundedHealthInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_SelfFundedHealthInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647047693216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Income tax expense</a></td>
<td class="nump">$ 2,889<span></span>
</td>
<td class="nump">$ 5,311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Income tax component - current</a></td>
<td class="nump">958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Income tax component - deferred</a></td>
<td class="nump">1,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">10,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred tax liability</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 5,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExciseTax', window );">Excise tax</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CorporateMinimumTax', window );">Corporate minimum tax</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CorporateMinimumTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CorporateMinimumTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480135/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139647157992512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Apr. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Stock repurchase plan, shares | shares</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase plan | $</a></td>
<td class="nump">$ 101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>fonar_10-q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20230331.xsd" xlink:type="simple"/>
    <context id="From2022-07-01to2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-05-05_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="AsOf2023-05-05_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="AsOf2023-05-05_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="AsOf2023-05-05_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-05</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CommonStockMember259982734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember259982734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_TreasuryStockCommonMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_SelfFundedHealthInsuranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:SelfFundedHealthInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_SelfFundedHealthInsuranceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:SelfFundedHealthInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2023-04-30_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-30</instant>
        </period>
    </context>
    <context id="From2023-04-012023-04-30_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-04-30</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-01to2023-03-31">0000355019</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-01to2023-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-07-01to2023-03-31">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-07-01to2023-03-31">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-07-01to2023-03-31">Q3</dei:DocumentFiscalPeriodFocus>
    <FONR:AccountReceivableRelatedParties
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0068"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParty
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0131"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember"
      id="xdx2ixbrl0194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      id="xdx2ixbrl0196"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0214"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0216"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0254"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      id="xdx2ixbrl0256"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-01-012022-03-31"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0693"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0697"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0699"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0703"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0705"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0707"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0711"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0715"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0719"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0723"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0727"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0729"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0731"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0733"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0739"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0741"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0743"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0745"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0775"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0777"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0781"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfNonControllingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0785"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfNonControllingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0789"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfNonControllingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0791"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0797"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0799"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0801"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0803"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0809"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0811"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0813"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_TreasuryStockCommonMember"
      id="xdx2ixbrl0815"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2022-07-01to2023-03-31"
      id="xdx2ixbrl0854"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInContractAssets
      contextRef="From2022-07-01to2023-03-31"
      id="xdx2ixbrl0866"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-07-01to2023-03-31"
      id="xdx2ixbrl0875"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2022-07-01to2023-03-31"
      id="xdx2ixbrl0896"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:PurchaseOfNoncontrollingInterests
      contextRef="From2022-07-01to2023-03-31"
      id="xdx2ixbrl0911"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2021-07-012022-03-31"
      id="xdx2ixbrl0927"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      id="xdx2ixbrl1037"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      id="xdx2ixbrl1041"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      id="xdx2ixbrl1119"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      id="xdx2ixbrl1123"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember"
      id="xdx2ixbrl1163"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember"
      id="xdx2ixbrl1169"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl1193"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl1326"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl1330"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1475"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1505"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1535"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1565"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-07-01to2023-03-31">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2022-07-01to2023-03-31">true</dei:DocumentQuarterlyReport>
    <dei:DocumentTransitionReport contextRef="From2022-07-01to2023-03-31">false</dei:DocumentTransitionReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-01to2023-03-31">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2022-07-01to2023-03-31">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-07-01to2023-03-31">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-01to2023-03-31">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-01to2023-03-31">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-01to2023-03-31">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-01to2023-03-31">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-01to2023-03-31">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-01to2023-03-31">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-01to2023-03-31">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-01to2023-03-31">694-2929</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus contextRef="From2022-07-01to2023-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-07-01to2023-03-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2022-07-01to2023-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-07-01to2023-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-01to2023-03-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2022-07-01to2023-03-31">false</dei:EntityShellCompany>
    <dei:Security12bTitle contextRef="From2022-07-01to2023-03-31">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-01to2023-03-31">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-01to2023-03-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-05-05_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="Shares">6538148</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-05-05_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-05-05_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="Shares">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2023-05-05_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="Shares">313438</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">49640000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48723000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">32000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">32000</us-gaap:ShortTermInvestments>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3720000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4336000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">30000</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">20460000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">20109000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">35201000</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">33419000</FONR:ManagementAndOtherFees>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">9088000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">8603000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2661000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2360000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1166000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1104000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">121998000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">118686000</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1003000</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1872000</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">10911000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">12843000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">22775000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">22282000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">33581000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">34232000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">779000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">928000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3494000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">3704000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">526000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">526000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">199336000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">199342000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">43000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">40000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1719000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1552000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3496000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">6417000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3615000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4289000</us-gaap:DeferredRevenueCurrent>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParty contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">28000</FONR:UnearnedRevenueOnServiceContractsRelatedParty>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3981000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">3880000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">217000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">210000</us-gaap:FinanceLeaseLiabilityCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">826000</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">361000</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">13925000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">16749000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1015000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1857000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">216000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">216000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">93000</FONR:AccountsPayableRelatedPartyNoncurrent>
    <FONR:AccountsPayableRelatedPartyNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">93000</FONR:AccountsPayableRelatedPartyNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">32630000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">33091000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">657000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">838000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">126000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">155000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilities contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">57000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">107000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">34794000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">36357000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">48719000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">53106000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-03-31_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="Shares">6607000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="Shares">6566000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="Shares">6538000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">184130000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">184531000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-25428000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-33567000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2023-03-31" decimals="-3" unitRef="Shares">69000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="AsOf2022-06-30" decimals="-3" unitRef="Shares">12000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1522000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">675000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">157181000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">150290000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">-6564000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-4054000</us-gaap:MinorityInterest>
    <FONR:StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">150617000</FONR:StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest>
    <FONR:StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">146236000</FONR:StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">199336000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">199342000</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">8188000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">7641000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">25000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">135000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">1831000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">1876000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">12375000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">11904000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">2975000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2987000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">25422000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">24571000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">4056000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">3306000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">196000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">53000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">801000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">747000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">12000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">11000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">7157000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">6696000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">1455000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">1698000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">435000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">354000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">7143000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">6068000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">21255000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">18933000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">4167000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">5638000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">-6000</us-gaap:OtherNonoperatingIncomeExpense>
    <FONR:InterestExpenses
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">15000</FONR:InterestExpenses>
    <FONR:InterestExpenses
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">-31000</FONR:InterestExpenses>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">356000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">58000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">4502000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">5727000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">17000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2465000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">4485000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">3262000</us-gaap:ProfitLoss>
    <FONR:NetIncomeAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">625000</FONR:NetIncomeAttributableToNoncontrollingInterest>
    <FONR:NetIncomeAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">971000</FONR:NetIncomeAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">3860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2291000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">3627000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2153000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders
      contextRef="From2023-01-012023-03-31_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">174000</FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders>
    <FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders
      contextRef="From2022-01-012022-03-31_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">103000</FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders>
    <FONR:NetIncomeAvailableToClassCCommonStockholders
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">59000</FONR:NetIncomeAvailableToClassCCommonStockholders>
    <FONR:NetIncomeAvailableToClassCCommonStockholders
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">35000</FONR:NetIncomeAvailableToClassCCommonStockholders>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="Shares">6481000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="Shares">6609000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="Shares">6682000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">21393000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">21935000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">225000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">481000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">5489000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">5720000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">83000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">83000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">36717000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">35985000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">8962000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">8576000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">72869000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">72780000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">11879000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">9785000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">580000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">352000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">2241000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">2190000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">34000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">32000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">20281000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">20497000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">4345000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">5024000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1126000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">1109000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">20074000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">15928000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">60560000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">54917000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">12309000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">17863000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-203000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">858000</us-gaap:OtherNonoperatingIncomeExpense>
    <FONR:InterestExpenses
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">41000</FONR:InterestExpenses>
    <FONR:InterestExpenses
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">9000</FONR:InterestExpenses>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">770000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">180000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">12835000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">18892000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">2889000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">5311000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">9946000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">13581000</us-gaap:ProfitLoss>
    <FONR:NetIncomeAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1807000</FONR:NetIncomeAttributableToNoncontrollingInterest>
    <FONR:NetIncomeAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3383000</FONR:NetIncomeAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">8139000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">10198000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">7647000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">9583000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders
      contextRef="From2022-07-012023-03-31_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">367000</FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders>
    <FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders
      contextRef="From2021-07-012022-03-31_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">458000</FONR:NetIncomeAvailableToClassNonvotingPreferredStockholders>
    <FONR:NetIncomeAvailableToClassCCommonStockholders
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">125000</FONR:NetIncomeAvailableToClassCCommonStockholders>
    <FONR:NetIncomeAvailableToClassCCommonStockholders
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">157000</FONR:NetIncomeAvailableToClassCCommonStockholders>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="USDPShares">1.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="USDPShares">1.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="Shares">6487000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="Shares">6615000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="Shares">6682000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184130000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-29288000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-751000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">6022000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2022-12-31" decimals="-3" unitRef="USD">148070000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">3860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">3860000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">771000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">771000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1167000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">1167000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">625000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">625000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184130000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-25428000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-1522000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-6564000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">150617000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-12-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-38101000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-12-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">675000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-3314000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2021-12-31" decimals="-3" unitRef="USD">142442000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">2291000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2291000</us-gaap:NetIncomeLoss>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1430000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">1430000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">971000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">971000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-35810000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-675000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-3773000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2022-03-31" decimals="-3" unitRef="USD">144274000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-33567000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-675000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-4054000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">146236000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">8139000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">8139000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">1249000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1249000</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-401000</FONR:CancellationOfShares>
    <FONR:CancellationOfShares
      contextRef="From2022-07-012023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">402000</FONR:CancellationOfShares>
    <FONR:CancellationOfShares
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1000</FONR:CancellationOfShares>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">4317000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">4317000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1807000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1807000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_CommonStockMember259982734"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184130000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-25428000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-1522000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2023-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-6564000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">150617000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">185101000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-06-30_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-46008000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-675000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-3049000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">135370000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">10198000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">10198000</us-gaap:NetIncomeLoss>
    <FONR:PurchaseOfNonControllingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">-570000</FONR:PurchaseOfNonControllingInterest>
    <FONR:PurchaseOfNonControllingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">24000</FONR:PurchaseOfNonControllingInterest>
    <FONR:PurchaseOfNonControllingInterest
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-546000</FONR:PurchaseOfNonControllingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">4131000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">4131000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">3383000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3383000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_RetainedEarningsMember"
      decimals="-3"
      unitRef="USD">-35810000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_TreasuryStockCommonMember"
      decimals="-3"
      unitRef="USD">-675000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests
      contextRef="AsOf2022-03-31_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-3773000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests contextRef="AsOf2022-03-31" decimals="-3" unitRef="USD">144274000</FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">9946000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">13581000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">3357000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3543000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">3306000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">2953000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:ProvisionForBadDebts
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">4441000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">2150000</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1931000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3484000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">701000</FONR:GainOnForgivenessOfPppLoan>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">5604000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">4950000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-11000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-32000</us-gaap:IncreaseDecreaseInReceivables>
    <FONR:IncreaseDecreaseInContractAssets
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">15000</FONR:IncreaseDecreaseInContractAssets>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">301000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">705000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">73000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-112000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-132000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">168000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-855000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-4409000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-5480000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-2865000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-2579000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">175000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">151000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">465000</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-370000</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInContractLiabilities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-15000</FONR:IncreaseDecreaseInContractLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-49000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-49000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">10149000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">10117000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">3553000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3807000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <FONR:PurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">546000</FONR:PurchaseOfNoncontrollingInterests>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">87000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">60000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-3640000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-4413000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">26000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">23000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1249000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">4317000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">4131000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">-5592000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">-4154000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">917000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">1550000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48723000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">44460000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">49640000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-03-31" decimals="-3" unitRef="USD">46010000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_80C_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zl0QkKRN4qcc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
1 &#x2013; &lt;span id="xdx_82F_zjoYqtEItFJb"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR
Corporation (the "Company" or "FONAR") is a Delaware corporation, which was &lt;span style="letter-spacing: -0.1pt"&gt;incorporated
on July 17, 1978. FONAR is engaged in the research, development, production and &lt;/span&gt;manufacturing of medical scanning equipment, which
uses principles of Magnetic Resonance Imaging ("MRI") for the detection and diagnosis of human diseases. In addition to deriving
revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base of customers through service and upgrade
programs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;FONAR,
through its wholly-owned subsidiary Health Management Corporation of America &lt;span style="letter-spacing: -0.05pt"&gt;("HMCA")
provides comprehensive management services to diagnostic imaging facilities. These &lt;/span&gt;&lt;span style="letter-spacing: -0.1pt"&gt;services
provided by the Company include development, administration, leasing of office spaces, &lt;/span&gt;facilities and medical equipment, provision
of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collections and the development
and implementation of practice growth and marketing strategies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"/&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
&lt;span id="xdx_90A_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zRSWF8diuPU1" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"&gt;24.2&lt;/span&gt;% interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_905_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_znfURC63pu81" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"&gt;45.8&lt;/span&gt;% in HDM, and the original
investors in HDM retained a &lt;span id="xdx_904_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zUejIbMXVdFh" title="The ownership interest of the original investors of HDM"&gt;30.0&lt;/span&gt;% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $&lt;span id="xdx_90B_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3d_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_ziuGnZjCD8Ci" title="Direct purchase of Noncontrolling Interests"&gt;546,000&lt;/span&gt;. Currently the Company has a direct ownership interest
of &lt;span id="xdx_906_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zL7MfEnHQaX" title="Direct ownership interest percentage"&gt;70.8&lt;/span&gt;% and the investors&#x2019; have a &lt;span id="xdx_90A_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zYGm9Nz1Tw26" title="Investors ownership interest percentage"&gt;29.2&lt;/span&gt;% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#x201c;Health Management Company of America&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basis
of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three and nine months ended March 31, 2023, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2023. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2022 for the fiscal
year ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and economies which
has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations. The Company
was able to enact certain decisions to allow the Company to sustain operations during the global pandemic and from further losses or
additional decreases in scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program
(&#x201c;PPP&#x201d;) and Medicare advances/stimulus payments. The Company has been able to navigate through these challenges and
avoid any significant disruption of the business and the volume has recently risen back to almost pre- COVID-19 levels. Recent
legislation was passed to end the national emergency for COVID-19 which the Company believes with positive cash flows, low debt and
cash on hand, it will be able to maintain operations to pre COVID-19 levels going forward.&lt;/span&gt;&lt;/p&gt;
















</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestOfOriginalInvestorsOfHdm
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.300</FONR:OwnershipInterestOfOriginalInvestorsOfHdm>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember"
      decimals="-3"
      unitRef="USD">546000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FONR:InvestorsOwnershipInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.292</FONR:InvestorsOwnershipInterest>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_80E_eus-gaap--SignificantAccountingPoliciesTextBlock_zCJlbHruw7yk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
2 - &lt;span id="xdx_822_zH37tuZ9jrl"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zShxYJYKZrCe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_861_z1cwLrtGsJqd"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zn67hGQVlNkg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_861_zzLpcFrOkto9"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgements employed in
the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z12o1EQ7Kzfg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_z9r8AyDU6xei" style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC Topic 260-10, &#x201c;Participating Securities and the
Two-Class method&#x201d;, the Company uses the Two-Class method for calculating basic income per share and applied the if converted method
in calculating diluted income per share for the three and nine months ended March 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and nine months ended March 31, 2023 and 2022, diluted EPS
for common shareholders includes &lt;span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230101__20230331_z8kpeeiDuqil" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220101__20220331_zKoVKw2pQQZ2" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20230331_ziBqwqwJUTdh" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20220331_z04fnBBOmodd" title="Shares included upon conversion of Class C Common"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;shares
upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zXFnwxKgAPmc" style="display: none"&gt;Schedule of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,860&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,627&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,153&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;































&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine
    months ended &lt;br/&gt; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine
    months ended &lt;br/&gt; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,139&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,647&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;10,198&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;9,583&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,615&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zfAr5NoPyaDa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL5uSIjLpOr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_869_zQOiX1DAhZM4"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected the Company&#x2019;s financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not
believe that any of those standards will have a significant impact on our consolidated condensed financial statements at the time they
become effective.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_849_eus-gaap--ConsolidationPolicyTextBlock_zShxYJYKZrCe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_861_z1cwLrtGsJqd"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_846_eus-gaap--RevenueRecognitionPolicyTextBlock_zn67hGQVlNkg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_861_zzLpcFrOkto9"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgements employed in
the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_z12o1EQ7Kzfg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_86F_z9r8AyDU6xei" style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted average number
of shares of common stock outstanding during the period. In accordance with ASC Topic 260-10, &#x201c;Participating Securities and the
Two-Class method&#x201d;, the Company uses the Two-Class method for calculating basic income per share and applied the if converted method
in calculating diluted income per share for the three and nine months ended March 31, 2023 and 2022.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three and nine months ended March 31, 2023 and 2022, diluted EPS
for common shareholders includes &lt;span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20230101__20230331_z8kpeeiDuqil" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220101__20220331_zKoVKw2pQQZ2" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_90A_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20230331_ziBqwqwJUTdh" title="Shares included upon conversion of Class C Common"&gt;&lt;span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20220331_z04fnBBOmodd" title="Shares included upon conversion of Class C Common"&gt;128&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;shares
upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zXFnwxKgAPmc" style="display: none"&gt;Schedule of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,860&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,627&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,153&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;































&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine
    months ended &lt;br/&gt; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine
    months ended &lt;br/&gt; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,139&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,647&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;10,198&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;9,583&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,615&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zfAr5NoPyaDa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_pn3n3_ziJ5zl8SbdX1" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zXFnwxKgAPmc" style="display: none"&gt;Schedule of earning per share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331_zR5PgRqcF74c" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,860&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDsmpWH5OwF2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,627&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zIZJjWEAKhoh" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331_zygB3FVMYcV2" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,291&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbPc5Wt47Ulf" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,153&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zenvKvlN9ql8" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331_z7SVPxNlwnjd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9avCVl42vWe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zxPMLZapReIe" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331_zts0aw1qp616" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUaQIh1ptKma" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zr1oLql4yJ1b" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331_zwRRRzbkNDYk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.60&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zFVy98NvnANa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--EarningsPerShareBasics_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z1CphJY2taHa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331_zWWFsFWO0RT4" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.35&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpnsldKbIBqd" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zMDRNn5usvXk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfr7cUCvVQh6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zh4E5vjBFf13" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze0txTi0WMRj" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zp1ANh7BVx9j" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJ2TUZbL4U2d" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z8XbHhGGIpfg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1037"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ9Nq2vJSByf" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ConvertibleClassCStock_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpL1jg9fZ3L2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1041"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX8LXjuNuNGh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,609&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6gMiCO4Cfag" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhw4MfV7Iefk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zUtmp5PZrGrc" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVVAcNQaoPk1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--EarningsPerShareDiluted_pip0_c20230101__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z5fDSgbujRfj" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zO7PJIdcOp7h" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--EarningsPerShareDiluted_pip0_c20220101__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z4HD8aqD7Oqb" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.09&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;































&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine
    months ended &lt;br/&gt; March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine
    months ended &lt;br/&gt; March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331_zL8mCm0P8chc" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,139&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znaM6YFXAKXk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,647&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zdCPum9YMPA5" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;125&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331_zwV6IwavaU5b" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;10,198&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z9F0utkpl519" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Common Stock and Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;9,583&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetIncomeLossAvailableToCommonStockholderBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_ztfwWzjq7vKk" style="border-bottom: Black 2.5pt double; width: 6%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;157&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331_zAEh0KyaYdsh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zltpYJ6TToj6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTExMJgbfkie" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331_zBJULbrr1elh" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zHhC3Ib41Bb2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zny3pF31a3z8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331_z3weKdOPM3K9" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zynp17GmaDti" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.18&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EarningsPerShareBasics_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zm65JVtlXHQ8" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331_zOxqN5BGqj8i" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.56&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnYkrweUMs3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zTH25oKwQoF2" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwUJ5FGckbed" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0Ip2LLtu5H6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLN42RgimSDh" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfnwfJZ03Dd3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztKah4t9j6g" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zfvOxHsqLJ37" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1119"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVvjx3EswZg" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zYbFQKMKJWc1" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1123"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCSMSjTFNCxf" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,615&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zFMrDtHBNBdg" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsbRrwokVTaa" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--WeightedAverageNumberOfDilutedEarningsPerShare_pn3n3_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zu4U6yjh62E1" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total Denominator for Diluted Earnings Per Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQSW9kAze7Zk" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.16&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--EarningsPerShareDiluted_pip0_c20220701__20230331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z6Ly2DAJY6e6" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoxfyIWIlLhi" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--EarningsPerShareDiluted_pip0_c20210701__20220331__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zuo3vrUeQtx" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Income per Common Share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.41&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">3860000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3627000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">59000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">2291000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">2153000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">35000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="Shares">6481000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6481000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <FONR:EarningsPerShareBasics
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="USDPShares">0.60</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.56</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">0.35</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.33</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.09</FONR:EarningsPerShareBasics>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6481000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:ConvertibleClassCStock
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6609000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6682000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-01-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-01-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.09</us-gaap:EarningsPerShareDiluted>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">8139000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">7647000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">125000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">10198000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">9583000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <FONR:NetIncomeLossAvailableToCommonStockholderBasic
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">157000</FONR:NetIncomeLossAvailableToCommonStockholderBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="Shares">6487000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6487000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="USDPShares">1.25</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.18</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.33</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2021-07-012022-03-31"
      decimals="INF"
      unitRef="USDPShares">1.56</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.46</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</FONR:EarningsPerShareBasics>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6487000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6615000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6682000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <FONR:WeightedAverageNumberOfDilutedEarningsPerShare
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedEarningsPerShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-012023-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012022-03-31_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.41</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_84B_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zL5uSIjLpOr" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_869_zQOiX1DAhZM4"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March 31, 2023
that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected the Company&#x2019;s financial accounting measures or disclosures had they been in effect during 2023 or 2022, and it does not
believe that any of those standards will have a significant impact on our consolidated condensed financial statements at the time they
become effective.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_806_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_z6NJBZHCZI5i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
3 &#x2013; &lt;span id="xdx_82B_zn04OKqJ8TG9"&gt;ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivables,
net is comprised of the following at March 31, 2023, and June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zqZUh9VPBLsl" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_zLWjIe3nGvP6" style="display: none"&gt;Financing receivable noncurrent allowance for Credit loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,925&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zJaYQDiLAe14" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,720&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zr7LeRJ6okt4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zfRvJ1t1s07c" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1169"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zN82vr4gSvD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;55,043&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zMqmN68lDgXe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;19,842&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331_z2lRYZnKXGW5" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35,201&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztFPol0sWH08" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;15,002&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zbdgiQnHaOjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,914&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331_zSAubPsMmUA8" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;9,088&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,336&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z8M8ZmFuTWwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zjRCwaddIXxe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;50,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zyhBAhuWIBXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,628&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630_zTMBJd5sfgoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;33,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3pGzfyAsTH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,290&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zhcSK1FmC8Eh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630_zVRSXYxlWjzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,603&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zhinEhAPq8c1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company's customers are concentrated in the healthcare industry.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Long
Term Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following three years as of March 31, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zk3M3S8Nrvc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_8B7_zVuGEp02lIw8" style="display: none"&gt;Schedule of facilities owned or managed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230331_zyuPkTCCWnul" style="width: 43%; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;792&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230331_zAsflSXtAWT5" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;216&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20230331_zNgY4R7r7hwj" style="border-bottom: Black 1pt solid; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,015&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_z801hYFKhXdf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
Receivables&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Payment
of the management fee receivables from the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_90D_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20230101__20230331_zQ0KBYo30K0f" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;67.6&lt;/span&gt;%
and &lt;span id="xdx_907_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220101__20220331_zvPWAEkHaks8" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;66.6&lt;/span&gt;% of the PCs&#x2019; net revenues for the three months ended March 31, 2023 and 2022 respectively, were derived from no-fault
and personal injury protection claims. Approximately &lt;span id="xdx_906_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20230331_zDRtt91TvcEk" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;67.9&lt;/span&gt;% and &lt;span id="xdx_901_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20210701__20220331_z23GkfayzObl" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;66.6&lt;/span&gt;% of the PCs&#x2019; net revenue for the nine months ended March 31,
2023 and 2022, respectively, were derived from no-fault and personal injury protection claims. The Company considers the aging of its
accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps
to collect its receivables. Credit losses associated with the receivables are provided for in the condensed consolidated financial statements
and have historically been within management's expectations.&#160;&lt;/span&gt;&lt;/p&gt;


























&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
revenues from management and other fees charged to the related PCs accounted for approximately &lt;span id="xdx_90B_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20230101__20230331_zKOyxHFSp4Zd" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;11.7&lt;/span&gt;% and &lt;span id="xdx_902_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220101__20220331_zh5z3Wa5IWba" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;12.2&lt;/span&gt;% of the consolidated net
revenues for the three months ended March 31, 2023 and 2022, respectively. Net revenues from management and other fees charged to the
related PCs accounted for approximately &lt;span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20230331_zM2ua95QwnQh" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;12.3&lt;/span&gt;% and &lt;span id="xdx_908_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20210701__20220331_zwQSUijctVFl" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;11.8&lt;/span&gt;% of the consolidated net revenues for the nine months ended March 31, 2023 and
2022, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenue, net of contractual allowances and discounts for the three and nine months ended March 31, 2023 and
2022 are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zintqeAeMla2" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span id="xdx_8BF_zJjOMnWk6aJg" style="display: none"&gt;Schedule of patient fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
                                            the Three Months&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Ended
                                            March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,037&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,095&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;303&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;287&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,186&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,635&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,188&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,641&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
                                            the Nine Months&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Ended
                                            March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,905&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,249&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;788&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;809&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,683&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,092&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,393&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,935&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zRGIuXR46sti" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_pn3n3_zqZUh9VPBLsl" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span id="xdx_8B6_zLWjIe3nGvP6" style="display: none"&gt;Financing receivable noncurrent allowance for Credit loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
    31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--AccountsReceivableServiceAndRepairFees_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,925&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccountsReceivableServiceAndRepairFees_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zJaYQDiLAe14" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AccountsReceivableServiceAndRepairFees_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,720&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AccountsReceivableNetRelatedParty_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zr7LeRJ6okt4" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AccountsReceivableNetRelatedParty_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;30&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zfRvJ1t1s07c" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1169"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--MedicalReceivable_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,460&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zN82vr4gSvD4" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;55,043&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zMqmN68lDgXe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;19,842&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20230331_z2lRYZnKXGW5" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35,201&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_ztFPol0sWH08" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;15,002&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zbdgiQnHaOjg" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,914&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20230331_zSAubPsMmUA8" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;9,088&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,336&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_z8M8ZmFuTWwj" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_zjRCwaddIXxe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;50,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zyhBAhuWIBXj" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,628&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ManagementAndOtherFeesNonRelatedParties_iI_pn3n3_c20220630_zTMBJd5sfgoe" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;33,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_z3pGzfyAsTH7" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,290&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zhcSK1FmC8Eh" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_iI_pn3n3_c20220630_zVRSXYxlWjzc" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,603&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">3925000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">205000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3720000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">30000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">30000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:MedicalReceivable
      contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">20460000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">20460000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">55043000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">19842000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">35201000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-03-31_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">15002000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2023-03-31_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">5914000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">9088000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4541000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">205000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4336000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:MedicalReceivable
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">20109000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">20109000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">50047000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">16628000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagementAndOtherFeesNonRelatedParties contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">33419000</FONR:ManagementAndOtherFeesNonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">13290000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">4687000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">8603000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_pn3n3_zk3M3S8Nrvc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;span id="xdx_8B7_zVuGEp02lIw8" style="display: none"&gt;Schedule of facilities owned or managed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20230331_zyuPkTCCWnul" style="width: 43%; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;792&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20230331_zAsflSXtAWT5" style="text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;216&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20230331_zNgY4R7r7hwj" style="border-bottom: Black 1pt solid; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,015&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <us-gaap:ContractReceivableDueOneToTwoYears contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">792000</us-gaap:ContractReceivableDueOneToTwoYears>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">216000</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">7000</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">1015000</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="Pure">0.676</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="Pure">0.666</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="Pure">0.679</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2021-07-012022-03-31"
      decimals="INF"
      unitRef="Pure">0.666</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2023-01-012023-03-31"
      decimals="INF"
      unitRef="Pure">0.117</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-01-012022-03-31"
      decimals="INF"
      unitRef="Pure">0.122</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="Pure">0.123</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2021-07-012022-03-31"
      decimals="INF"
      unitRef="Pure">0.118</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:ScheduleOfPatientFeeRevenueTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_pn3n3_zintqeAeMla2" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span id="xdx_8BF_zJjOMnWk6aJg" style="display: none"&gt;Schedule of patient fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
                                            the Three Months&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Ended
                                            March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,037&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,095&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;303&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;287&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,186&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,624&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,662&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,635&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20230101__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,188&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220101__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,641&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
                                            the Nine Months&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Ended
                                            March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,905&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,249&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;788&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;809&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,683&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,092&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,017&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,785&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,393&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20220331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,935&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</FONR:ScheduleOfPatientFeeRevenueTableTextBlock>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-01-012023-03-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">1037000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-01-012022-03-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">1095000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-01-012023-03-31_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">303000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-01-012022-03-31_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">287000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-01-012023-03-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">5186000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-01-012022-03-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">4624000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-01-012023-03-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">1662000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-01-012022-03-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">1635000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">8188000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">7641000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012023-03-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">2905000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012022-03-31_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">3249000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012023-03-31_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">788000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012022-03-31_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">809000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012023-03-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">13683000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012022-03-31_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">13092000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012023-03-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">4017000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012022-03-31_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">4785000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">21393000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">21935000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_80E_eus-gaap--LesseeOperatingLeasesTextBlock_zFtD9UIckw03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
4 &#x2013; &lt;span id="xdx_822_z8YaEraSjH61"&gt;OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will
not apply the standard to the comparative periods presented in the condensed consolidated financial statements. We have also elected
the transition package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior
conclusions about lease identification, lease classification and indirect costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of March 31, 2023
is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_zf6de1HtaBH8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8BD_zOfwVh5Cq7Fe" style="display: none"&gt;Lessee operating leases liability maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Twelve
    Months Ending &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease &lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,613&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,661&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,304&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,520&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;204&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,642&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zXcKMcW9uTX9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1326"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,835&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zZL2xC0vNGm3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1330"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PresentValueDiscount_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(9,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PresentValueDiscountFinancingLease_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(62&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;36,611&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;874&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:LesseeOperatingLeasesTextBlock>
    <FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_pn3n3_zf6de1HtaBH8" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span id="xdx_8BD_zOfwVh5Cq7Fe" style="display: none"&gt;Lessee operating leases liability maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Twelve
    Months Ending &lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease &lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,613&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="width: 26%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,661&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,304&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,520&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;204&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,642&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zXcKMcW9uTX9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="2028"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1326"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,835&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zZL2xC0vNGm3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1330"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PresentValueDiscount_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(9,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PresentValueDiscountFinancingLease_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(62&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;36,611&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FinanceLeaseLiability_c20230331__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;874&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5613000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5661000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5304000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">4520000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">204000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">3642000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">21835000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">-9964000</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">-62000</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2023-03-31_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">36611000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="AsOf2023-03-31_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">874000</us-gaap:FinanceLeaseLiability>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zM27HCXjJac1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
5 - &lt;span id="xdx_82E_zaQmlCkoIXH5"&gt;INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zHHVGifWLXr5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B8_zJlWPuC2Xmz2" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20230331_zoqVkC5bN56e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20220630_zPUFMbxA9ku1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
    31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzjFD_zR68CrEwejXk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,456&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,126&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzjFD_zLHNioTC1cK2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzjFD_zx6wIeBIEmS" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,661&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,360&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_pn3n3_zHHVGifWLXr5" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B8_zJlWPuC2Xmz2" style="display: none"&gt;Schedule of inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20230331_zoqVkC5bN56e" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49B_20220630_zPUFMbxA9ku1" style="font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
    31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzjFD_zR68CrEwejXk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,456&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,126&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzjFD_zLHNioTC1cK2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;234&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzjFD_zx6wIeBIEmS" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,661&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,360&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2456000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2126000</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">205000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">234000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2661000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2360000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_80F_eus-gaap--IntangibleAssetsDisclosureTextBlock_zyKSmmN3pD8l" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
6 &#x2013; &lt;span id="xdx_822_zBwRpSudoelc"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_z1AjpVHk6Ms6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zEbTVwVJb3L9" style="display: none"&gt;Schedule of other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
    31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,420&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,475&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,388&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,981&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,684&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,494&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,704&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of patents and copyrights for the three months ended March 31, 2023 and 2022 amounted to $&lt;span id="xdx_906_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zjPIwtAHpyj5" title="Amortization of Intangible Assets"&gt;46&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zvLoY5iIZ7c6" title="Amortization of Intangible Assets"&gt;44&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of non-compete for the three months ended March 31, 2023 and 2022 amounted to $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zhMYvqkAbzE2" title="Amortization of Intangible Assets"&gt;0&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zeFPp5Ypbq3g" title="Amortization of Intangible Assets"&gt;13&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of customer relationships for the three months ended March 31, 2023 and 2022 amounted to $&lt;span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20230101__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z5HzUsaLk31k" title="Amortization of Intangible Assets"&gt;50&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220101__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zCF0lGgKsDY4" title="Amortization of Intangible Assets"&gt;50&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of patents and copyrights for the nine months ended March 31, 2023 and 2022 amounted to $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zxZeKK1OYcc3" title="Amortization of Intangible Assets"&gt;147&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zitapwsRoVt7" title="Amortization of Intangible Assets"&gt;140&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of non-compete for the nine months ended March 31, 2023and 2022 amounted to $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zzkFjrIh4aj9" title="Amortization of Intangible Assets"&gt;38&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of customer relationships for the nine months ended March 31, 2023 and 2022 amounted to $&lt;span id="xdx_90C_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20220701__20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z9qGoaLyIHPh" title="Amortization of Intangible Assets"&gt;150&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20220331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zISASBoy3thl" title="Amortization of Intangible Assets"&gt;150&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;


















</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_pn3n3_z1AjpVHk6Ms6" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zEbTVwVJb3L9" style="display: none"&gt;Schedule of other intangible assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
    31, &lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 12%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,420&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,333&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_c20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,475&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,388&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20230331_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,981&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,684&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets - net&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20230331_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,494&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,704&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5420000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5333000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-03-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">20475000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">20388000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">16981000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">16684000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3494000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">3704000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-03-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">46000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-03-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">44000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-03-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-03-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-01-012023-03-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-01-012022-03-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-03-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">147000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-03-31_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">140000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-03-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-03-31_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">38000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012023-03-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">150000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012022-03-31_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">150000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_801_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zdDSwhYOTkKb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
7 &#x2013; &lt;span id="xdx_825_zgOb5BPq8i5h"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHrcBkEQFTg4" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8B1_zS8sgM1f5Bq4" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20230331_zNaAi5NQOBld" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220630_zVn1pwwmIpl" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
                                            31,&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
                                            30,&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzBfQ_zE56UO2NpdVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,046&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,653&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzBfQ_zDw15wTFKYD2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;210&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzBfQ_z9cJaKOmmVL" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;382&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzBfQ_zW8pYuhRjlT8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzBfQ_zz0d1PDiaIsb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzBfQ_zFnq5SwfZDkc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzBfQ_zbxbF8jxpnK6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzBfQ_z7fBg2Q0UjKl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;902&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;854&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzBfQ_zPzaRuODK2g4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,417&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_pn3n3_zHrcBkEQFTg4" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: center"&gt;&lt;span id="xdx_8B1_zS8sgM1f5Bq4" style="display: none"&gt;Schedule of other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_495_20230331_zNaAi5NQOBld" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 11pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" id="xdx_497_20220630_zVn1pwwmIpl" style="font-size: 11pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March
                                            31,&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-size: 11pt; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-size: 11pt; text-align: center"&gt;&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
                                            30,&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzBfQ_zE56UO2NpdVe" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,046&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,653&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzBfQ_zDw15wTFKYD2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;210&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzBfQ_z9cJaKOmmVL" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;382&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzBfQ_zW8pYuhRjlT8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;11&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzBfQ_zz0d1PDiaIsb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;89&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzBfQ_zFnq5SwfZDkc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;35&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;79&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzBfQ_zbxbF8jxpnK6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzBfQ_z7fBg2Q0UjKl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;902&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;854&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzBfQ_zPzaRuODK2g4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,496&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,417&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">2046000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4653000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">210000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">249000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">200000</FONR:StateIncomeTaxesPayable>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">382000</FONR:StateIncomeTaxesPayable>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">11000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">21000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">89000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">120000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">35000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">79000</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">59000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">902000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">854000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">3496000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">6417000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_808_eus-gaap--SegmentReportingDisclosureTextBlock_zDqs0rjkEDSb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
8 - &lt;span id="xdx_82E_zdcn7lbVPgLh"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#x2019;s 10-K as of June 30, 2022. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Summarized
financial information concerning the Company's reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zG5iedbA3Qha" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B9_z0QG7wJSlePg" style="display: none"&gt;Summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the three
    months ended March, 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt; Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,884&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;23,538&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;25,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zhiQbGlmYfT6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,308&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,167&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,075&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,139&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,191&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,204&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,039&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;22,532&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;24,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zWo1LAFkij4d" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1505"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(537&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,175&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,638&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,121&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,185&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;43&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the nine
    months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt; Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,797&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;67,072&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;72,869&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntersegmentNetRevenues_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;735&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zm1qfv1Egyp2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1535"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;735&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(2,495&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;14,804&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;12,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,156&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,357&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;87&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,553&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the nine months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,284&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;66,496&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;72,780&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zanQVRQd1vtl" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1565"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(1,054&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;18,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;17,863&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;199&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,344&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,543&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,577&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,807&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zdikaxwrwYga" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"&gt;&#160;&lt;/p&gt;





















</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2022-07-01to2023-03-31">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_pn3n3_zG5iedbA3Qha" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B9_z0QG7wJSlePg" style="display: none"&gt;Summarized segment financial information&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the three
    months ended March, 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt; Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,884&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;23,538&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20230101__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;25,422&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--IntersegmentNetRevenues_pn3n3_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zhiQbGlmYfT6" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(1,141&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,308&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncomeLossFromContinuingOperations_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,167&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,075&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,139&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,191&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20230101__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,204&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,039&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;22,532&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;24,571&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IntersegmentNetRevenues_pn3n3_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zWo1LAFkij4d" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1505"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(537&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,175&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperations_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,638&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;64&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,121&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,185&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;43&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,620&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220101__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the nine
    months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt; Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt; of Diagnostic &lt;br/&gt; Imaging &lt;br/&gt; Centers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,797&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;67,072&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20220701__20230331_pn3n3" style="width: 11%; font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;72,869&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IntersegmentNetRevenues_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;735&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_pn3n3_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zm1qfv1Egyp2" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1535"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IntersegmentNetRevenues_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;735&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(2,495&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;14,804&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;12,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;201&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,156&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,357&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;87&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,553&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20230331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,640&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the nine months ended March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,284&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;66,496&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NetRevenuesFromExternalCustomers_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;72,780&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--IntersegmentNetRevenues_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_pn3n3_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_zanQVRQd1vtl" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1565"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--IntersegmentNetRevenues_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(1,054&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;18,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;17,863&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;199&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,344&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,543&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;230&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,577&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20220331_pn3n3" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,807&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">1884000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">23538000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">25422000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-1141000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">5308000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">4167000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">64000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1075000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">1139000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2023-01-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2023-01-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">2191000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2023-01-012023-03-31"
      decimals="-3"
      unitRef="USD">2204000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">2039000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">22532000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">24571000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-537000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">6175000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">5638000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">64000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1121000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">1185000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-01-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">43000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-01-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1620000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-01-012022-03-31"
      decimals="-3"
      unitRef="USD">1663000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">5797000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">67072000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">72869000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">735000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">735000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-2495000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">14804000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">12309000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">201000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">3156000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">3357000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-07-012023-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">87000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-07-012023-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">3553000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">3640000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">6284000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">66496000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">72780000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">720000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">720000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-1054000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">18917000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">17863000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">199000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">3344000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3543000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012022-03-31_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">230000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012022-03-31_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">3577000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">3807000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_809_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zP94toHF7ba7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
9 &#x2013; &lt;span id="xdx_82F_zKUwW8USZ4s3"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
the nine months ended March 31, 2023 and March 31, 2022, the Company paid $&lt;span id="xdx_902_eus-gaap--InterestPaid_c20220701__20230331_pn3n3" title="Interest paid"&gt;42&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--InterestPaid_c20210701__20220331_pn3n3" title="Interest paid"&gt;279&lt;/span&gt; for interest, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
the nine months ended March 31, 2023 and March 31, 2022, the Company paid $&lt;span id="xdx_90D_eus-gaap--IncomeTaxesPaid_c20220701__20230331_pn3n3" title="Income taxes paid"&gt;1,140&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--IncomeTaxesPaid_c20210701__20220331_pn3n3" title="Income taxes paid"&gt;1,105&lt;/span&gt; for income taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaid
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">42000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">279000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1140000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">1105000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zxTgmwXhR8Yh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
10 &#x2013; &lt;span id="xdx_828_zro1ji9JsGG2"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $&lt;span id="xdx_90D_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926_zjYV2rN8KZ84" title="Stock purchase plan"&gt;9&lt;/span&gt; million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the nine months ended March 31, 2023, the Company
repurchased &lt;span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20230331_zl6jleIiHv4c" title="Number of shares repurchased"&gt;70&lt;/span&gt; shares at a cost of $&lt;span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodValue_c20220701__20230331_pn3n3" title="Number of shares repurchased, value"&gt;1,249&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_90B_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_iI_pn3n3_c20230331_zNLr7P6z7nu" title="Maximum limit for individual claims under stop-loss umbrella policy for health insurances"&gt;150&lt;/span&gt; per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of March 31, 2023 and June 30, 2022, the Company had approximately $&lt;span id="xdx_901_eus-gaap--SelfInsuranceReserve_c20230331__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--SelfFundedHealthInsuranceMember_pn3n3" title="Self-funded health insurance reserve"&gt;35&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--SelfInsuranceReserve_c20220630__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--SelfFundedHealthInsuranceMember_pn3n3" title="Self-funded health insurance reserve"&gt;79&lt;/span&gt;, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d; in the
condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.&lt;/span&gt;&lt;/p&gt;


















</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="AsOf2022-09-26" decimals="-3" unitRef="USD">9000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="Shares">70000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1249000</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">150000</FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2023-03-31_custom_SelfFundedHealthInsuranceMember"
      decimals="-3"
      unitRef="USD">35000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="AsOf2022-06-30_custom_SelfFundedHealthInsuranceMember"
      decimals="-3"
      unitRef="USD">79000</us-gaap:SelfInsuranceReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zwiNmwcRTUBg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
11 - &lt;span id="xdx_823_zCubvGHEu9x9"&gt;INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC 740-270, &#x201c;Income Taxes &#x2013; Interim Reporting&#x201d;, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the nine months ended March 31, 2023 and 2022, the Company recorded income tax expense of $&lt;span id="xdx_90B_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20220701__20230331_pn3n3" title="Income tax expense"&gt;2,889&lt;/span&gt; in 2023 as compared
to $&lt;span id="xdx_909_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20210701__20220331_pn3n3" title="Income tax expense"&gt;5,311&lt;/span&gt; in 2022. The 2023 provision is comprised of a current income tax component of $&lt;span id="xdx_905_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220701__20230331_pn3n3" title="Income tax component - current"&gt;958&lt;/span&gt; and a deferred income tax component of $&lt;span id="xdx_909_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220701__20230331_pn3n3" title="Income tax component - deferred"&gt;1,931&lt;/span&gt;.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#x201c;Interest expense, net&#x201d;. Penalties if incurred would be recognized as a component of &#x201c;Selling,
general and administrative&#x201d; expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company recorded a deferred tax asset of $&lt;span id="xdx_906_eus-gaap--DeferredTaxAssetsNet_c20230331_pn3n3" title="Deferred tax asset"&gt;10,911&lt;/span&gt; and a deferred tax liability of $&lt;span id="xdx_90F_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20230331_pn3n3" title="Deferred tax liability"&gt;216&lt;/span&gt; as of March 31, 2023, primarily relating to net
operating loss carryforwards of approximately $&lt;span id="xdx_909_eus-gaap--OperatingLossCarryforwards_c20230331_pn3n3" title="Operating Loss Carryforwards"&gt;5,191&lt;/span&gt; available to offset future taxable income through 2032. The net operating losses
begin to expire in 2023 for federal tax and state income tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss
carryforwards. As of March  31, 2023, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Inflation Reduction Act (&#x201c;IRA&#x201d;) was enacted on August 16, 2022. The IRA includes provisions imposing a &lt;span id="xdx_902_ecustom--ExciseTax_pip0_dp_c20220701__20230331_zDJfJO9kFbTk" title="Excise tax"&gt;1&lt;/span&gt;% excise tax on share
repurchases that occur after December 31, 2022 and introduces a &lt;span id="xdx_90F_ecustom--CorporateMinimumTax_pip0_dp_c20220701__20230331_zqT8bTRouTu6" title="Corporate minimum tax"&gt;15&lt;/span&gt;% corporate alternative minimum tax (&#x201c;CAMT&#x201d;) on adjusted
financial statement income. The CAMT will be effective for tax years beginning after December 31, 2022. Currently, the Company does not
expect the IRA to have a material impact to the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">2889000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2021-07-012022-03-31"
      decimals="-3"
      unitRef="USD">5311000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">958000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2023-03-31"
      decimals="-3"
      unitRef="USD">1931000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">10911000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">216000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2023-03-31" decimals="-3" unitRef="USD">5191000</us-gaap:OperatingLossCarryforwards>
    <FONR:ExciseTax
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="Pure">0.01</FONR:ExciseTax>
    <FONR:CorporateMinimumTax
      contextRef="From2022-07-01to2023-03-31"
      decimals="INF"
      unitRef="Pure">0.15</FONR:CorporateMinimumTax>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-07-01to2023-03-31">&lt;p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zuhnhZ7GtVMl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
12 &#x2013; &lt;span id="xdx_826_zrDzIiQSJd6g"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company has evaluated events that occurred subsequent to March 31, 2023 and through the date the condensed consolidated financial statements
were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
April 2023, the Company repurchased &lt;span id="xdx_904_eus-gaap--StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_iI_pn3n3_c20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z13GysIc4lNa" title="Stock repurchase plan, shares"&gt;6&lt;/span&gt; shares at a cost of $&lt;span id="xdx_904_eus-gaap--StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_iI_pn3n3_c20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHDvpBbYpYJ7" title="Stock repurchase plan"&gt;101&lt;/span&gt; which was authorized under the stock repurchase plan adopted in September
2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
April 2023, the Company amended the revolving credit agreement. The agreement was extended to July 7, 2023. The interest rate on borrowings
is at the current prime rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230401__20230430__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh0Mrg79Vbad" title="Interest rate"&gt;8.00&lt;/span&gt;% along with certain financial covenants.&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
      contextRef="AsOf2023-04-30_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="Shares">6000</us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="AsOf2023-04-30_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="USD">101000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-04-012023-04-30_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.0800</us-gaap:DebtInstrumentInterestRateDuringPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>55
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3T5GU05.2D?>ZN\?:R45>-VD8M"IC.K*6QVUEE%!^W.>_5*QW<D;ZFL'CNI
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MF]RDBRSAZ&N>)>ANS:O)SE+8;:S&.K;D7 B@3(O*LPV@1"UHR-H(@MF.U5/
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MVX,R6]>OP3QG99DE]<<5#P6[%4#\_I)EY>Z@.L'^7:W)_P!02P,$%     @
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M<#%'%;>Q&*:!2H!XOB&$GQ;203V>C_X"4$L#!!0    ( "Z"KU9;*#B2)08
M / F   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULK5IK;]LV%/TKA%<,
M&U#7(O5TEQA(K4<SK&D6IQN&81\4FXF%ZN%*=-+^^U&R(EGDM6@;^F)+]KF'
M5^?2ESR6+EZR_&NQII2A[TF<%I>C-6.;]Y-)L5S3)"S>91N:\F\>LSP)&3_-
MGR;%)J?AJ@I*X@G1-&N2A%$ZFEU4G]WFLXMLR^(HI;<Y*K9)$N8_/M X>[D<
MX='K!W?1TYJ5'TQF%YOPB2XH^[*YS?G9I&%910E-BRA+44X?+T=7^'U S#*@
M0OP5T9=B[QB5E_*095_+D^O5Y4@K,Z(Q7;*2(N1OSW1.X[ADXGE\JTE'S9AE
MX/[Q*[M?73R_F(>PH/,L_CM:L?7ER!FA%7T,MS&[RUX^TOJ"J@2765Q4K^AE
MA[6G([3<%BQ+ZF">01*EN_?P>RW$7@ A!P)('4"$ -TZ$*#7 ;HX@GT@P*@#
M#'&$0RF9=8 I!N@' JPZP!("\*$ NPZPJV+MU*U*XX8LG%WDV0O*2S1G*P^J
M^E;1O")16D[%!<OYMQ&/8[/YYQO7NUEX+N)'B\]_7+M7]_QD<<_?/GDW]^BS
MC^8?KVX";X&N;Y#WYY?K^W_0&'U9N.B7-[^B-RA*T?TZVQ9ANBHN)HSG5#)/
MEO7X'W;CDT/C9TG"9^2"9<NOZ-]/-'F@^7\ S;R?YFJUBLJI'<;H-HQ68Y[4
M/-Q$C)_WD+K]I'>4\=\R72$OS-,H?2KZN+Q^KGO>)XIM_F-WI6]1?=T]A'X_
MX4V6+K.4Y5G,OWE"URFC.2U8'V.@2#'C<G7#)GPV-5.*-%.*5#SZ 9X/81RF
M2XI"AG[?IN^0KKU%1",8FAP[)JMB*KOF\XS#GO?K#B <$VL"S)5A8\/2-*<+
M\P"899M=D ^ =,V8=E$!D)ANZK;6P#KBZ8UX^C'B05KU!I9+UOMB$R[IY8BO
M207-G^EHAJ!?TD \[H['V!= PU-1\3-&^_DG;&F_03^)@5(/5*EW2F<TI3/.
M+5UOX FE&XC''8C'&XC'-Z1ZC VL"[_Q0(7J5,ULJF:>6[7>P!.J-A"/.Q"/
M-Q"/;TKUT'5'%XJF '5J9C4UL\ZM66_@"36SY+EF[O7V74$&&LP;B,>7DR:&
M4 [HN@P++H?=E,,^=L'_%.9\P<?5@D^@^MARYQ46? #A&*;8#%P9-M9-!PLE
M\@"8O.!#7+8MSF0@,<,@M@&+YS3B.<>*Y])E(QZX6W*4X@$(2#P9-M8=:5/E
MR3!9.XA*Q^*T _(R"%</UF[::#<]MP],I0&%F3%7(EP90<A4U$A)XRL1@6*@
MCC98:YV==JXZ=62?/&J(JX9X:H@/0,;8T$6-E+"N2GO^%Y^M$E:KI(2X:HBG
MAO@ 9&J+&R0%J*M0:^?PT7Y.V=YKJKX6!4&@'@7@P X/X>0V!;+)/1Y*KJ?)
MX];6X:-\G6B*81$!>R**"$! $64<;\^F98LB CA 1 !E:*;8[*'D#(OH![89
MN#58^&R'U1]YPL9O*"(7RW;%P?I4%'XH"S444:#*NUN[UF;ALWU6?^0IM1O*
M:0U%Y&'9_HPQ$?]+\H<:+U".UZU>:[CPV8ZK/_*4Z@U$Y Y%Y U%Y&/ =ADZ
MML7&J8)UJ]?Z,WR400.KUQMY2O4&(G*'(O*&(O(Q9$DUJ7@*5+=VK3W$1_E#
ML':]D:?4#C!QAO07^U##><!PAD;$ECC0: $PVJ$M<>L[\5'&4]P2ZV"59'<G
M[>8 B&-@T0.Y &Y,3(.(_[E#.&P226( 9IF6M)T#LC,UZU!;(JU!)4<95/&O
M#W!/3&3[)]TI B"0B@!N3*;$D>X5 3C;%$;U 92EB5('4&X&[PX'["MI[2LY
MV[X2M7U50UP HCN6:,+41+X:$JC&ZFJT=S_R* ,+:M0;>>+MJ3F1W:,DIQ+B
M 9"Q+7I]7TT4J(BZ<K96EIQ]BY+(SD^:<DJ(JX9X:H@/0,88B\XW4,*Z*K5>
ME9SM58GLL"25E!!7#?'4$!^ 6,04->H'=15J'2$YRA$>M8C65+T/"@ 0L/W+
M.' 1A7# (@K!@$44R@Y:1"=[C_*4SX)Q99ZBM$ Q?>2!VCN;\^2[QZMV)RS;
M5$_W/&2,94EUN*;ABN8E@'__F&7L]:1\8*AYR&WV/U!+ P04    "  N@J]6
M0)1N+4,'  !.(0  &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;*U:;6_B
M.!#^*Q:W6K72LL1VPDNW16II>UMI^Z*EO?UL@BF^#3$;F[[<K[^Q@002QVT1
MTFJ;A/'PS(QGGO&$XV>9_593SC5ZF26I.FE,M9X?M5HJGO(94U_EG*?PR41F
M,Z;A-GMLJ7G&V=@NFB4M$@3MUHR)M-$_ML_NLOZQ7.A$I/PN0VHQF['L]8PG
M\OFD@1OK!S_%XU2;!ZW^\9P]\B'7#_.[#.Y:N9:QF/%4"9FBC$].&J?X:$![
M9H&5^$?P9[5QC8PI(RE_FYNK\4DC,(AXPF-M5##X\\0'/$F,)L#Q9Z6TD7^G
M6;AYO=9^:8T'8T9,\8%,?HFQGIXTN@TTYA.V2/1/^?R=KPR*C+Y8)LK^CYY7
MLD$#Q0NEY6RU&!#,1+K\RUY6CMA8 'K<"\AJ 2DO"&L6T-4":@U=(K-FG3/-
M^L>9?$:9D09MYL+ZQJX&:T1JPCC4&7PJ8)WN#VYOSB]NAA?G"*Z&MS^NSD_O
MX69X#W^N+V[NA^CV$@U.A]_1Y8_;7T-T\'!S^G!^!3*'J(D>AN?HX-,A^H1$
MBNZG<J%8.E;'+0W(C/Y6O$)QMD1!:E#TT+5,]52ABW3,Q]OK6V!1;A99FW5&
MO JO6?854?P%D8!0!Y[!^Y<3#QR:>YE:?5&=EYF:HDM(&84FF9RAVSG/F!;I
M(SHUVUAHP=61RVU+M=2MUJ3XD9JSF)\T((<5SYYXH__Y+]P.OKELWI.R+0^$
MN0?"7;7?0+$2:2QGW.6!I=JV56MJTE._UPO;QZVG3<NJ0IA&79Q+;4&.<LB1
M+V@^R*?C?R$UH9IIA;2$<A;+-!8)1VENBWEN[F(3^GDFGP3L;#1Z13*//?/'
M/MIG[/>D;,N1[=R1;9_V_CD'I;%@R[J=CA&;R4R+_^P#E^5+=>%&."F-.J68
M.X2BD+I#WLF1=KQ(3S> (<-3A@2:<M)<*(Z84EP[BUO'@3<H[]&J$.E%-7B[
M.=ZN%^^=V5>648'0@<[&P& C-\9NY>O#,,0EC%4A@J/ C;&78^R]$?T)SS+8
M^^N\8"_H\U]=@O$WDR NK+T*#-RC9:Q5(1IV0S=6'!1T&'C1_@V=#UKZ\Q'Z
MBY0KA>0$W=W=H40RYV[U:W3G%G+EZ$K1IDG-3E!3Q? &PV,O^1Q<I3%T>(H?
MPNY87AFZWJA#=F-_,=%P%J*5_CU5HGUIV_8&*;Q!_"D>QW*1&G-G?"QBEMB*
M-&,I-*VFH*,)YZ:@<_'$1@D_4(=.EY!JJ*)V$);VJ$LL[-5E%"[:">SEZOZ-
MU%QMH'1"I-4L*N>00X:2&G %TV,OU?<'T,IEP&V>@NG7\)&4":L.QE&-!07Q
M8R\=]J]2R'PM,V!F)_JH^J4TJ/C6(=4)ZK 57(K]9'J7\3D38\1?X"2G8!>8
M[2OUE&=P7( ZFWK]7B7-9H>6@5>%,*[;%06S8C^UWEJ('FC>Y1_9$E6BQ;6;
MNB!:W/46T74-10?K&GJX7403P48BL=V<IY)ZZ?S#E71/VK9=4O Z]A/[NI*B
M.7NM+4(.*F]WRQNN*M3L1C690@HJ)WXJO]U*BHWXN( 2!_>&8= K076)16&W
MIJ"3@J.)E_7ZQ8$PL;OL+;2X"H-TVU$9K4LLZO1JT!8<2OP<>BE2!N>==Z-U
ML"#N5,"ZI**:[H<45$G\5#FP,Q38"&,^ETJXBP^I\F!8]695J$D[=:$OZ)*\
MDR[?\N*^.)-\@#-)P9G$SYG+;'O+!@<GAI4<\PMMXRMXD_AY\^:]9W$G;@<E
M!KB*W"F&.S78"^XDG5TG$>7)DFE=U'LF2V0'OJVGHGUIVW90P<[DC7/P(HNG
MS'1#<%:# $-8]:OMC/B?A9B;OM[I@^IYMTFCJ-P0.<6Z05U8"P(E7@+U>65M
MD+$GE7!PAAHAD\3$5:2:@W1-(=OA&]U%PL')T<;<;7L,6G R]7/R0"IM8\2T
M&9XY1YX.BNV6AS\NH79-*:8%"U,_"^<U8J'LO +^K;/)7Q^H@VAI.PS*J!UB
M88AKAD"TX&-*]E4?"NI^:_+L;0$^/'K>D[9M!VV,WW>>;?^$X]2K/?C#MAS)
M#'2#=Y;'JIC-A6;)JLN1HT0\VM&@>P\XV@-2'@(ZA>KB7[00=.?A^F8AT>;<
MLLA>$71$\6^G#:[6@%1X;A<XR!?(HLN@.P^JSX72F1@M;(#L]/T#=9.Z>@Z*
M*V7')89I39-*B^:$OK,Y61>>29ZF;Q0>QX$^BGJDC-LA%N*H9EI*B\:$[LSK
MQJ3\T P6V4)DDLI>7  M/[&DE@.J9_A>-1B.@WY4-UNC12]!_;U$+5#41&?\
M4:2I"8N9"?-,R+$3OF/8WNV0<E_A$@O#6AHK^@KJ/YC[++@PTR(O]E[E75K8
M<U"90ZP=X#+VUL:;:3B$/=H7]@K9P<'R;6[^-/]1P*E]%5YZ?H:/!LM7^X6:
MY2\-KED&05%0I">@,OC:@1S-EB_OES=:SNW[[Y'4<!*TEU/.QCPS O#Y1$J]
MOC%?D/^$HO\_4$L#!!0    ( "Z"KU9;Z[6!CP<  )D0   8    >&PO=V]R
M:W-H965T<R]S:&5E=#@N>&ULK5AK;]LX%OVN7T%H@-D&</Q*TJ9M$L!Y%,T,
MDGCC=':!Q7Z@)=KBEB(U)&77\^OW7%*2E2(-9H#Y$DL4>9_GGGN9LZVQ7UTA
MA&??2J7=>5IX7WT8C5Q6B)*[H:F$QI>5L27W>+7KD:NLX'DX5*K1=#Q^.RJY
MU.G%65B;VXLS4WLEM9A;YNJRY'9W*939GJ>3M%UXE.O"T\+HXJSB:[$0_DLU
MMW@;=5)R60KMI-',BM5Y.IM\N#RF_6'#;U)L7>^9D2=+8[[2RVU^GH[)(*%$
MYDD"Q\]&7 FE2!#,^+V1F78JZ6#_N97^*?@.7Y;<B2NC_B5S7YRGIRG+Q8K7
MRC^:[6?1^'-"\C*C7/C+MG'OR3AE6>V\*9O#L*"4.O[R;TT<>@=.?W1@VAR8
M!KNCHF#E-??\XLR:+;.T&]+H(;@:3L,XJ2DI"V_Q5>*<O[B^65P]WLZ?;A_N
MV<,G=OEE<7M_LUBPV?TUNYPM;A>T.G^\6=S</\UHU]G(0RT='F6-BLNH8OH#
M%>_9G=&^<.Q&YR)_?GX$<SN;IZW-E]-7!=YQ.V1'DP&;CJ='K\@[ZF)P%.2=
M_$#>+,M,K;W4:S8W2F92./:?V=)Y"\S\]R6'H[RCE^51'7UP%<_$>8I"<<)N
M1'KQ\T^3M^./KUA[W%E[_)KTOR=CKZNX?WBZ22;LYY].IY/)1_:7-;)KX3(K
M*ZJ[Q*S89>V@P3GVZ>%^]IA<&5L9RT-5OO&%8.F5*2NN=RDSEJ5A4WK I&,<
MDA3?<BM8MC\T8-M"9@7;<L>D;C^(/(&\7VJU8Y-W S9Y_^YT&!62)*'7X)@<
M^QEII+1PFQ4#5/ &S%2!9_R 5=;D=4,7.H^G!XDOK*G7!9/>0;-1:G=HMAK"
M7+UT,I<@,_99<.4+=L<UU) PUO<2,9B5PLJ,LS?IY[NK67J00-=&YH!:!N>M
M*(CH-@*UW4D@Y,@,.[QAT++6QGF9,5GR-6%UQ3.II =:A^RI@$/=@59VSI:[
MX&X37XJ6JG/QW&F>@U<DH3T&5PGN2#Z,-JL5Y+$ 9C=@-ZN5""R:Q#!3!4Y.
M!L]4(++>(H:UA7KZT.4'R5US+?_H0D)?>^YBY04O,WP2UL&W=;O+U&#B!E+#
MY"FD\YEL D;?"L-*$R!45DIXH2@07JR#460$6EQTWI'X/YU*@LCGZ[LANRTA
M0'*59" Z*Y<UP,BX4K290,.=$_AYT\!6P);:(W=_[ '9^O-7##@@SV! ,,2*
M3" ST)M,CX=3=GPR/&5'X^&8G1R_'8S'8_9NC)7I>WR[1((=%>:<ZD#[*!B!
M3'B6Q3Q2Z&O-ZUR2+_ K!S[CDP-'YE1O;"4UUQD<1[2Q0*8Z5G"@>"F$1C6)
MBMOH(PFV.78+-#@XMQ8:,4<IT1=1A8!U- S\ JD2R7(,<T?(EI5E3Y_4<1YI
M*S7(I#A*'1,?DHGP4.MFD_'A/\.VF06TE, "A?%1K&L592P._SUDLV C]*M=
MP/0NR0W3QG=ETZ0TZGENP,H8CZTPV(K?:VEC[>U=8CV77O"]0<$7'<*]H&BZ
M7J83BD(+WQ?##A#J!LLHY@B3?6T-@ND\_Q\&BIBE-Y1(%'U3Z)J<402BVEI:
M@V6VYLH=A(R#2^!1HH$QYXCNR!X.!I*657T,[9/?Q"P?LH=871"*G1B68D[)
M5A"K$"%\&N!'D88Q0="8 /2#GKLN#P=0-)2+U@:I=HG4.8)#A-2FI=7@"^[A
M_PZV,/&M FL17!NU*^DR.+M#!R!E9-DO-?0?C:.R(:&&K6J+S;:?Z0&-H5@"
MKB*S[6LA>;$6GB.#Q F<;4/39KVASG\X-M,:00<P4>V@.MW!]U<8K7""H$J(
M*9<P8WH:[)U^YUC2.H;]?;^FH4TD:V66T &-N2A!M(C<U<-OM]>'D_=(']H1
MKZG009W+6@DJ6/*BQH/U&/+][F6PTJ90ISJ$"AHPY'\531 $8F5*&JP"!R:D
MB.<;$#NQ,0]]A=P#L],4#X<R@4XD44I@()3C/KS$13+4-Z5C(W1-K0D=;R4]
M7U)'W 65>T;MV#T$H UW0EV"+\$&2(G0&/58XR+:8R9=RR"H' QH_1:'18="
MHIV]SI'7H7!HX_<A#C"PINPPI0PZ BRS"<^C,]@.K;A6T3H$(Y&:;8RJ2_',
M:ICCS)[LG2FASB"0.HX,7I:UJE%BM<Y=5$H6S?D.U[GL*Q@?4(P3#A[1 LOD
M#<UYT_''^7P>GB8?#X+%=X*J"V6'1!%QNU$GO>*[AG7ZIE%20^VW4=5\(]>Q
MR<8)RH<Q)2L04PQD$34)WQ@)]H< )]=:8N+@\"27SM95?U3H$DK&T4(,3U!+
M =$>4+(29(1[&EP-N2LQ31!%'>Y!KFCX@>F/X4RBQ%HZM1\<*NK6>01%U-,A
M&E5M0=Y9Y+].8&SK?80LA9+0XF)?JHR3@:0R[@JV IP 6 )5+I8^A"!\"/2I
M\P%&!IP#7X.[VDC2]?I[P&$9CGWO%] 0AD-C,3;GPY<N'*/>=3%X1)=BFD/1
MJN+-L5OM[MVS>-W<;X^7=K TIC0'W2L<'0_?X8YEXT4XOGA3A<OGTGA<9<-C
M(3C:"6W =V+']H44=/^-N/@_4$L#!!0    ( "Z"KU:@Q9/48PD  -47   8
M    >&PO=V]R:W-H965T<R]S:&5E=#DN>&ULQ5AK;^.X%?VN7T%XB\4,X#A^
MQ$XR>0"))]D-T#PPSG11%/U 2[3%'4GTDI(][J_ON9>4K#S;3E'TBY[D?9Y[
M>,G3C;'?7*I4*;[G6>'..FE9KC[M[[LX5;ET/;-2!?XLC,UEB5>[W'<KJV3"
MD_)L?]CO3_9SJ8O.^2E_>[#GIZ8J,UVH!RM<E>?2;B]59C9GG4&G_O!%+].2
M/NR?GZ[D4LU4^77U8/&VWTA)=*X*ITTAK%J<=2X&GRX/:#P/^(M6&]=Z%N3)
MW)AO]'*3G'7Z9)#*5%R2!(G;6DU5EI$@F/%'D-EI5-+$]G,M_9I]AR]SZ=34
M9+_II$S/.D<=D:B%K++RB]G\JH(_8Y(7F\SQ56S\V(-11\25*TT>)L."7!?^
M+K^'.+0F'/7?F# ,$X9LMU?$5GZ6I3P_M68C+(V&-'I@5WDVC-,%)6566OS5
MF%>>S[[>WEY\^:NXOQ:SFU_N;JYOIA=WC^)B.KW_>O=X<_>+>+C_\\WTYFIV
MNE]"'\W:CX/L2R][^(;L8W%KBC)UXJI(5/)T_C[L;(P=UL9>#M\5>"MM3XP&
M73'L#T?OR!LUSH]8WO@->1=Q;*JBU,52/)A,QUHY\;>+N2LMP/+WUQSV\D:O
MRZ,"^N16,E9G'52(4W:M.N<__S28]$_>L?:@L?;@/>G_9:K>E?VZY7?WCU?1
M4.R)?U^S>+"ZB/4J4RXR"S$UA4-@$\D5^)BJJ"IDE>A2)2(V0$7A_%,8A9>%
M+B0DR$RX$A]0_Z43D)E5B1)EJE#'G#0G(/_Z_N[B"[38E;&LHRLT_N3R=V-U
MN16R2,0F-5FVW3.; M)=-7<ZT=(BU1']74E;%LJZ5*^<^(!J8KI8JVS+RG[^
MZ6@X[)],3;Z2Q9;?!B<?>^(B@WUZ6>B%CF51PL!2V=B/VEE("H"EPDFF("=2
MN59BKE0A5*91S>1QI(M6!#"L)[ZHM2HJ@)$B9OT+&# V4,B11&B*1-H$>L7%
M;"HF_8D(C NML*Q89DJ0/5:EQ*!0FYM$90(T7DOZ!^&^EBZ=6"G+)%_$2IAY
MII=LC>L2R4$P&RK)5"X/\%29TCMSE+(D86E,@KR \P$@'<,6]GZAK$7L2\,A
M;29 G/H>I[)8*C:+@J 352=26B4<GMU"JZ1'H6C<CF3F#$S_H]( *Z0@[& 8
MD6@79\95]-&J)4:2BZ2TE<#!X8D3KP5U55, I:V=W-^K9!F J/)59K:* A^1
MW$0A[YQ(D@!$!L$]<5_9.G4(C +&)&"(_QF23K$HL.*N, ]RQ4*QQ;%"HE "
MUN1B#8R:"EF16\!3>*SR:$<>Y5C8UIA4P7';)(4J!8#7<0HXV.B-C')H8<'*
MFC4"CK#)96%<J>-6XGRR:I4M3-)D"IOEB%>V#C&4:9.0WB>Z2A.]I^=9EA&U
MMW#(&'E+Q"[ C3!AUH3*8!>Q$4B)8B>1J +6R*U'51V\"IS#Z2%MS <,\3H$
M78IM#MTB1A> 5P:A+M8&B8">,M4VV2,^V?JDB0^W*@&"K.H*_Z23;@2_T.R
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MG8X[U#.VS8U5A7N5O5(6[<E=HF.CU$D OZ^5LO4-;=#\;^/\/U!+ P04
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M1_(""6#I9'@T/>QW;F*K2F*KZK/]ZGAX/)^QU^S5/&6ODR71-WD8PAVP3><
M.<'@Z.V,/?7 &^V]Q$')=?C>(*+!2'R4]ZO])\TBON3OC\?O(61G+36]B0J(
MC@_>XCUKXS=&G'A3AW?]RGCP/PQ+?)8)2P>P7QCCNPD9Z#_TSO\%4$L#!!0
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MD?*W5+\P<NYNAK?2H.QN.L.+/2AK@.\G4IKUP@;H_BH,_P902P,$%     @
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M5J6J9D5U,#(O^W,IC>WV<IO9\8K*.=C[E91F=W !ZH$=_P102P,$%     @
M+H*O5M.5691X!0  C@L  !D   !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL
ME5;;<MLV$'W75^PHG3PINMIQ+K9G?&OCMK8SL=L^=/H D4L1-@@P "A%_?J>
M!:E+VL0S?;!%D(O=LV=W#W"\<OXIE,R1OE3&AI-^&6/];C0*6<F5"D-7L\67
MPOE*12S]8A1JSRI/FRHSFH['KT>5TK9_>IS>??2GQZZ)1EO^Z"DT5:7\^IR-
M6YWT)_W-BT]Z449Y,3H]KM6"[SG^5G_T6(VV7G)=L0W:6?)<G/3/)N_.#\0^
M&?RN>17VGDDRF3OW)(OK_*0_%D!L.(OB0>%GR1=LC#@"C,^=S_XVI&S<?]YX
M_S'ECESF*O"%,W_H/)8G_3=]RKE0C8F?W.H#=_D<BK_,F9#^TZJU/9SV*6M"
M=%6W&0@J;=M?]:7C86_#F_%W-DR[#=.$NPV44%ZJJ$Z/O5N1%VMXDX>4:MH-
M<-I*4>ZCQU>-??'TXN[FYOKAYNKVX9[.;B_IXN[VX?KVIZO;B^NK^^-11 @Q
M'&6=N_/6W?0[[M[2C;.Q#'1E<\Z_WC\"M"V^Z0;?^?19AS?*#VDV&=!T/)T]
MXV^VS7>6_!U^+U]753JBJV(@97.Z %QM%VPSS8$N=<B,"XUG^O-L'J)'T_SU
M+1;:(+-O!Y%!>A=JE?%)'Y,2V"^Y?_KRQ>3U^/TS*1QL4SAXSOO_+]GS[F[O
M'JYZDS&]?/%F.IF\IV?=TZ\ZZH5* _50<@]TULJN20>,]?P1HT;1D>&%,E1[
MES'G8+>E.C-*5WCT.N =%=Y5%$LFYV$#0:#,-3Y@79!&=>8-S#B$ 6F;F4;\
M4,T^. O?VCXV?CWH)H1]+T,=I5HI$E>U<6LI<A=T2->VC55K*]@1HU(6JB-&
M@_1)+18>N".3T6JNC8[PKPLXQ.]*QQ(:%.HNP]!D95(49X-\-8:LB[U2+>$(
MKB-[#9@J7[*DQ$4A&UT+ EB#,SJ'54X%<D?S"5\NZ$2L\Q(*LA($)_37)\+3
M2O9WI ^E IY[*_Q#]%W4K%3HZ "2D,JV7!W?*L)Y[;S$A@$H)Y$WFHQ?_4(0
M^12AP!S T9J5)Y9)II\;RS0;ISF<#ND.5KYWHR)"!KJSO7NN(U=S]C29M4:#
M?:Q@PM424A$*ECT)AL8#*,BIC;(IE_1$>"?9\)=:MWF3$-5VD+)@&:*+J-!"
M3A%LD\*"FU J\-9;E1K%2369\UZ@'+ M[8!.7^\#/7?*Y^+E4GO4RB$M0:)J
MM/$2P)M:ZOX#O:6C,4T&TX.W7PV G'\1?T$R9%.\*IK$6\G*H'7PH?&H,\M4
M++RJVHY*;-2O(#F!D(;'X:30!T9GZXU!+#5PU<K'=>L%R&7$-&0L <=AH*NF
MZM4NHI>E_MO^3?74-M=+G3?2&.T$ICPFAV.:'=+1UVE@ AJCO$'!,&;KOZ6+
MT(:=B(7.8=9XC]SF392NW_53ZW^0:E6D+NX^;"QKI;<Z@&33  !-&V++44_V
M[Y/X'_9"VR\;U',VFI?_QHIF0-OQYP9AAO3!K6#B!Q3TPNI"HY<B/3;Y(LF$
MEFE9.K-LIT*% .6!XO3 <."=SW;NP\Z 2HT2>BWCLI<=.$ PZ L9!?F;<UPQ
M=].?#)+:'KW?D2E-/M@Q)LM6-L5K+RU;8M-\>J2%,VM-+56()>5&]V[T+DD#
M>D/(H5Q#?SSL>0<%XB4M$3A&DU205.6:S;&($8 L<[['ILU[;8>(,DGF*G^$
M^G9'*8*U,MT2B.G%Q0UZ*T534K:YFAON8@C=3]:M[ ;G1L+V:[/O?@M'6ZF(
MG /:Y0%*BLREO]8R)Z&C;_BM0W:T=T?"@;%(-T'Q #SM=6G[=GO9/&OO6#OS
M]J:*.\E")MUP@:WCX1$N&[Z]_;4+S'2Z<<U=Q.F4'J$#.7LQP/?"85:[A038
M7L%/_P%02P,$%     @ +H*O5J3$B6@/"   1Q(  !D   !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&ULC5C;;MPX$GW75Q ]@T$"M-VW.+'C"^ X"=8/F0GL
MS.X @WE@2Z5NQA*I(2FW/5^_IXI26^W8WGVP6Z)8Q;J<.E72R<;YF[ FBNJN
MKFPX':UC;-Y/)B%?4ZW#OFO(XDGI?*TC;OUJ$AI/NA"ANIK,I].WDUH;.SH[
MD;6O_NS$M;$REKYZ%=JZUO[^ U5N<SJ:C?J%*[-:1UZ8G)TT>D77%']OOGK<
M3;9:"E.3#<99Y:D\'9W/WG]XP_MEP[\-;<+@6K$G2^=N^.:R.!U-V2"J*(^L
M0>/GEBZHJE@1S/B[TSG:'LF"P^M>^V?Q';XL=: +5_W'%'%].CH<J8)*W5;Q
MRFW^19T_!ZPO=U60_VJ3]BX6(Y6W(;JZ$X8%M;'I5]]U<1@('$Z?$9AW G.Q
M.QTD5G[449^=>+=1GG=#&U^(JR(-XXSEI%Q'CZ<&<O'L\M>+W[Y\4M_.__AT
M?3*)T,CKD[R3_I"DY\]('ZDOSL9U4)]L0<6N_ 26;,V9]^9\F+^H\(OV^VHQ
M&ZOY=+YX0=]BZ]Y"]!T\YY[-74WJF[Y3'TW(*Q=:3^K/\V6('H#XZRF7D\;%
MTQJY2-Z'1N=T.D(5!/*W-#K[Y:?9V^GQ"_:^V=K[YB7M_S,=+TH_;=NOOWW[
ME,UF:D\-E:M+F^D\=[[0-B> +J[5^?6%>O=FNC=_-QVK7WXZG,^GQP\!I"!K
ML]DQ9"-Y4ZLK:IR/QJYD\^QXK.*:U(6K&VWOE0FHVK];XZE0.LHCLH5RI2*=
MKY7IE#3X[PH5'8H)*\ X9;QW22$J_!F4'K&4B4%I:UM=*2I+DG)6$9GUO$%#
MM6Z:ZAX'X319@\Y[TGXONKU"E/C"6% /SA:OG%= 1-A7WW > H9*AC.BD^Y
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MJ$KI/1$;M4_&O?!W,![@:C@\"7]Q'VQIL+L9 NCL=MBN;F<XXI^>_QD,_<^
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ML^#W O;RI$]T)$O.'_5@D@]<7Q."$C*E$1B*)TBA+#40TOC:8+I'E]KPM']
MOS&Q8RQ+)B'EY><B5YN!F[@DAQ7;E>J>[S]!$T^L\3)>2M.2O5T;!R[)=E+Q
MJC%&!E516\F^-?MP8I#XKQ@$C4%@>%M'AN4U4VS8%WQ/A%Z-:+IC0C762*ZH
M]:',E<#9 NW4</YP>SNZ_T+N;LA\\G$ZN9FDH^F"C-+T[F&ZF$P_DMG=;Y-T
M\F%.?EVP90GR7=]3Z%B;>UGC9&R=!*\XZ9%;7JN-)!_J'/*7]AX2/K(.#JS'
MP47 6R;:)*0M$OA!> $O/.Y":/#B5_!&6<9WM2KJ-9GQLL@*D.2/T5(J@5GS
MY[F +5YX'D_?I"NY91D,7+PJ$L03N,.W;VC'?W^!;71D&UU"'\[Q9N:[$@A?
M$6"BUK2W@#=MPP2<(WL1[CS9BSZ<Q48 .)4]5-"'2KY7.0NN6$E27J'6F2N>
M/9*T9%(Z::,D_[K"&3-99,YT5X%@BHLKYQ<2MI*.3[3L!%V4<0^;H!7TJ)$T
M#O5D[%Q#S?'&6+//YGHB*?:$2&NP@4B"[Y14K,YU?)U6E-"F#9,0>W$<-2V.
M&RY%G?$*S&9D-@H#A3[]MN'EM^..$=2*,+8B-,+O.==%N=-47A#\IUOM,.4U
MLE4%7CO'[ M)B=TE&B3D[9LDH,'[T[[=\E-@@N\VR:W#PT'*YY-$9QV_U[CM
M)(%Q>^!W*=(X?A%B<(AMBLGU,C&^T_Q?>9&T:*A3H=OJ1#HO:* Y4K]%>PEV
M>JTXT4= X^Z/I4:W:7\D-6C;DFG3Y#D9J$T4VH[L+D;T]=3H_I34H/%_3@UZ
MS D;8A0VL9%S+Y]W4KGP*->F/DMB7F-;Q([:XQ=@9"O?\W+[?\":L"YJ24I8
MH:G?[N)C+VQ-M@/%MZ8.+KG"JFJZ&_S&@- +<'[%N3H,M(/CQVCX-U!+ P04
M    "  N@J]63\DKZ'\$  #\"P  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6RM5MMRVS80?>=78)A.FLRP)@G>;4DSLBPG[D2R1E:2ATX?(!*2V)"
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M'=?0CP9O]2E]Q\DVNH-7F9!3TNNF88S_*$FLJ6<-:;A34U3C(-FI5R3I]J(
MGX%3^R3NIDE$SD[Z41C==F8EX'I:&% D"KO]N->>3&U]PG36E*^ %$SG<B4,
M.;_N7J<)N2#G:40N.C-I*.^X@O?J/25QBB1#%/I7"3ETJ?[>&%:@EF[9:.*2
M-!/96MM]-FK&^,.]68;XU)=,8+]A@:'!Y16^8=4LF$8QLG9#/9<&5X032]S)
MH*P#GB^D-#O%)FBW?/874$L#!!0    ( "Z"KU8O0V$%<0(  $L%   9
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;'U4T6[:,!1]SU=8V31M$FU" EG7
M0:32=AJ3VB%@[<.T!Y-<B%7'SFRGM'^_:R>D3 )>8M_K>X[/=7P\VDKUI L
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MYZ8%OG:@; &NKZ4TN\!NT+V?Z3]02P,$%     @ +H*O5H@Q*@WO @  .08
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M8)P#G2^TMIN%2[#]6XQ_ U!+ P04    "  N@J]6E*/93Q,#  !R!@  &0
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M71W%F#)](3,4M+*1*F6&AFKKZDPA6^=!:>(&GM=U4\:%,^SG<RLU[,N=2;C
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MU6[;<<Y7[3KUAN)(46JM0EPI2J_G+449\$SF)S88MNK*791!/E5S';0!N6U
MW@5051"M%$2[T+ CGC3SDT9P[-K+I U(,V[DDC<S(&O771&Y71%Y'1!5KT#I
MG6&S>7XD# 6G!0E>^.^Q4,5[,>F%T=N48@N0VP;D70!5A2@-,VQVS!]P3#GC
MI;XD0XE]2882^Y(,=;8OE?X8-AOD8Z+)SFMT3<T\[[5-G;*YG;)Y7;%5KTAI
MWV&S?^_:.^7359R1I0WJI2JB-&@*FU1$#2RC?B,G00W-L]NT=/BPV>)WYZ/R
MB2[<V<I0XJVMG$N0Y )759+29L,V/OL]?LJ6W>I9ZNF/H(,LIMZ?7 F*W_K9
M=1UD*./,'2\L'39LMMB=NBO1^<J*0X*2%(>42RB."US5YX2EV=::S?:['%;.
M=;H&J-6NGM,&Y+8!>1= U8Q+DZTUF^PN'(TFNEW+JG]G.U*477\:(D7!^BWG
M):ZJ&*7!UIH-]@=<3<YXX4&0%"4\"9*@)(^"I"CA69!R\OZ!?RUNTA<_E#>[
M?<2RA\7%:/%RZ3I]I5(;OX$C!TK&73CRLE=')7WV)FN.XHT?41#@%SZ5VA]P
M<Q!G+X>R$T9VZ=N/9\(8"=/#+4;\RS@!\,]?"&''DV2"XA7=]#]02P,$%
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M\,,:_F@X]!J>)+0J)UGM/5.!(A!E+V]$T)Q$1+QH_6)I?G$/-FQ;N"-%V%K
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M<.[105S1WW#Q0RX!%/J9)DP.G*52V87KRG@)*9'G/ .FK\RY2(G20[%P92:
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MYOL_:2/(+OF6><*J?\&^P9H&6.X8S],F6&20QEG]E[PV"W$4('CT :@)0'*
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M>]_ZA>?;ZF+S.>?B,UX];BB):%$"Q.^K/.=O+^4$[>W[Y%]02P,$%     @
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M&1R=X%&LJHJMZAA9N*)G)@V64*ZYQ"H7E)V [^=2FFW')JCKYO$?4$L#!!0
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M5WHXV&.NIS$*XZ#?EYRKK6$(NOD>_P902P,$%     @ +H*O5G-TDH<Y P
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "Z"KU:JCRNX[P   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "Z"
MKU:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ +H*O5EP4WHI'!@  3"0  !@
M ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "Z"
MKU95;N]>;@D  -XW   8              " @8L.  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    "  N@J]6"2J =$H$  #[%@  &
M        @($O&   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ +H*O5@G,GNN0"0  MS4  !@              ("!KQP  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( "Z"KU;&NZN?R@,  *H/   8
M              " @74F  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    "  N@J]66R@XDB4&  #P)@  &               @(%U*@  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ +H*O5D"4;BU#!P
M3B$  !@              ("!T#   'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( "Z"KU9;Z[6!CP<  )D0   8              " @4DX
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  N@J]6H,63
MU&,)  #5%P  &               @($.0   >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ +H*O5C&MVD_S"0  YQ@  !D
M ("!ITD  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  N
M@J]6'/\SM4P&  #T#0  &0              @('14P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( "Z"KU;LC._?IP(  +0%   9
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M970Q-BYX;6Q02P$"% ,4    "  N@J]6TY59E'@%  "."P  &0
M    @($^;   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M "Z"KU:DQ(EH#P@  $<2   9              " @>UQ  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ +H*O5I$> MK9 @  - 8  !D
M             ("!,WH  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    "  N@J]6:0)]O:@)  !P&0  &0              @(%#?0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( "Z"KU8U8X*1@ ,
M "0)   9              " @2*'  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ +H*O5D_)*^A_!   _ L  !D              ("!
MV8H  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  N@J]6
MN?I?WK8"  #Q!0  &0              @(&/CP  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( "Z"KU8O0V$%<0(  $L%   9
M      " @7R2  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ +H*O5H@Q*@WO @  .08  !D              ("!))4  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  N@J]6E*/93Q,#  !R!@
M&0              @(%*F   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( "Z"KU;(LWIUT0,  / )   9              " @92;  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ +H*O5M(ZBWM]
M P  U L  !D              ("!G)\  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    "  N@J]6N/W-'%\%  "N&P  &0
M@(%0HP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( "Z"
MKU;*;EYJN0(  /T'   9              " @>:H  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ +H*O5N$(CPA.!   >!0  !D
M         ("!UJL  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    "  N@J]6O#F4AVT"  "B!0  &0              @(%;L   >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( "Z"KU:4ZKI9@@0  &09
M   9              " @?^R  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ +H*O5K0<F@$K P  <@D  !D              ("!N+<
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  N@J]6,F"Y
M1#L#  #E"P  &0              @($:NP  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( "Z"KU:\92EE@@(  %(&   9
M  " @8R^  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M+H*O5@K==0#7 P  ?A$  !D              ("!1<$  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    "  N@J]6 _VM?)0#  #*$0  &0
M            @(%3Q0  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( "Z"KU:X#4U.=P,  '@*   9              " @1[)  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ +H*O5CC;'J@"!0
MB1<  !D              ("!S,P  'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    "  N@J]6EOCUDY4"  !<!@  &0              @($%
MT@  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( "Z"KU8_
M,76\Z@,  .<1   9              " @='4  !X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ +H*O5IAUHR0_ P  0PL  !D
M     ("!\M@  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( "Z"KU9''&"YI $  )L:   :
M          "  :#G  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( "Z"KU8NTOC K@$  ,H:   3              "  7SI  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     T #0 (PX  %OK      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>141</ContextCount>
  <ElementCount>247</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>28</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfIncome</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesTables</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingFinancingLeases</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonar_10-q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="fonar_10-q.htm">fonar_10-q.htm</File>
    <File>fonar_exhibit-31.htm</File>
    <File>fonar_exhibit-32.htm</File>
    <File>fonr-20230331.xsd</File>
    <File>fonr-20230331_cal.xml</File>
    <File>fonr-20230331_def.xml</File>
    <File>fonr-20230331_lab.xml</File>
    <File>fonr-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar_logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="503">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fonar_10-q.htm": {
   "axisCustom": 0,
   "axisStandard": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 503,
    "http://xbrl.sec.gov/dei/2023": 32
   },
   "contextCount": 141,
   "dts": {
    "calculationLink": {
     "local": [
      "fonr-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fonar_10-q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fonr-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 358,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2023": 40,
    "http://fonar.com/20230331": 23,
    "http://xbrl.sec.gov/dei/2023": 5,
    "total": 68
   },
   "keyCustom": 61,
   "keyStandard": 186,
   "memberCustom": 12,
   "memberStandard": 15,
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://fonar.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - OPERATING & FINANCING LEASES",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://fonar.com/role/OperatingFinancingLeases",
     "shortName": "OPERATING & FINANCING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://fonar.com/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - OTHER CURRENT LIABILITIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "shortName": "OTHER CURRENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://fonar.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://fonar.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - OPERATING & FINANCING LEASES (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://fonar.com/role/OperatingFinancingLeasesTables",
     "shortName": "OPERATING & FINANCING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://fonar.com/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2015-07-01_custom_ControllingInterestMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2015-07-01_custom_ControllingInterestMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetIncomeLossAvailableToCommonStockholderBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockCommonShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:AccountsReceivableServiceAndRepairFees",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "lang": null,
      "name": "FONR:AccountsReceivableNetRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31_custom_OperatingLeasePaymentsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "shortName": "OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31_custom_OperatingLeasePaymentsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - INVENTORIES - Inventories (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "shortName": "INVENTORIES - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "shortName": "OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31_custom_PatentsAndCopyrightsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31_custom_PatentsAndCopyrightsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetRevenuesFromExternalCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
     "shortName": "SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetRevenuesFromExternalCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2022-09-26",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2022-09-26",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - INCOME TAXES (Details Narrative)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-04-30_us-gaap_SubsequentEventMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2023-04-30_us-gaap_SubsequentEventMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2023-01-012023-03-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EarningsPerShareBasic",
      "reportCount": 1,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
     "shortName": "CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10-q.htm",
      "contextRef": "From2022-07-01to2023-03-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 28,
   "tag": {
    "FONR_AccountReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - related party"
       }
      }
     },
     "localname": "AccountReceivableRelatedParties",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsPayableRelatedPartyNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Due to related medical practices"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartyNoncurrent",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term"
       }
      }
     },
     "localname": "AccountsReceivableNetLongTerm",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts",
        "label": "Accounts receivable - Related party"
       }
      }
     },
     "localname": "AccountsReceivableNetRelatedParty",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableServiceAndRepairFees",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CancellationOfShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of shares",
        "verboseLabel": "Balance"
       }
      }
     },
     "localname": "CancellationOfShares",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Non Voting Preferred Stock Member",
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredStockMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance Managed Care Member",
        "label": "Commercial Insurance / Managed Care"
       }
      }
     },
     "localname": "CommercialInsuranceManagedCareMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ControllingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Controlling Interest [Member]"
       }
      }
     },
     "localname": "ControllingInterestMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ConvertibleClassCStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The shares of convertible class C stock.",
        "label": "Convertible Class C Stock"
       }
      }
     },
     "localname": "ConvertibleClassCStock",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_CorporateMinimumTax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate minimum tax"
       }
      }
     },
     "localname": "CorporateMinimumTax",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFees",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related medical practices"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToProductSales": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "localname": "CostsRelatedToProductSales",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFees",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees - related parties"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDeposits",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct purchase of Noncontrolling Interests"
       }
      }
     },
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DisclosureOperatingFinancingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Financing Leases"
       }
      }
     },
     "localname": "DisclosureOperatingFinancingLeasesAbstract",
     "nsuri": "http://fonar.com/20230331",
     "xbrltype": "stringItemType"
    },
    "FONR_EarningsPerShareBasics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic income per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasics",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "FONR_ExciseTax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Excise tax"
       }
      }
     },
     "localname": "ExciseTax",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_FinancingLeasePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "localname": "FinancingLeasePaymentsMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_GainOnForgivenessOfPppLoan": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnForgivenessOfPppLoan",
        "negatedLabel": "Gain on forgiveness of PPP loan"
       }
      }
     },
     "localname": "GainOnForgivenessOfPppLoan",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership interest rate.",
        "label": "The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "HmcaOwnershipSizeOfImperialManagementServicesPercent",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_IncreaseDecreaseInContractAssets": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInContractAssets",
        "negatedLabel": "Contract assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractAssets",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInContractLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractLiabilities",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInCustomerAdvance",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInFinancingLiabilities",
        "negatedLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_InterestExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestExpenses",
        "negatedLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenses",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IntersegmentNetRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of intersegment net revenues.",
        "label": "Inter-segment net revenues"
       }
      }
     },
     "localname": "IntersegmentNetRevenues",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_InvestorsOwnershipInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors ownership interest percentage"
       }
      }
     },
     "localname": "InvestorsOwnershipInterest",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee operating leases liability maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFees",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesNet",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesNonRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable"
       }
      }
     },
     "localname": "ManagementAndOtherFeesNonRelatedParties",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees - related medical practices \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management of Diagnostic Imaging Centers - Member - Custom element",
        "label": "Management Of Diagnostic Imaging Centers"
       }
      }
     },
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related medical practices \u2013 net",
        "verboseLabel": "Management and other fees receivable from related medical practices (\"PC's\")"
       }
      }
     },
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.",
        "label": "Maximum limit for individual claims under stop-loss umbrella policy for health insurances"
       }
      }
     },
     "localname": "MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical equipment - Member - Custom element",
        "label": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_MedicalReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivable \u2013 net",
        "verboseLabel": "Medical Receivables"
       }
      }
     },
     "localname": "MedicalReceivable",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicareMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Medicaid",
        "label": "Medicare/Medicaid"
       }
      }
     },
     "localname": "MedicareMedicaidMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetIncomeAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NetIncomeAttributableToNoncontrollingInterest",
        "negatedLabel": "Net Income - Noncontrolling Interests"
       }
      }
     },
     "localname": "NetIncomeAttributableToNoncontrollingInterest",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_NetIncomeAvailableToClassCCommonStockholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Available to Class C Common Stockholders"
       }
      }
     },
     "localname": "NetIncomeAvailableToClassCCommonStockholders",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_NetIncomeAvailableToClassNonvotingPreferredStockholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income Available to Class A Non-Voting Preferred Stockholders"
       }
      }
     },
     "localname": "NetIncomeAvailableToClassNonvotingPreferredStockholders",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_NetIncomeLossAvailableToCommonStockholderBasic": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Numerator: Net income available to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholderBasic",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_NetRevenuesFromExternalCustomers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.",
        "label": "Net revenues from external customers"
       }
      }
     },
     "localname": "NetRevenuesFromExternalCustomers",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OperatingLeasePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "localname": "OperatingLeasePaymentsMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OtherRevenueSourceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Revenue Source",
        "label": "Other"
       }
      }
     },
     "localname": "OtherRevenueSourceMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership interest rate.",
        "label": "The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_OwnershipInterestOfOriginalInvestorsOfHdm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of the original investors of HDM"
       }
      }
     },
     "localname": "OwnershipInterestOfOriginalInvestorsOfHdm",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PatentsAndCopyrightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and copyrights - Member - Custom elements",
        "label": "Patents and copyrights"
       }
      }
     },
     "localname": "PatentsAndCopyrightsMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Patient fee revenue, net of contractual allowances and discounts.",
        "label": "Patient fee revenue, net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue \u2013 net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of consolidated net revenue from management fees.",
        "label": "Percentage of consolidated net revenue from management fees charged to related party medical practices"
       }
      }
     },
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims.",
        "label": "Percentage of net revenue derived from no-fault and personal injury protection claim"
       }
      }
     },
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PresentValueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value discount.",
        "label": "Present value discount"
       }
      }
     },
     "localname": "PresentValueDiscount",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value discount financing lease.",
        "label": "PresentValueDiscountFinancingLease",
        "verboseLabel": "Present value discount"
       }
      }
     },
     "localname": "PresentValueDiscountFinancingLease",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProductSalesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net"
       }
      }
     },
     "localname": "ProductSalesNet",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProvisionForBadDebts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForBadDebts",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfNonControllingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of Non controlling interests",
        "verboseLabel": "Balance"
       }
      }
     },
     "localname": "PurchaseOfNonControllingInterest",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PurchaseOfNoncontrollingInterests": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PurchaseOfNoncontrollingInterests",
        "negatedLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "PurchaseOfNoncontrollingInterests",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ScheduleOfPatientFeeRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of patient fee revenue"
       }
      }
     },
     "localname": "ScheduleOfPatientFeeRevenueTableTextBlock",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_SelfFundedHealthInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Self Funded Health Insurance [Member]"
       }
      }
     },
     "localname": "SelfFundedHealthInsuranceMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ServiceAndRepairFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesNet",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees - related parties \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StateIncomeTaxesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the value of state income taxes payable.",
        "label": "State income taxes payable"
       }
      }
     },
     "localname": "StateIncomeTaxesPayable",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StatementOfIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STATEMENT OF INCOME"
       }
      }
     },
     "localname": "StatementOfIncomeAbstract",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "FONR_StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingsInterests",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of facilities owned or managed"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_UnearnedRevenueOnServiceContractsRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts \u2013 related party"
       }
      }
     },
     "localname": "UnearnedRevenueOnServiceContractsRelatedParty",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_WeightedAverageNumberOfDilutedEarningsPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Denominator for Diluted Earnings Per Share"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedEarningsPerShare",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_WeightedAverageNumberOfDilutedSharesOutstandings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Diluted Denominator: Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstandings",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers Compensation Personal Injury.",
        "label": "Workers Compensation/Personal Injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjuryMember",
     "nsuri": "http://fonar.com/20230331",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r415",
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r9",
      "r392"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "auth_ref": [
      "r463"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.",
        "label": "Total"
       }
      }
     },
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Legal and other professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accounting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r11",
      "r376"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued salaries, commissions and payroll taxes"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r64",
      "r392",
      "r468"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Paid-in capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r307",
      "r440",
      "r441",
      "r442",
      "r459",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r3",
      "r36",
      "r40"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r96",
      "r114",
      "r133",
      "r168",
      "r176",
      "r181",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r241",
      "r245",
      "r256",
      "r281",
      "r338",
      "r392",
      "r403",
      "r452",
      "r453",
      "r461"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r109",
      "r120",
      "r133",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r241",
      "r245",
      "r256",
      "r392",
      "r452",
      "r453",
      "r461"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r57",
      "r87",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r24",
      "r25",
      "r26"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r22",
      "r84",
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash Equivalents - End of Period",
        "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r1",
      "r84"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net Increase in Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r106",
      "r117",
      "r118",
      "r119",
      "r133",
      "r151",
      "r152",
      "r157",
      "r159",
      "r162",
      "r163",
      "r190",
      "r204",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r256",
      "r300",
      "r301",
      "r302",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r326",
      "r347",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r424",
      "r437",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r91",
      "r202",
      "r203",
      "r374",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r397",
      "r398",
      "r399",
      "r400",
      "r440",
      "r441",
      "r459",
      "r466",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r63",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r6",
      "r63",
      "r326",
      "r344",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r63",
      "r283",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock Value"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r51",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractReceivableDueOneToTwoYears": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "ContractReceivableDueOneToTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027"
       }
      }
     },
     "localname": "ContractReceivableDueThreeToFourYears",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "auth_ref": [
      "r464"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "ContractReceivableDueTwoToThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTS AND EXPENSES"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r425",
      "r439",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Income tax component - current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r13",
      "r53",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r439",
      "r457",
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Income tax component - deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r3",
      "r93",
      "r104",
      "r235",
      "r236",
      "r439"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred income tax \u2013 net"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r427"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r46",
      "r456"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred income tax asset - net"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r455"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "auth_ref": [
      "r5"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.",
        "label": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r3",
      "r171"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [
      "r220",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r220",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DoubtfulMember": {
     "auth_ref": [
      "r33",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A category of financing receivables that have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable.",
        "label": "Doubtful [Member]"
       }
      }
     },
     "localname": "DoubtfulMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r127",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r148",
      "r151",
      "r157",
      "r158",
      "r159",
      "r160",
      "r254",
      "r255",
      "r276",
      "r292",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r127",
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r151",
      "r157",
      "r158",
      "r159",
      "r160",
      "r254",
      "r255",
      "r276",
      "r292",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders",
        "verboseLabel": "Diluted Income per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r27",
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r6",
      "r107",
      "r123",
      "r124",
      "r125",
      "r135",
      "r136",
      "r137",
      "r139",
      "r145",
      "r147",
      "r161",
      "r191",
      "r192",
      "r219",
      "r221",
      "r222",
      "r223",
      "r231",
      "r232",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r268",
      "r294",
      "r295",
      "r296",
      "r307",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Direct ownership interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r266",
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Total lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Financing lease liability - current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Financing lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2028"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Right-of-use Asset \u2013 financing lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r112",
      "r198"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r90",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Gross other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r37",
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r111",
      "r194",
      "r275",
      "r382",
      "r392",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r50",
      "r75",
      "r86",
      "r140",
      "r141",
      "r142",
      "r143",
      "r155",
      "r159"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "(Loss) Income from operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r72",
      "r101",
      "r168",
      "r175",
      "r180",
      "r183",
      "r277",
      "r288",
      "r381"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income Before Provision for Income Taxes and Noncontrolling Interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "totalLabel": "Income From Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r200",
      "r201",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r201",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r225",
      "r227",
      "r228",
      "r229",
      "r233",
      "r237",
      "r238",
      "r239",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r105",
      "r146",
      "r147",
      "r172",
      "r226",
      "r234",
      "r293"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r21",
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts, medical and management fee receivable(s)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilities": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Notes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r153",
      "r154",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Shares included upon conversion of Class C Common"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r35",
      "r38"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets-net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.",
        "label": "Inventories",
        "totalLabel": "Total Inventories"
       }
      }
     },
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r428"
     ],
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r79",
      "r80"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2028"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "OPERATING &amp; FINANCING LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r10",
      "r133",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r242",
      "r245",
      "r246",
      "r256",
      "r325",
      "r380",
      "r403",
      "r452",
      "r461",
      "r462"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r68",
      "r98",
      "r286",
      "r392",
      "r438",
      "r446",
      "r460"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r110",
      "r133",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r242",
      "r245",
      "r246",
      "r256",
      "r392",
      "r452",
      "r461",
      "r462"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r7",
      "r58",
      "r59",
      "r60",
      "r61",
      "r133",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r242",
      "r245",
      "r246",
      "r256",
      "r452",
      "r461",
      "r462"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Long-Term Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.",
        "label": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-term debt less current portion"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r18",
      "r97",
      "r133",
      "r190",
      "r204",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r256",
      "r285",
      "r328"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Balance"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r84",
      "r85",
      "r86"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r73",
      "r86",
      "r102",
      "r108",
      "r121",
      "r122",
      "r125",
      "r133",
      "r138",
      "r140",
      "r141",
      "r142",
      "r143",
      "r146",
      "r147",
      "r155",
      "r168",
      "r175",
      "r180",
      "r183",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r255",
      "r256",
      "r291",
      "r346",
      "r363",
      "r364",
      "r381",
      "r401",
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income \u2013 Attributable to FONAR",
        "verboseLabel": "Balance"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r52",
      "r94",
      "r121",
      "r122",
      "r146",
      "r147",
      "r290",
      "r433"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Balance"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r128",
      "r140",
      "r141",
      "r142",
      "r143",
      "r148",
      "r149",
      "r156",
      "r159",
      "r168",
      "r175",
      "r180",
      "r183",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income Available to Common Stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r49",
      "r219",
      "r440",
      "r441",
      "r442",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liability - current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r265"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use Asset \u2013 operating lease"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.",
        "label": "Amortization on right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Accrued interest and penalty"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r95",
      "r113",
      "r280",
      "r403"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Costs related to patient fee revenue"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r3",
      "r41",
      "r77"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventorySupplies": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.",
        "label": "Purchased parts, components and supplies"
       }
      }
     },
     "localname": "OtherInventorySupplies",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r55",
      "r279",
      "r321",
      "r322",
      "r403",
      "r467"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r392"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities",
        "totalLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other (Expense) Income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r11",
      "r42"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other general and administrative expenses"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.",
        "label": "Payments for Repurchase of Convertible Preferred Stock",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Cost of patents"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class A [Member]"
       }
      }
     },
     "localname": "PreferredClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [
      "r393",
      "r394",
      "r397",
      "r398",
      "r399",
      "r400",
      "r466",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r62",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r62",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r62",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r62",
      "r326",
      "r344",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r62",
      "r282",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock Value"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r108",
      "r121",
      "r122",
      "r129",
      "r133",
      "r138",
      "r146",
      "r147",
      "r168",
      "r175",
      "r180",
      "r183",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r240",
      "r243",
      "r244",
      "r255",
      "r256",
      "r277",
      "r289",
      "r306",
      "r346",
      "r363",
      "r364",
      "r381",
      "r390",
      "r391",
      "r402",
      "r433",
      "r452"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r4",
      "r278",
      "r287",
      "r392"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment \u2013 net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of borrowings and capital lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r56",
      "r224",
      "r465"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r65",
      "r92",
      "r284",
      "r297",
      "r298",
      "r304",
      "r327",
      "r392"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated undistributed earnings (deficit).",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r107",
      "r135",
      "r136",
      "r137",
      "r139",
      "r145",
      "r147",
      "r191",
      "r192",
      "r221",
      "r222",
      "r223",
      "r231",
      "r232",
      "r247",
      "r249",
      "r250",
      "r252",
      "r253",
      "r294",
      "r296",
      "r307",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated undistributed earnings (deficit).",
        "label": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r348",
      "r375",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r126",
      "r133",
      "r169",
      "r170",
      "r174",
      "r178",
      "r179",
      "r185",
      "r187",
      "r188",
      "r190",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r256",
      "r277",
      "r452"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues [Default Label]",
        "totalLabel": "Total Revenues \u2013 Net"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUES"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r9"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales tax payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of other current liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "auth_ref": [
      "r32",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.",
        "label": "Financing receivable noncurrent allowance for Credit loss"
       }
      }
     },
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of earning per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r37",
      "r39",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of other intangible assets - net"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r8",
      "r69",
      "r70",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Summarized segment financial information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r173",
      "r177",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "SEGMENT AND RELATED INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self-funded health insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r99",
      "r100",
      "r431"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r87",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r106",
      "r117",
      "r118",
      "r119",
      "r133",
      "r151",
      "r152",
      "r157",
      "r159",
      "r162",
      "r163",
      "r190",
      "r204",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r256",
      "r300",
      "r301",
      "r302",
      "r303",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r326",
      "r347",
      "r365",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r424",
      "r437",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r6",
      "r16",
      "r107",
      "r123",
      "r124",
      "r125",
      "r135",
      "r136",
      "r137",
      "r139",
      "r145",
      "r147",
      "r161",
      "r191",
      "r192",
      "r219",
      "r221",
      "r222",
      "r223",
      "r231",
      "r232",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r268",
      "r294",
      "r295",
      "r296",
      "r307",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r161",
      "r272",
      "r299",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r161",
      "r272",
      "r299",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r326",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r345",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r365",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock purchase plan"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.",
        "label": "Stock repurchase plan, shares"
       }
      }
     },
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock repurchase plan"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r6",
      "r62",
      "r63",
      "r92",
      "r303",
      "r365",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Number of shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r6",
      "r62",
      "r63",
      "r92",
      "r307",
      "r365",
      "r371",
      "r402"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Number of shares repurchased, value",
        "negatedLabel": "Balance"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r63",
      "r66",
      "r67",
      "r89",
      "r328",
      "r344",
      "r366",
      "r367",
      "r392",
      "r403",
      "r438",
      "r446",
      "r460",
      "r469"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "FONR_StockholdersEquityIncludingPortionsAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.",
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r269",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r15",
      "r43",
      "r44"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost - 69 shares of common stock at March 31, 2023 and 12 shares of common stock at June 30, 2022"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r150",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Diluted Shares Outstanding - Common Stockholders"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r148",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Basic Shares Outstanding \u2013 Common Stockholders",
        "terseLabel": "Basic Denominator: Weighted average shares outstanding",
        "verboseLabel": "Weighted Average Basic Shares Outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncomeParenthetical",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.B)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org//280/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org//330/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//350-30/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org//740/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)(iv)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(i)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//842-20/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org//855/tableOfContent",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(17))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(e)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(f)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(g)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "205",
   "Subparagraph": "(h)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(14))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(17))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(19))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-29",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(8))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-05(4))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "220",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07(9))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(a)(1)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(d)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "830",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r404": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r405": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r406": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r407": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r408": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r409": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r411": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r412": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r413": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r414": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r415": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r416": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r417": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r418": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r419": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r421": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r422": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r423": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org//310-10/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org//450/tableOfContent",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "910",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "205",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(18))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-09(7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org//1943274/2147480135/944-740-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org//205/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org//230/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org//235/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org//275/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org//440/tableOfContent",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000355019-23-000031-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-23-000031-xbrl.zip
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M:I?;TYDV@!()B8?_EB7(ODD1\D5AQ8K$@_%/,&F3\!\FG2:I_#;/S=N>6Q@
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MR A+66RE++([^5UUV3W@!4YG'OHI\"<I5\Y,P/IJ*WV%)2F:DA0_G?1;5EZ
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M\.U?R21Q+0"1OR3J; ]\)9IZ7S4.0"^=2"8M,>:%-XL6(\F4U.3AI;$=WOS
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M(L5@'"0)<@XKHF-11/KQCENA)NA38>+9/12#(!X@L-^<5 &7%,;)OL#S +X
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MTW97D0<$.^(%M$NL:Q30P:>H&JN! ?0YU//HT!TU/C8!^/B!Y3AY !\R@9"
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M/IR/89U98)=6=,H!E.5"PW^%IX_U0"I/?S?!RR,XQ$-*]+^W47B^$!U\K+6
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M(@M6D8J&_;+$D<LVA^S//\5&-G>VC;<320E=.U8_I#672E ,&6^9O8Z^S#:
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M@?$DNO;#G87@^=R(/RW\@&R&<GK O(BR_$B04 &L!1BH@Y,EEG*_CS@.O0E
MU=%:S&R5F!=MV75Q/'Z_9M\(FJ$HHH > )D</A'5LR#MU%#0@C6+^% ]BMN/
M@O\ !5H"(EK- .&"M36X6HY#ZBI\2(SJ"69E+NX_!<_<E&QS5::P.]LT%6)A
M!*%C9.LRYE0]Y/B">QRH\IMN)J%"YGT!N'LP)@H8H/.(SG46G94<Q,5JIJQ!
M.3P],:\R9-#1Z=B<8*#"0-5 %Q(P6<>Y!.%U.V E8>IP#/I7ET3#ORP19-.2
MT"#?#NQ/(9CO6;K1+V@KXSMS[N'HCG8O0Z9&,K[-$=?J0)S@$O0!7A5:A6P.
M:D8<#Y_O&=T0BY^7Z_""&\$'0-*=GN R=U3_#E\+KR'T:02D+.[_3OVP5 @
M%V/H4/2GLVO?WM$F*_B)M@97@%<"+TX #P>^%[+.G/*>1W.2[=EDYR..;4)
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M;P]XFI8NQ-ZY:KQE)R\1.P<S&9^AXA_2\)FGZ7DRJQN/^6=5_/:W<U.'*/2
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M T+L-5\_8NQ/=#RBXQT)?&=\@>] 8O$@H;]WA<1=O?U,$-P#@D>[!C1J(D!
M(H(@L:&.I]"%QC!;O'W/$X3P R&(CA>YZ+J7^>=TJ'69)5G"I.B)P-P6YAJJ
M9 XC\IA108>1O'2T6O1J!HC:K;F46?>4M@;?3&FR*/ 1R^19E;CF$C03F+&
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M&7M' "D:@.2'>?4A_:UX<7/54U4:B,2\\@5/?,YWF^DQZ72*P :!C8UAHQ(
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M/ER7A:L"H%-$U&U1GR>2#P+.)(AX'YEX%W>XP\G-:GH3?;@XLTSBD"0KD&;
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M>(4JR*J]+DX>P4N ,Z\^N4^]R>H+I0 5H3?\+'H;^EA/$$4(K^@3[,A<.'R
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M)@J\BQ'CX?(^#,B0$/# 5O$H.F/S:" G+$@RE&5X68)W3C1X\/??_\3C5%4
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MZ3H*,[$3(J%)*&-]:T735KC M93_1%%SRNFPNA >PS@,DD [XNI")IVYN=E
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M<5!T;<N[[<(>Y82W;]Q*P6*U%KO5R2"@@C?F>W3Q$!&'$9<Y&$IV1XY.,+5
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MH9B":I#]35F@H:GY_%"MG#=]AL!(M$C<W-V9E## W2PB7 IW^C@T0:HIY1O
M"[BSGSPY)O')Y*W>5T1*E#&(YE]J%G,X7!J/Q'-O G"C:RFC &K C&K;CZV+
M)_A!YPD329Q#*Q.XF#]$N<=@RH9]-^/!!P<#3!K#WE(4C>2A+1Z E'=-]AMJ
M 421K.X$39$C(5%BR>X.["M2O#T8*6GE]_.C )\(U$E0$.0=FN1]1$ MI&CN
MBD)\K'!N0 !!$6!.1,>,5>CX4D[-O'#:M6!<S'S0;<OTDVLH"T2#C;!YK2[Y
M+@V5<PL%88%WN$[<4^_Y_'598$S8&4J% )T<'YUP-(,!PWL@:W6JJL5,&H5G
MTJ (-BD1@7X/IWWQ1#"9ZC A@A3QOP6HAB!H2!!T/(.<[JI8O)H9SC+:W:&9
M4U4U)D9@#I+NW&/V#P(+B608P[ >>8 >#V@'G2NZTPTEDR-(#?(S@1')Q1P?
M:TJ02!^HIZWW54.& T1","X=.0YQ^358,,.BQJ(\UQ >)3)N)@Y-"#X)QT,^
M4" 9(*Q.1V_K^!B>) *BBCT S>!=[$EW>/:3X_6Q+( '8&TLTW9@0F(J-L/'
M:AR%";_P1_ G@Q9N3HZNOP"IX;4<<CVZQU3A,*WZJ!K&$YEVS\W0ZYK=7Z5/
M[K=S(V9F@K"-LE-!BHLW0_MH6-._-CYKQ5ML37'8./YZ?5QO*L??(BZ<6!-2
M),:.:5R,\R3" M%NA=1:%$*.OYG([1,J3F0LC$0794QRS-=)R"&3-!@!F:H[
MCC<>Q(C;ZFV%K) M 2IP7ACC>(?*++C#_+.(EQQ6[Z+#8?\"Y,FF=<A"4'FC
M,&;Y")+0B(C 4 @'#IIVA< +&F9RGP9.K9TWZNH(C.8(Z&A*N.*6 ]2<<Y+3
MPM5Y!!82;[B9.)/50"Y.SR:8"W'Q^<V^H@,<>T+[2Q!<,X9XNM*=/CUZZ!^V
M?O9_?B[-WNGE=GB>F;W6]HI\G^F9"@([%=,B_=&' %8GHO#Z*+UZ""9W=V?5
M"-*)U)TB=8$FJ6A3Z,F6\8"F$-?.%?769HS;0DU"9Q<?N>7PY(I;+>6S![I_
MB1^__%H_T9?<)%@R8-FV]8B)VV#".;(85];68$(1$]=V9HK_(]9R:R88<!Z.
M1*;R7L&=81C4B(L*F-]W4:U(#'33Y_9MJ?RMI6KC#9%P&L_GB\TSC8DN+V)U
MJB!<)=,_XPX[V$]/Q:W\"PPW"ZB&$KZE;1LH58@4!7^#L<<Y9CZC(:3&9THW
MPZ%>O^MIU7NWNSJPB8##@N2460DI^9&$E"3M9&-I)_F--T)^_122U1XGZXDV
MQG",BR5WQ' "<6M7$9S&YT>5=U+HUT!5 SUMW_=,G%?JE4^4-B)" PWEJ-:H
M7C<:<@O@@K.?C5I#N3@)99M@.DK-WZ:KX\;U69,NN;@\YOO7>'-N.?&E3JY\
MN&B_H)NK\+!T+/2PHH:'T!^>X\C25,(==73>Z\:S(Z>WJ04EK)-;XCC=H#I*
M)54>[KKS3*[XD%J #_5,U=-T<@\'GIA)SA=ZE6FYLD@0P4I#$)>7JNTJM92"
M)*AD%.GS_NK!]PQ15#DF#&J=LFW-5WJD/Y+P.&;[@28,1;K)IW6^B8P5WU;A
M>#'CH_*;Z6 X<&8W'2IF"M6D7^\W]C$?V!/U/SC*XR>>CJM0.S:^M^\;QU4*
M/(9:D!RLOD'/IHAX:[D/=GRT&:8$UIG<">21!9BT*D72)%Q01_E/>;_LMS2Q
M3(IOF!XCKOQ/*1OZ,831XA=HA)Z3R>T79SWHP/^Q,X;V,V/X<"@$=1@RQLC
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MRW\4*M>>(78S>!S]K+S' T.P-OK/0AKCI:T_D)3WDX* *."_MQ*N Z4-877
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ML?%]$\<H/2S<QENT:@YBV:%P-4U5T7A3:!GGQF7?%UH35XX(N(A1^V7EZD1
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MGB9W:KPO9-(^/7P(@H-PJ@8C\?OP.F,SQG%0]%J(-&R"-C9KH=EQ+9D#)E"
M5@UOHB@?)4+B&89$L)@PRRC!;U2Z2JR%D)0-T<$>VB$A4IBRKJ'UD9HPT I6
MWF+^%":=86@IAY@C*7EDG.7V\N.K Z3B-U(U!N*\FW 6());5.GRI6V0\X1B
M5]CHFLY3@46#L5 Z<S33D[P(84;0Y.QI/UJ>@1=G<_NE@D]_I&>_SQ1S(1)8
M+,J43:),KQ5ERB91IC?@S_E3HDR)OC;J21L_R4(6#S]JA%Y&8A)T]-\>YKZX
M*F\)(!- N?4-DMQTHH<)3Q22X0X5_^U'I,1!00<<CRR 9J2V?<=R4#LB,G_'
M#10,J*#/&9T$\N+ PQ5YK0/?<F<$KSH =8>KD-&2'\0:H2EI^V1MC=]_JR,*
MNJT[/C2I7^Y";K<GG@5,F#XP#@IA\5RAMJ%ZFLQ&[ZF@=:"OA=Q5I N(>A=5
M#YHED/Y!"%&$:0ISLUF/M 94M-1['U_=1[#1>1:UVFMYHJ\W!YC"!R.Z%-IH
MJC-M<NC)"*)3?GQN=\</&#H,GH/^2F'4P9C!0/0SI\G_(6J:3 2,CX3Y_*>$
M;#MXD\F1Y7FBV( B8B.Z;AO3P*ADA.?^T=I@T V7%Y/8>)@N,?DV+4*F&6KH
MK2"7?(L!(S.PTGQ('5YS@V58HELTWT5KSR], V,?3'T.X^3()+I;ACT#*$N.
MO/*>V<79H.] I89C?IKTJ%>[RU1M<L32(]\"2203P44<3 7TNW1)$J0Q^95"
MLII.=09[*-] S^[IVAYE]^_)@D)@&.'+YGE]'&Q&1^@N;K/PK"\?>(<BPRI(
M5QWX'19ISVG;C(>30[F*W#/=!D.'AM0EC+!.J*R!JLHH3A8&,)$2SL<R[O*2
M 2IA\D#??Y#M4/J(EC5D(W)4- 8>)-RU\8&3+4B1%Y)[KL"^]H]:/(+.CX^H
M=JEY=5QIGA_7FP+SB4X,^/U;K7%=.:O].@:%J]*\.*]5E:/C9J5V)FF\96F#
M_W7@NB960/W_[7UGC^-(LNWW!NH_"(M9O!E(7?)N]MY]D/?>EKXL*!J)$D5*
M-'*__F5$&E*J:C-O>KJ[=K2[P'95T20S(S,C(TZ<TZN.0^/&:#2IC$*_(HHB
M C/(=B-/'[:Z8JK$X V(H4;(\FT0(R4_>N;* 394FFN(X X(.P,$#?:&YX!)
M_Q\:71'-,BWS(PB:.]23&$P*W7&C^A+Z57U>/0O'8AR/A,:)".YOGD/#AC)@
M%^D9E4Q)6_J-%4=@6"# .D4_B'\++ XB#_%N#>(G1V*U=;*$*;I[H0(B)6FO
M@\[54'7(6D76G$>_?[^&ER2'Z;C(@&, UD>RT%.D%*9!05X\!*XJF:_$_W)W
MK'(J*$ &P41*\Y_*W6H!W-+\H]!'_A-J 2CBDGR (O[*<69Y=QPUG\ .Z@R/
M-,KXU7S2$'K\)1[0N7H.P2M"7WS#27+\:E@\, :E8F')5]V@WGC>U\,B"[Q*
M3@FR[A]9I!U4 %U%@O>7I*\K$KG[JTGC2!]=ZR/$;R7'45D](;DKZ=^%G^!P
MBNFE!&2J2YK0^R45E"U!FE5&-<=:[$IGJI(>;+6E:>15T"-WG.'$);4\F&JO
M%#B"JAN?4N. ]Z0#@G^OF;DIV[A,,]%D/_:CR7??\M"7^T$3TF-EW71M_5.3
M,>F; IN+GWVX#XYY^O#%%X"*%XV%T&05F!-50 1#RF41P2 J1<DFOF:X5B#&
M((<C6D#BTY_3.>>W]R=W6/Y+C$S33>)\_RDC2P>-;+P.+-Y@;7B/3/&0;[X-
M1'4$)NN+6@<GCH2VU;UT$27YXHUDS8-Z]8_HG< :':)^#'4G#2J]N21][&>O
M?DED$'%#J^2"E@IN/SE,0);-HHPU9!%/W"[V4 L%VQ8EPZ&G$T9\;8C*?M41
M>T7RNQGX8V4-A)R@TOSI0W"[\Q5GR2:<X\)5]\[JF\)5Z>1GA*N>>7RZ!SLM
MCTF_L>$2PP\V(95^9KIW25^&X]/:69_32L-9R-^(]=#4$X*P#T-64G)V,@L_
MTRGQ-,A>T!9E/M.B>T6.@)&_T;82DAT1'X0X;I#.#QP<R*Z#'Y?,4.6_-P\+
M.3I=7[?C#V9_DX_L[X_*_B8?V=^_P<'UD?W][]M'"_1P?+OP,A$/%*:G7KR_
M?_DE0-87MD,&#:59&=N#4B/)D+" AHEY@$L%IVGT*9\^_)+P674B"(12 T=N
MX(60+KA,HX_'(-6^X-;7B&!CL('>^7#7OC>5/Q#OH\@$<]YOI67CL=RM$_:F
MFQ2/!:(N;SI*>D"4 ^^YC<<\?>"F2F-#H5]_B<<_&]"\]X;BB8"=OF[HF_)I
M;WJ+[(LR7XJFQI.WG_QY+^D]F,.[M6/,= .V KCSB)T)D#JL+")." %"9ETZ
MN. @-(0'6YIE\Y'O>!A&;2&X!]<VMN %CM"(U5<P#\VT8-:6 X!,%6B_@/\+
M4F+D3(JIW*5*[Z=*-+A:VC3EC:I'$'CU0[:&!1AESJ5):Q4 [P+'#4:&1,-"
M0- %<1Y:[G;79A2)QIIN>HX7^E*J>=1MR^2'>O@K5QQC\BNDH_8&J\&BU7HK
M!EO925O: 0!$@58Z#-?J,J8RU5%!>-'UFPK$AUB6SJ ]NDM+F4E+#7T+J44L
MQP'\JF!C6I*QT.#,@I-1)EXW5G*]&DG21[9](6[F2;(5@-Q ?AV>!!ACTG>T
MMID:!.G!IP\-$[/E*U._J<'634CP@Q:0[FR!7-0O7<(2,R1Q0\AO &+.PS=(
M1$H,E17W\U*G^[9&0K\&PNW 3"RXHSCK%HMK8VT<#@_<3)6VZ.[L-P9>KEC>
MT@7D!@]F_P:U:F\V7:?]P=6!H,S1)'9%*>-T)(YDJ&_8ER&- +<A"HORWGK[
M/6:C*,L=L3OJA( IBI.OC=W..N"-9CS6Q+\H2#I^BR:-JF_!> 82)(@, Z8(
MSK\FQ-GX8@$.GD=UZ(3\X<V"8*$E>";CNJ;"< :O#'GZ<"3.I.4Y(:C*=I0
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MPWW *,5;Z0N*!W3CX6<01(R@B%,DM#55VD?<W01I7] HUV6:P@09&(L-'V>
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MB3]@V<'1XF1-( _J"K01[3#2\T==/<'!!+B2EA:<EJVW0%B,?-4AW66OH&A
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M/[GCS+^6RO&\:8%\57TC6A4(E?U*?!>FK 2#RX-+_!=<N_TW>I1$32'/Q%Z
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M*=91Y^XC=1!@:BY51OG) %J[P%A!0':#H37VPN=0 [0%78DAC:4+#35R2*)
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M.8T:M6YA/!D^NOJO4I'H0]6=!$6UK$KS!H/$@"6?$*L.":UJN&B(Z4\;!'$
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ML3V.^H(J@LVAO4B>G+VU:NY6H^1I_]=%R0<3HF@5+>]I^9@XLX2X^S SHDK
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MIJO#;'E&785T9S,6KX*VNK1]YJ>*\ ?.KU_"Y3]]OHG^&L=E>??+Y'FD%OR
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M:[FDE,Q(0G<?=7$?.:E,E";ONO:O9_]WCH7^__+L?SGVO_T:!GC9]L"+QR8
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MQ9?P,X0CB59U8V9SM8@B3$1/DT9LD;*OAWFK4T]7,^*4MEOATQC%G*"!>KP
M"R!\!TO7&C2_2)?2VE@ )^."RY%R]C1>6>$>7SFU24Z<"VHD .(<S&2#N)CP
M=(=@H$L&H!<_3<K;FR:S,L>D(FF;@66,QTIBIJ7OK\C]O)TT(U9$08L0.R2)
MJ<IWRPP%;3^-^UN(M#"RU3AW=$]O^\%+<0WT.B*=0OU$CM!OD;)P-(37[B"S
M#)R?#[Z++B^RZM6G>X.U8M.:YA#79I#)'3$64&K. HC%2 *&(XX%[*/@FPM
MNO^3]+K2&ZU(VF$6\)N.6+E1!;9+F._.+7Y;:@9'"P17FD>H'\DO=]P[]1A:
M2"J\D)E8<B1TP+8Z&UF"8P@,@AV7<"P "8WILX #^;!E.+JSGDY 6$80MK"
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M62,%7]L^%#/0 'JY("@"BI50/ MXZ4+<8G)_!@D__V5)]?#SH0)A4^V"<"3
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M"F[-T8S!,W([80/*2V<MZ^R53'\81GN\3#Y#C-MC97GT6-A@S  1RQ!*@N"
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M7]3UKVH6&=GNF?,5:'X=H2NF5^AMP'B!JYBZ,3)L?%'46^=;59!B'*.*XDM
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M6(._)4=8@,[9$"S09KO  @(VD6G06U*V4**Q:05SG07T@ -_MJ.;L:0;N,&
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MZ.EO/N=C2!MF5I8:#_WS'+_[+78GQ'SJ,5)-#NFQS0ENA3'% ![F>BK_T/A
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M+!FNX'5=NJ1%JF52?NEB^X)9(,/(8#1_)/U1&LYCY$,%ZC=KZ'\ 4$L#!!0
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M,4[IA.P=*"\IN^=G>78C&@UEIO95[5/O>J3^2QFK R!YE'H7#,EQ;]*["5=
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M+;"8X'O[47U8H^ ,F^7DFND;E=7*9M47.B-+$IRFWL S96!70[4KVT:BT :
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M]=( VUGG\1Q[F#RCAP#?89_/L=<OF.KN4(@>4_C9ARF;AG2$<8%&)5:S3VE
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MC)""S(RP5  12&23,-H=^.-Z"$F)S(AJ!?@ Q#4)'>[,?R-!((;BM849T:A
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M.CU,7*U4^H0+JHJN8Q8 JF0R"Y@SQ=$)S+MDA8:X 8J7RDEVOZ B1*IKHB,
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MYRT F6#!O)UV__[ >VZ7SUZ7@Z>SRDM7^W>9]4]_M6]]LVOZ4ALT/0$C3Q=
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M8ZD'@T;#P/9Y56JCMOJ[2A]Q V>BVJ)XPEFG]55S2RWKC$PFN#5[5((PZ&)
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M!J>"9AW5"[XG!=%4,]P HA:\,&X2AN1%Y>5_;J($OU?Z+Y5URRX-W"ZG)(*
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M@#C\^':/-SBCYPX>\&OQD3SH-\T(PT+7]>C-VIW^8,ZH"(*$0]&JAGHY:AM
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MQ+L.+77\QB8)?'UL:BE (=@0L+)\RJ4$0'(MV:6)H7Z^UJSFEV)R)_0LZ^K
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M<?B%$4UIC78\,;>']B1<YR#"=>/K-,-A5-RD>8[S>QS35*4/:7TZL746E]Y
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ME3[B!KPT0LMZ,F6Q6:[S)H7=%1G4/..0IAB[2S?!(:89O[L>+[.TP&OJ"C^
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MAGPB7U=?D7_1*QG(-_\/4$L#!!0    ( "Z"KU:$JX\\Y3(  #M  P 5
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MZ$8&7_I!JFPU94O"?GQW_>$#.MZ\PY,!_S$ 8)XKBXR[!%<U^+GFIP1\M("
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MQ2P98R4[#XC- 42A[)W"P0$V,C DZ.15[D0@U&D%H<2=PO\!)@X(!SIM^?,
M"%NR\E"23N'G ).D5AZ=F^)<"O>WP_DXA2L#/MI)%$9GPG %>.0R[Q2.#[B-
M -=R9[SM!A$)I^\4_I(Z]+T!TN+''QZIQX$.DM<C("]GRF7 =V+1O21ZS=$'
MR<,G.N(W!>2L5!:&TH&8PD#5?$MXR+UZIB&A7!+* &+6 FG;+8&_NUS&;\<Z
MWL1QEP._YVQ=/FXJPEAD E R$#,9Z%2PA),I"1VNPK+O,%^\+M]=+*)-%#M#
M;LG*7;B*^0,B"V4*,16"@3:6D#9G?/,<L5?(2%95%DH*8@X$1>OKKM6^3]9J
M/ED+3BU;K9FLTN $(B9(4+3^[!?;]ZY/6980D02*(;)<$DH=8LH$:=M;/:8H
M]Y2!G][FF(B$)]0/NF'(W(<H%![[.14[/1$Y13U>^5K!A:B^L=JA_"'F,FQ4
M7TNFO-QNO>LO3<9/O2244L0$B6!=6AA;+4M],HD1?22A>&=FI_!!'I1/Q^9!
MZ?SEX"N7O"AM:7;)BW+)BW+)BW+)BW+)B](J#9>\**=]?/BMYD5I/2V'+9E1
M_LQI.:Q*C7+)RF'KK'W)RG')RE'W"+S5K!RM'?J]F:P<)TER9D5R%'OSG!UV
MD(G#QBPV]V5\RC4A+,XF#341N?RYY$XQP\,R^I+,W]TH?*3,_6/OZ=315I;#
MWKG4Y$L&@)4\#8(@,N4HD\%.FG(4/X>*6\G-. J#T/'%.94900>"V"N%HUBJ
M@ "=JMP\:CY5@82QD[#4":^S?I;*M14^12F%L!=_=6BR=G(JM5$W,TD%L%/
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MBC*2/?B5JI[],Q'/);+IOW  .6^N[[#7V!50_7"8Q)%X$+.%U2IHM\3WI]C
MWAEW_GA=PS6DF:<C@4([]>CDH!T(_\$X& (MK=8+O5*V!"\7 Q\+X[ZQ*-/O
MK)^F'?A/7"6A>])5-.-X16$H>_AW6!6ZHJ^[X$._\>C>Q+Q<XZ/0?H%_=_8$
MV)_QK+K3.AWW;OA.9J5Z)UXJ .T1^/=T-3J?]8@_892K(GJ[G,)\&2AK^%=U
MRYKAF9UDC<2GG*1O'?&VM6$=4/X0[_#6T.H-&.).8[4M%HI!Z<2_^UNI7VNO
MR>_>Z$U[D3S^(GDO75H>"C!B^(Q& TN6M ?\=Y\<UTM,.G?M.'W-_,8)W 70
M B 502G$]_C4Q*@E*]J/P;F6B#L9?!1^JGBT-&V:=IXRK U*'Z*_Y2C]<#CL
ME?N4*7&558!CSRUE2X$+^A":):?*7IK1#)22XE"&\#TT2GVM8^/6]:)0]7Z+
M5 #*"+YO1*,S.B>_$'?]R!O4?2+,69-1).X.CE>E]TPTEF-8#90_?$]&+7QL
M937M? 8O]1A7!&46W]M1$Z,S>3<&D/;GK\T\(F-'\I_+HS*71V4NC\I<'I6Y
M/"K3'"F71V5L>53F1.^8(";X433>DC7U27T)Z*OCBR?!L@?D+XZ$(QP)^'Z@
M8_T(9L?O_",/-""HQ[/V^R!L[13G[8(8KWJ/CK\FP< O9%D^\#Y\8^A]$,Z'
MWD_=T>?^K#,8=?K_^#*8_XJ>:+B<4]HHT[!*_.*'."K5L)Z9BU?"PFVPG5Z)
M2_9"5?9"/ _%)7NA*GOA-\C^BI8SYK6_)S-@PM[,>=WETA7(.=[$<9<#O^=L
MW=#Q=+QHQ*S9>!EP!$("G:\I";D1DV6VX=<1)2MOS2[(@"&U[NC45"05T;&C
M$,%^][(.05H$T#FJ#GC7T:26PGXNLPY3$!Q:"R8O;KT&_L*+A MC0ED,FN*.
M0K"[55U!5Q*YW53UUBPTI(ZB9O4]TJNX)<REPM'#PC=\\0/=*ZB[]W%^KN"X
M!T_)-F*+1R<@R]N(B<X;=Z<X$Z1J+ZT5M6:AHR,6#,-97\NZ=WW*XD$J&7=N
MR4(L&HBX&WPKWNT1(Y6X%"R[G/:3-+@^_41S7[!F":;K.DV#>M8][/#23[V+
MH%5C;:/W0?%3NM:&J:W7"$66#<^+@<I./B5+O.JBV ^DPY9K*C4Q9W%9*I)T
M-AJO>*?H@2]1Z\7L?T4=IH>US)W)-NM?'\_A1?:F-6YDJ]7WBQ.M1>?\P7C5
M<X+'.X\^[]$\..+_MLX%@UYW]E/G;CC^98:?J38?TY"I:G2^7R&%MF02;9DP
M^N1R]F]>OW!:!_[N3?ON(G2?7/%&M%Z_.G79$O:H(+*\>JJ)&+H+M*47:MIW
M@\'943Y5@W7.]N\H>1TM?LN**Q)/-',Z)7R66+@>.5B0SVEC!MG^EZWQG<%[
MR*GH0.]W\9N5MX13LG 30OQE=R/6*W_$_Y3W&[TDMFOM9"16/ ,*@!2?^TRU
MH7 &344TZ7C%M>X& 0GS+=:_X6I<$[;O#*MOU(2\):=*K%# /W='V8VSO"4/
M\CROE46QW5FGIE&.A"4V?9ON$XW?C=0*8OO/D"P6"&A+!OK9<?VQZ&AK]XE_
M4%R#FVRW0^I43<Q"0B6 [5/#,%8]@&=]F,'1BD]RLA.=/#YB2@&L_PVJL,81
M!U_(&P.$/H*76]Q=)&G%N9D0]TE]LP(FC9U'T9P5':MRC-Z8?>\55/AG-&+H
M"1V;Y[\"%DSBI4D:BNV.#XVXHHG:DDE=+X:>'[(VHS#]\!EMP91%1@2??Z@Z
M Z44V ,Q](R3S9MR!2QOC/@)$RDVEUJWBEX2/:=E\_17@_/&>D"6*F@1,0&R
M=/27HUQ= 7J2S.;[@Q*JM]8M=NY!UWEP/> )CFD]Z"DXF]W'*;"R>#,W<5[K
M[N1VHNC9.&NR MW,%3 ZZRAVR<#62T:U'%K&LT!5%>C)0%OJ&1K,WEH/J8#L
MV&G @HR<;?4-!5JM)5TL-N+.]1U_H:6L>M=;+8R> /,XODQ4Q5_4P1TW41#2
M#6'=Y9,(V89[;HIRZ/DWVZ!7@HZ%<=!RWU,="ZZ41<_1V0K#<I3L7'6SB/>U
M>O-HE31Z@LWVUMX2I-!IA0?5RLDUJ0,]8V8C%)NCAI>WL:TNDN0>;B9275F7
M/>DZCXY5!V"&/B),G-<XG&1.NXO?(Y<1K@3OU^'KQ'/\L.LOQ46<K2@BI]FD
M#O1LGD=P16MK;>VJ_.#Z7<655&DLHUX./='G\4P#-<5GM_EA@*OG^&OWP2.Z
MDQ6 *'I*TO:,7H;36?<&.%Q-S/T6Y#MMK'^8(_?VEHH[QU0#2T5E7?;D63UZ
MJ0C #'VI."7;=/03<V%(] =P<@GTI*M'\%!\,E&-REE/!-ET=T?9_MTDWMDI
M'\]8*&:]PQ3!^E4"O";TK*^-=9&Z*+Z)KB/2*0C\_&50?$1)WUN4PNA):!OO
M( "LSKI/P %K8J%@09K;QGJ(.7)GO*X4FHK_$PZ4)\<C\:4$\<;:@G=@\8>N
MOSS\1:YD\IQ?T>_;?TD?DN$_Q-E1IMP8^JL54:U)3]T.]-R]C757' ;_K%V^
MI1X,[Y"G=M:>N$,>W;]L>;C7QEYF\#S9IU.[BD_<S][*NV6W)%@P=YL\P'@3
M!:ZX-<P5%[GUQ.WAW'=V"A\\7/9=YZISZP8+CP81(^(?_5EO.IC,!^.1>*/L
MYLML,.K/9IWNZ+9STYT-XI?+)M/^K#^:=T4IG/?*TJC;^+TZSUW '@]2R.",
M$AEC.1JKR9OS3G'C*;?]=>I"?JM,3V+!YNOCA9U(<!9M-@Y[':]F[MIW5^Y"
M'%R6U*^VT>^+-CK[<G_?G?XJ+'$V^#P:W UZW=&\T^WUQE]&\\'H<V<R'@YZ
M@_[L8IQ'/(FH8@I@D%#Y<S-",URP#:]\U_Z>+'GCO?TO^!!R[_C..CY?X/^(
MX_;O"*FZGY\WS.L/1<-,+7#6F?9[_<'/W9MA_S\Z]_U;;I_#W._BR?2^.^I^
M3O)]BG^.YS_UIYV[?C\OC&.^N>OI>KNM+(QCL.*AE" ^&)@S9TDR)G,MW),%
ML-^:U2&;LX*\@AT?!1>V6>\B O>Q^<)U43V#7E\7#74\Z4^[\4SY?YS-]F^=
MN\&H.^J)?P_[W5G->5,2^+/_L*S1"BL3-9A4@&1Y?$U&]JU+&@4Q,8T<EBV9
MHEYM7R!0L VIZ@&# ]OY6+2=P>AG/FF-IVC+RZS)K_MF0>X=*X2P(O]+30+8
MC%H*>?8!4%,*ZM>#@&TC\;PH#3\[L)9/I9DF7M<-1O/NZ/,@7OO-9OTYDN5\
MIG3Y['H>G^N+ZIC8DF$U6-8E:QG(R #"R+96B\R2]8%!LL((%;>I#\SPZVHS
M['V93L6&:SCHW@R&@SG:%)9&+@E7;7R'R?$ 6RVE$-)+\(>/'Y3O8V6[BMRO
M]KRD; +LL>GO()LN@/[B&^^M (UMTS.R3GTN4^*)F)F!OZ)L(S^ON/YKR1?:
M_[SSH4S[PSC-RF!T-Y[>(YY.I'I-R58\DNVO 9E4I!)(SL]">XQF3Y P=IX4
M#45%IR<<#W2CBK9;+_9E.EX6*ZVUJV_*9PR3R3!V3W:'^TQ%%IA6A7;]Y!>0
MA$4@:;R0 =&>?!OWE$#<*? :L(W/@,2*8W\3E+"M462.=Y-WQ/DT)QXBX*,'
M\:6G?=??%BVQ-[Z_'\R3K&%BENN-XS.^_@CO@$^AE,D^TK :)+.$-!)BG(;U
M()MH+8J+MEH+.FR+W25/D%EH*69F,.(VVN_,N__$<XFF;39SB2J$T!Y#*38)
MY*U12:&[1+74E-\YT8* ;22SZ"$@OT>\KO[30>#F@:541*[<S/K_^"(V;'UQ
MBH!D+L760Q:.,@FD_5FA/9!=F5P$?3FHIJ.X%]/ICF\<D& O9=#7QU)L"3SH
MJ_.7K&JD9+)O(_YKGPJ8]X>X4:^@99Y*ZMQBO2 86'!;F@\#$1&)F;BY&;$%
M$,5.&6O,&1@.=.+Z#O-%.O$)8;-'C@68-JT@=A978]* 4*!3-B+/.=T8]?F/
MB\1QDS09S*%Y3>@I6DU)K0O6>:Q?YH<)C Y6+Z6 .Y/52U+Q9>URS/9@\4B6
MD4?&J^+ (BY+++K^\M;UHI L8ZPAFX>Z%9[;BN=(Y+!-MYEP=Y5IE^(!FPYZ
M1QX SC7Z?=]Q>XQ3'HJLI(+3^%Q]3G>QJ[DF[Q/5F \##7SD;"+E6X"VI3?^
MY^)Z_9VS2"- QL\^68Y98N[ZL5Y4850#]MX(0*&Q3JWRL^])$PX25Y"/N^E^
M#<2.@3SV%@C(C3$BV#.L[#: :LXL1P5K[I\<-P>>[4442<,K;U)D@6ZO]TX8
MB?>;0 94KZKSO(=27U\[+"UW-45E7*58W]P%%>2UY%NYJ;(?I'>-Z]5=..IJ
M0#^N-;W!8@H.MEE5WF91&5@IYE9RIP79V/Y,EUOR?>ZPC;S9F09U;!-<V1NX
M_'($B%;8</DRC,J*2Q&^TBLQR';\5N[&[+M7\?)&VL:#^QOFQEJGUK.[]]($
MB-C&JKKEHK+84B2PYJX+LMV^@4LON\Y6;%F.L9O7](]&QFI8(79 EN'EF.-P
MP[9/@T?T;DGHN%XP<IC83S]5OPOT\?A']3I_2;_4V7WJ<AYZC&5GZ2/FZC0*
MQ7(Z.RQU8$L.,0MJ[/SP'] )X)9*!OQ'Q2.G567M(**Z&\G SS4_GQ<7F0#Q
M"FKXVJ.;+?7C8-L7%\)%M=@YTE*M2>ZH"BD8[K!9MW3CN+Z<&$EQRPA1=;9B
M!%RU0ON53I,G"KUR=KE[LGD@K )P(: HCWT&JNPW^:, K<[XP865:?^DQ&11
M=DHI[&-0$#T@35H]F/YILW#$N3@+'MWMS/U#.,4VXHEKQ]L'"\T(>W(71$1$
M+4AEFE)15[VJL'<\TO5)WH2.0:DEXG;-R;I+=Q6*1QPY#([O_A'C=T?93\3Q
MPL=](WN4\2V:D^QYNANN M=L-2+/WFO_9>N(K=-/RXV:Z--\&GM\A?6,4])P
MJIXT7HV9NW9]QTN2*E+&=\.\.=#N()?''I1K<JH#I"5B;EU&%F'=_,%@:>SP
M>A@IAF"@KVF2^?^>A(\BT8[H-7$6RZQKI:;-AP/=4A]4!9##]C.Z2SDTUZE5
MV]H;<M'8)>:D$@"BWUH.'Y@%Z57&=LC"[I]<%0/TKU*?:;53]H@L"KQP]JT.
M_U@G_AK_9>:DO;AF+Z[9BVO6$I?3Q35[<<U>7+-GX)IMY&4NZL=YG'4^PHJB
MV'M0$\>@5%/T[<VN._4\)^"[X;B-P'&K+&*9B8#&K+(6N9Z#9!BY)ND&JZJR
MEM$@ZUI%(ZG0Q(XA*FY9#S9&'9;%]LG(>U+E"%6E:$L;]Q$)DW?2Q&7,[A/?
MAL6Q?S0W5#Y2CZ,37]N6;.9-*SF+0XIZR*#/)+\0=_T8DF7WB3!G34:1Z$2\
MZXF]=C".PB!T?)&46L9G6H]A-?:?+M33JT2J89INP@)R3 )EB=56OJD@\US+
M"F.OW&!FJ%:UI5%1TDO2)RM*G46&O'DUV!,5C).Z\+3$5H_ZO"&AN'>2S)SQ
MX"P/0:DL;+_+7]5Z1&LH&F@M6RA7<AZ' /6@05\D%!N6ME?ABY$) &GZ!GWB
MUZA<>XKGQ#_0TB1OX3D/*.;^TU'OI5Z"[9O4@N\^6);<(=ESQ!-K-PR9^Q"%
MV6Y$3 A!'/@RR3JN;/Y+:SZZXG-[C*PA)+'/<YMYE.QJ2/WUG+!-N3K5P>^G
MTEN$C3]8=M413>N(MG6RQG7VK<,^)S[_%\TR4.-LU7'>:MY%*I[=TATAUZW0
M#H=HG0?+#!7%/XT^:#!O:]SF?3M+JR5YKD!]#7;0>F0WER0*U&N/?_ -U??F
M-:<[;X_Z?.FX6M]\GS!&!/WX_;!1N@.MZM)VT-I$AR^]]EZE+O:Y5]6*3WWZ
M)9? =M&KNI_$T&1JH_M/;FGT$*XB3\=&L1RVR]V @VH56_(PE@E/;__$CWUL
M'3?>PT@\BU!A.W:MX!59WLUHAD_#OJQV"!Z1,'W&9>*P\!7,;4D.>UQKEE<)
M+"W97<E_(*&AHASV4'8,[%*U+;2<:G?.B/JY;N)*QT:P-/;!XU%TFD'4EBV)
M5LC=;FE;TJXW$5X'<;N5VWO7\^@S7[JJ23RV9NSSS:,);@;:<S[G.97_][K:
M =Q^Q@JH [AS?7$!F^;@B[^?HSHB8Y_,Z?R9_DH<IO #063/)@4%' CT/69E
M4WDK>5/Y%T@=UDK2V&OG(XF3H&$I=:*=<WI'(U:+NY(X]@K\6/(D>*"S5YX7
M;US/(\L[RK*I,U,H&+,)HVOF0 Y23.O#7I+#^3T.L;=QK*X\.R\E+FD^V=?E
M;+R6(]<-G/6:D77Z=DP^98["K:N4LN.,!&Z]:FWPC[(E[2OM&,$\#6T[NH;T
M0AAI0YO.I9-7FGH<@7'N^::TI3,^[_-]N?H,&E[#V1()5Q'] !G25-VQLDD=
M=G!JVHMK\-OV(YV;#6$+5SRWQ9<?PAV6YNP3K=*\UPD1Q=Y%FO?+PRL5<'A:
M/89AZ;K372HYD17&WBX<QX(:@K8NME#V&V&!>#R ^$'<W@G_-XU?IOMWQ%Z5
M1("EL:^R',>,(4AMO:HH=EP'359R(R\.).-;.\G0P= 2^J6<HB,2CE?9GCYR
MO/U!2YS9.XAWU!)NZE:&[&2&;D/R=!V'VYMRC&CN'96R3[;F(4&_G83D*Y&9
M]NZ)R/%JL@CB^).XJ]X2QC%:WG$[&-&5$WF"W\.1?\)H2!:BG_4\QZW<B<=6
MT.@G[#]K:E[G=@?W7%/YT!10SUV*\_1]FT5C]V:N",6K5Q7V_J$&I:8X80_E
MLIS'5_%_)LZK:'"@]&&7TY?JDF]?=>+:.UGU1SJISS8=]Y_U;<_CTFY+=,+W
M1U\>^D3V*R?/,NW;)CXBL%.ZDI5"9T2)4@]T%[&D=3JOL$;,#GH W0[&5;ON
MWMTX>S"UJ[TE2A'LY1FH3QTX20 (M+26/IS;0."K1;"#?(S!AR" 'N(S)$%
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M0)8-JX&R:[_;4,>J+:_M3!*$?W:\B.C"6"N+0BE#SJJBTK.M,+.*3QX>%AD
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M4$L! A0#%     @ +H*O5MU.)@5 8@$ P^\1  X              ( !
M &9O;F%R7S$P+7$N:'1M4$L! A0#%     @ +H*O5EJ=@;@V"   #5(  !0
M             ( !;&(! &9O;F%R7V5X:&EB:70M,S$N:'1M4$L! A0#%
M  @ +H*O5A2A'V[>!   M2,  !0              ( !U&H! &9O;F%R7V5X
M:&EB:70M,S(N:'1M4$L! A0#%     @ +H*O5HU=FG#W-0  :#@   X
M         ( !Y&\! &9O;F%R7VQO9V\N:G!G4$L! A0#%     @ +H*O5C,?
M:P=A#P  59H  !$              ( !!Z8! &9O;G(M,C R,S S,S$N>'-D
M4$L! A0#%     @ +H*O5M[@YTG+$P  <?X  !4              ( !E[4!
M &9O;G(M,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0    ( "Z"KU::O+0\LR<
M #&% @ 5              "  97) 0!F;VYR+3(P,C,P,S,Q7V1E9BYX;6Q0
M2P$"% ,4    "  N@J]60K. I(Q*  #?^ , %0              @ %[\0$
M9F]N<BTR,#(S,#,S,5]L86(N>&UL4$L! A0#%     @ +H*O5H2KCSSE,@
M.T # !4              ( !.CP" &9O;G(M,C R,S S,S%?<')E+GAM;%!+
4!08     "0 ) $<"  !2;P(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
